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Characterization of Erv2p and Pdi1p, two thiol oxidoreductases involved in 
protein disulfide bond formation in the endoplasmic reticulum of 
Saccharomyces cerevisiae 
 
by Andrea Lages Lino Vala 
 
Abstract 
 
Disulfide bonds are essential for the folding and stability of a variety of secretory 
proteins.  One well-characterized pathway for disulfide bond formation involves a 
membrane-bound oxidoreductase, Ero1p, and a lumenal protein, Pdi1p.  In a sequence 
of thiol-disulfide exchange reactions, Ero1p transfers its oxidizing equivalents, obtained 
from molecular oxygen, to Pdi1p, which in turn transfers its to substrate proteins.  
Consistent with its proposed role, a conditional allele of ERO1 (ero1-1) is DTT sensitive 
and has defects in disulfide bond formation.  Furthermore, in this strain Pdi1p is in its 
reduced state, while it is oxidized in wild-type cells. 
Using genetic and biochemical assays, we isolated and characterized Erv2p, a  
small dimeric FAD-dependent sulfhydryl oxidase that that can generate disulfide bonds 
in the endoplasmic reticulum lumen of Saccharomyces cerevisiae.  Overexpression of 
Erv2p suppresses the growth defect of ero1-1 mutants and the DTT sensitivity at the 
restrictive temperature and restores disulfide bond formation in substrate proteins.  
Mutagenic and structural data show that Erv2p uses an internal relay between 
two conserved pairs of cysteines to transfer disulfides to substrate proteins: the FAD-
proximal active site pair of cysteines and the C-terminal pair of cysteines located in a 
flexible tail.  Oxidizing equivalents obtained from oxygen are transferred to Pdi1p via 
these pairs of essential cysteines.  Site-directed mutagenesis of the Erv2p tail suggests 
that tail cysteine residues and their spatial localization, and not the other residues, are 
required for Erv2p activity.   
Furthermore, the shuttle mechanism seems to provide specificity in the disulfide 
transfer by preventing direct access to the active site cysteines.  We found that 
mutations in the dimer interface that convert Erv2p into a monomeric protein bypass the 
need to transfer between two pairs of cysteines.  Analysis of the activity of various 
mutants suggests that converting Erv2p to a monomeric form yields an active but less 
specific protein.  Thus my work suggests that the Erv2p tail confers substrate specificity 
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by preventing access to the active site cysteine pair.  This mechanism seems to be a 
common mechanism of disulfide bond transfer since it is shared by Ero1p and members 
of the QSOX/ERV family. 
To better understand the role of Pdi1p in disulfide oxidation and isomerization 
pathways, we isolated and characterized temperature-sensitive mutants of Pdi1p.  One 
set of pdi1 ts mutants is impaired in CPY maturation, indicating that this mutant has 
defective oxidase activity.  These mutants are trapped in mixed-disulfide complexes; 
therefore they will be invaluable tools for identifying Pdi1p substrates and subsequently 
studying the mechanism of interaction between Pdi1p and substrate.  The second set of 
mutants accumulates a precursor of CPY, suggesting a novel role for Pdi1p in the 
translocation of secretory proteins into the ER.   
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Caracterização da Erv2p e da Pdi1p, duas oxidoreductases envolvidas na 
formação de pontes persulfureto no lúmen do retículo endoplasmático de 
Saccharomyces cerevisiae  
 
Andrea Lages Lino Vala 
 
Resumo 
 
A ponte persulfureto é uma ligação covalente simples formada a partir da 
oxidação de grupos tiol (ou sulfídrilo, -SH).  As pontes persufureto sao essenciais para a 
formação e estabilidade de uma variedade de proteínas da via secretória.  Previamente, 
vários estudos definiram quais os intervenientes principais deste processo.  As 
proteínas envolvidas neste processo possuem um centro catalítico onde ocorre a 
oxidação e redução reversível de dois resíduos de cisteína.  O processo de criação de 
pontes persulfureto é devido à acção conjunta de uma oxidoredutase localizada na 
membrana do retículo endoplasmático, Ero1p, e de uma proteína localizada no lúmen 
do retículo endoplasmático, Pdi1p.  Numa sequência de reações de intercâmbio tiol-
persulfureto, a proteína Ero1p transfere uma ponte persulfureto, que obteve do oxigênio 
molecular, para a proteína Pdi1p, que por sua vez transfere esta ponte persulfureto para 
proteínas substrato.  De acordo com a função proposta, um mutante condicional do 
gene ERO1 (ero1-1) é sensível a agentes redutores, tais como o ditiotreitol, e tem 
defeitos na formação de pontes persulfureto em proteínas da via secretória.  Além do 
mais, no mutante condicional do ero1-1, a proteína Pdi1p encontra-se no seu estado 
reduzido, enquanto que em células wild-type encontra-se no estado oxidado. 
Com a ajuda de ensaios genéticos e bioquímicos, fomos capazes de isolar e 
caracterizar a proteína Erv2p, uma proteína de tamanho pequeno, dimérica, e que usa 
FAD como grupo prostético.  A proteína Erv2p possui actividade de tiol oxidase e é 
capaz de gerar pontes persulfureto no lumen do retículo endoplásmico da levedura 
Saccharomyces cerevisiae.  A sobre-expressão desta proteína suprime tanto o defeito 
de crescimento do mutante condicional ero1-1, como a sensibilidade a agentes 
reductores e restabelece a formação de pontes persulfureto em proteínas substrato.  
Dados estruturais e estudos mutagénicos da proteína Erv2p permitiram demonstrar que 
esta usa um sistema de transmissão em cadeia de pontes de persulfureto entre dois 
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pares de cisteínas conservados.  O par de cisteínas activas localizadas próximo do 
grupo prostético FAD transfere a ponte persulfureto para o par de cisteínas localizadas 
numa região flexível da parte C-terminal da proteína da outra sub-unidade, e deste 
último par para as proteínas substrato. 
Estudos em que a proteína Erv2p foi mutada em resíduos específicos da região 
C-terminal sugerem que as características necessárias para a sua actividade de tiol 
oxidase sao: 1) a presença das cisteínas da região flexível da parte C-terminal, e 2) a 
localização espacial deste par de cisteínas.  Mais importante, este mecanismo de 
transmissão em cadeia de pontes persulfureto entre dois pares de cisteínas 
conservados parece conferir especificidade à transferência de pontes persulfureto, pois 
permite prevenir o acesso directo às cisteinas activas localizadas perto do grupo 
prostético FAD. 
Descobrimos que mutações na interface dos monómeros da Erv2p convertem-a 
numa proteína monomérica e eliminam a necessidade de transferir a ponte persulfureto 
entre dois pares de cisteínas.  A análise da actividade dos vários mutantes sugere que a 
conversão da proteína Erv2p duma forma dimérica numa forma monomérica dá origem 
a uma proteína activa mas menos específica.  Deste modo, o meu trabalho sugere que 
esta região flexível da parte C-terminal da proteína Erv2p confere especificidade na 
transferência de pontes persulfureto a substratos, pois previne o acesso ao par de 
cisteínas activo.  Este mecanismo parece ser um mecanismo geral de transferência de 
pontes persulfureto pois é tambem usado pela oxidoreductase Ero1p e por membros da 
família QSOX/ERV.  
Para melhor entender o papel fundamental da Pdi1p no processo de oxidação e 
de isomerização de tióis, isolamos mutantes desta proteína que são sensíveis à 
temperatura.  Foram obtidos mutantes da pdi1 sensíveis à temperatura que foram 
caracterizados bioquimica- e geneticamente.  Um dos grupos de mutantes de pdi1 
sensíveis à temperatura é deficiente na oxidação de proteínas da via secretória, tais 
como a carboxipeptidase Y, sugerindo uma deficiência na actividade de oxidoredutase.  
Uma vez que estes mutantes estao em complexos estáveis com o seu substrato, serão 
uma ferramenta valiosa que permitirá a identificacao de subtratos e o estudo em detalhe 
do mecanismo de interação da proteína Pdi1p com os seus substratos.  O segundo 
grupo de mutantes da pdi1 sensíveis à temperatura parece ser deficiente na 
translocação de proteínas do citosol para o lúmen do retículo endoplasmático.  Estes 
estudos atribuem uma nova funcao à proteína Pdi1p. 
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Initial studies of disulfide bond formation 
 
Pioneer studies by Anfinsen and colleagues on in vitro protein folding 
demonstrated that the presence of oxygen or another strong oxidant, such as 
oxidized glutathione, is sufficient to promote disulfide bond formation between free 
cysteine thiols.  However, disulfide bond formation in vitro is often a very slow and 
inefficient process, requiring hours to days (Anfinsen et al., 1961).  In cells, this 
process is more rapid, suggesting the existence of catalyst. 
The formation of disulfide bonds is a critical step in the folding and maturation 
of secretory proteins and cell-surface proteins.  The formation of disulfide bonds 
influences the thermodynamics of protein folding: disulfide bonds stabilize the native 
conformation of a protein by destabilizing the unfolded form.  In vivo oxidative folding 
is a catalyzed process that is possibly coupled to protein translation/translocation.  
Further studies by Anfinsen and colleagues lead to the discovery of protein disulfide 
isomerase (PDI), a protein that can accelerate the oxidative folding of ribonuclease A 
(RNaseA), a protein containing four disulfide bonds (Goldberger et al., 1963).  Since 
then, a variety of other proteins involved in disulfide bond formation have been 
discovered and studied and entire pathways of disulfide bond formation have been 
described (reviewed in (Sevier et al., 2006a; Thorpe et al., 2002; Tu et al., 2004). 
Recent studies have made it clear that the role of disulfide bonds is not 
limited to structural stability.  Reversible formation of disulfides takes part in the 
catalytic mechanism of various enzymes, in the regulation of enzyme activity and in 
signaling cascades (see review (Biswas et al., 2006).  Some proteins, such as 
ribonucleotide reductase, cycle between a reduced and an oxidized state during their 
catalytic cycle.  Others, such as OxyR, use the redox state of the cysteines as a 
redox switch to modulate protein function (Biswas et al., 2006; Ghezzi, 2005). 
In this chapter I will review the current knowledge on the pathways of 
formation of disulfide bonds. 
 
Chemistry of thiol-disulfide exchange reactions 
 
Disulfide bond formation is a two-electron oxidation of two thiols, in which two 
reducing equivalents are released (2 e? + 2H+).  Biologically, the formation of disulfide 
bonds is linked to the reduction of molecular oxygen.  The reverse reaction, the 
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reduction of a disulfide bond occurs at the expense of reducing equivalents, which 
are obtained from NADH or NADPH (Gilbert, 1963). 
Thiol-disulfide exchange reactions provide a mechanism for transfering 
reducing or oxidizing equivalents between two thiol-disulfide pairs.  A thiolate anion 
(?S?), formed by deprotonation of a free thiol, reacts with a disulfide bond of an 
oxidized species, resulting in the formation of a transient mixed disulfide complex 
between both species. In a second thiol-disulfide exchange reaction, the free thiolate 
anion reacts with the mixed-disulfide bond, thus “resolving” it. The net result of the 
thiol-disulfide exchange reaction is the oxidation of the previously reduced species, 
with the concomitant reduction of the initially oxidized species (Figure 1A).  In vivo, 
oxidation, reduction and isomerization reactions are catalyzed by cellular thiol-
disulfide oxidoreductases (Figure 1B). 
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Figure 1.  Thiol-disulfide exchange reactions.  (A) A thiolate anion formed by 
deprotonation of a cysteine residue reacts with a disulfide bonded species through a 
nucleophilic substitution reaction.  This mixed-disulfide is a transient species that is 
resolved by the attack of a thiolate anion, resulting in a reduced and an oxidized 
species.  (B) Three types of thiol-disulfide exchange reactions are possible: oxidation, 
reduction and isomerization. 
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Oxidative folding in the endoplasmic reticulum of eukaryotes 
 
Proteins that are destined for the secretory pathway normally contain disulfide 
bonds while cytosolic proteins are devoid of them.  Disulfide bonds are formed in the 
endoplasmic reticulum of eukaryotes or in the periplasm of bacteria (reviewed in 
(Frand et al., 2000a)).  
 
The main pathway of disulfide bond formation requires Ero1p and Pdi1p  
 
The main pathway of disulfide bond formation in the ER of Saccharomyces 
cerevisiae has been studied intensively.  Disulfide bonds are formed in substrate 
proteins by the concerted action of Ero1p and Pdi1p (Figure 2) (Frand et al., 1998; 
Pollard et al., 1998). 
The ERO1 (ER oxidoreductin 1) gene was identified by two independent 
screens: 1) a screen for temperature sensitive mutants with defects in export of 
secretory proteins from the ER, and 2) a screen for DTT sensitive mutants (Frand et 
al., 1998; Pollard et al., 1998).  The ERO1 gene is essential for yeast viability (Frand 
et al., 1998; Pollard et al., 1998).  Ero1p is a 65 kDa flavoprotein that is localized to 
the ER membrane and possesses eight potential N-linked glycosylation sites (Frand 
et al., 1998; Pollard et al., 1998). 
The conditional mutant of ERO1 (ero1-1) not only exhibits a higher sensitivity 
to external reductants, such as dithiothreitol (DTT) but it has a constitutive unfolded 
protein response (UPR) (Frand et al., 1998; Pollard et al., 1998).  At the restrictive 
temperature, this mutant exhibits a complete block in the maturation of proteins 
containing disulfide bonds (such as carboxypeptidase Y (CPY) and the GPI-linked 
plasma membrane protein, Gas1p), yet it has no defect in secretion of invertase, a 
periplasmic protein that does not contains disulfides (Frand et al., 1998).  Various 
other evidence suggests that Ero1p plays a role in disulfide bond formation: 1) at the 
restrictive temperature, the ero1-1 mutant is no longer able to oxidize CPY, 2) Ero1p 
is found in mixed-disulfide complexes with Pdi1p and Mpd2p, two proteins that had 
been previously shown to be involved in disulfide bond formation (see below), 3) at 
the restrictive temperature, the ero1-1 mutant Pdi1p is mainly in the reduced state, 
and 4) overexpression of ERO1 gene leads to DTT resistance (Frand et al., 1998; 
Frand et al., 1999; Pollard et al., 1998). 
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Mutagenesis studies have revealed that two pairs of cysteines, Cys100-
Cys105 and Cys352-Cys355, are required for Ero1p activity, as assayed by viability 
and CPY maturation (Frand et al., 2000b).  Recent elucidation of the Ero1p structure 
confirmed that through a series of thiol-disulfide exchange reactions, Ero1p receives 
its oxidizing equivalents from oxygen and passes them on to Pdi1p and/or Mpd2p 
(Frand et al., 2000b; Gross et al., 2004). 
 
dithiol substrate ?[Cys100-Cys105] ? [Cys352-Cys355] ? FAD ? O2 
 
Ero1p is a monomeric flavoenzyme that contains a core domain formed by a 
four-helix bundle (helixes ?2, ?7, ?8 and ?3) and two extended flexible loops.  At 
least two different conformations of the proteins were observed in the crystal 
structure: 1) one conformation in which the cysteine pair (Cys100-Cys105) in the 
flexible loop is near the cysteine pair (Cys352-Cys355) proximal to the FAD cofactor, 
and 2) one conformation in which the flexible loop is displaced from the core  (Gross 
et al., 2004).  The crystal structure thus showed a snapshot of the mechanism of 
internal disulfide transfer in Ero1p: oxidizing equivalents flow from the FAD cofactor 
to the active site cysteine pair (Cys352-Cys355), from active site cysteines to the 
loop cysteines (Cys100-Cys105), and from the latter to substrates proteins, such as 
Pdi1p. 
Mutagenesis studies have demonstrated that Ero1p uses an internal disulfide 
transfer mechanism to impart selectivity to protein oxidation of substrates (Sevier et 
al., 2006b).  Mutants that allow substrates increased access to the Cys352-Cys355 
pair presented a higher thiol oxidase activity toward small thiols (Sevier et al., 
2006b).  Interestingly, the most divergent regions between the Ero1p homologs are 
found within the loop region, which contains the second redox-active cysteine pair 
that interacts with PDI.  The differences within this region might facilitate the 
interaction between Ero1p and specific PDI homologs (Sevier et al., 2006b) 
Similar disulfide bond formation pathways exists in higher eukaryotes, 
although the number and/or diversity of pathways seems to be higher.  
Schizosaccharomyces pombe contains two homologs of Ero1p, SpEro1a and 
SpEro1b, and three PDI-like proteins. Like Ero1p, they are membrane proteins that 
are required for disulfide bond formation (Kettner et al., 2004).  Although both 
SpEro1a and SpEro1b are able to complement the growth defect of an S. cerevisiae 
ero1-1 mutant, SpEro1b can suppress only at low levels, because it becomes toxic at 
higher levels of expression (Kettner et al., 2004).  Furthermore, a S. cerevisiae ero1-
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1 mutant expressing SpEro1a is sensitive to DTT, while ero1-1 expressing SpEro1b 
is DTT resistant (Kettner et al., 2004).  At present it is unknown whether these 
proteins are required for disulfide bond formation in specific targets or if they have 
overlapping activities, but the previous results suggest that the SpEro1a and 
SpEro1b have different activities (Kettner et al., 2004).  
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Figure 2.  Pathway of disulfide bond formation in the ER of S. cerevisiae.  
Disulfide bond formation occurs in the ER of eukaryotes.  The membrane 
associated protein, Ero1p and the soluble protein, Pdi1p are the main 
players.  Together they transfer oxidizing equivalents, through a series of 
thiol-disulfide exchange reactions, to the substrate proteins that traverse 
the secretory pathway.  In an alternative pathway, which seems to exist 
only in fungal eukaryotes, Erv2p can function together with Pdi1p to 
generate disulfide bonds in substrate proteins. 
 
Two human homologs of Ero1p have also been identified, HsEro1-L? and 
HsEro1-L? which have 48.5% and 50.6% similarity to ScERO1, respectively, and 
50.6% similarity between each other (Cabibbo et al., 2000).  Both HsEro1-L? and 
HsEro1-L? are integral membrane glycoproteins that are localized to the ER 
(Cabibbo et al., 2000; Pagani et al., 2000).  HsEro1-L? and HsEro1-L? differ in their 
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tissue distribution, and while regulation of expression of HsEro1-L? is mainly 
controlled by cellular oxygen (Gess et al., 2003), the expression of HsEro1-L? is 
induced by the unfolded protein response (UPR) (Pagani et al., 2000). The different 
tissue expression and conditions of expression suggest that HsEro1-L? and HsEro1-
L? have undergone functional specialization in response to different demands of 
oxygen tension and high throughput protein folding (Dias-Gunasekara et al., 2005b). 
Both HsEro1-L? and HsEro1-L? suppress the growth defect and restore CPY 
maturation in S. cerevisiae ero1-1 (Cabibbo et al., 2000; Pagani et al., 2000).  Both 
HsEro1-L? and HsEro1-L? form mixed disulfides with PDI (Benham et al., 2000; 
Mezghrani et al., 2001) but do not interact with ERp72, ERp57 and P5 (Mezghrani et 
al., 2001).  HsEro1-L? can form complexes with PDI, ERp44 and PDILT (ref in (Dias-
Gunasekara et al., 2005a; Dias-Gunasekara et al., 2005b)  
 
An alternative pathway of disulfide bond formation is present in fungi 
 
Fungi contain a second pathway for disulfide bond formation that uses Erv2p 
as a thiol oxidase.  The ERV2 (Essential for respiration and viability 2) gene was first 
identified by its similarity to ERV1 (Lisowsky, 1996; Stein et al., 1998).  Erv2p was 
later identified as a gene that when overexpressed could suppress the growth defect 
of ero1-1 mutants (Sevier et al., 2001).  Biochemical and genetic data suggest that 
Erv2p might act in an Ero1p-independent pathway of disulfide bond formation (Sevier 
et al., 2001).  In the absence of Ero1p, Erv2p is able to transfer its oxidizing 
equivalents to Pdi1p.  Aside from Pdi1p, other potential substrates of Erv2p have not 
been found. 
Analysis of mRNA transcription has shown that ERV2 mRNA is expressed 
under various conditions, being highly expressed in glucose medium, galactose 
medium, medium supplemented with mating factor a, growth at 17 ˚C and in 
stationary phase (Stein et al., 1998). 
Mutagenesis studies have shown that two cysteine pairs (Cys121-Cys124 
and Cys171-Cys178) are required for Erv2p activity (Gross et al., 2002).  The other 
cysteine pair (Cys 150-Cys167) is not required for activity (see Chapter 4).  Recent 
elucidation of the Erv2p structure gave light into its mechanism.  Erv2p is a 
homodimer, each subunit containing a four helix bundle (helixes ?1-?4) and an 
additional turn of helix (?5) packed perpendicular to the bundle (Gross et al., 2002).  
The dimer interface is made of contacts between ?1 and ?2 helixes packing against 
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the symmetric-related helixes (Gross et al., 2002).  The dimer interface is made of 
hydrophobic residues and the hydrophobic nature of 10 residues in the interface is 
conserved among homologs (Gross et al., 2002).  The active site cysteine pair, in a 
Cys-X-X-Cys motif, is found at the N-terminus of a helix, in this case ?3 (like Cys-X-
X-Cys motif of thioredoxin).  The second cysteine pair required for activity is located 
on a flexible C-terminal tail.  Two different conformations for the tail were observed: 
one in which the tail cysteine pair (Cys176-Cys178) were in close proximity active 
site cysteine pair (the FAD-proximal Cys121-Cys124), and another conformation 
where the tail was displaced these two cysteine pairs were not in close proximity.  
These studies show that Erv2p uses an internal transfer relay between two 
conserved cysteine pairs to transfer disulfides to substrate proteins (see scheme) 
 
dithiol substrate ?[Cys176-Cys178]subA ? [Cys121-Cys124]subB ? FAD]subB ? O2 
 
Random and site-directed mutagenesis showed that in mutants where the 
transfer oxidizing equivalents from the active site cysteine pair (Cys121-Cys124) 
occurs directly to the substrate protein, loose specificity in the disulfide transfer 
becoming more promiscuous (for more details see chapter 3).  
 
Comparison between Ero1p and Erv2p mechanisms and structures 
 
Ero1p and Erv2p seem to share the same catalytic mechanism.  Both 
proteins require two cysteine pairs for the transfer oxidizing equivalents from oxygen 
to the substrate proteins through thiol-disulfide exchange reactions (Gross et al., 
2004; Gross et al., 2002). 
Although the two proteins do not share any sequence similarity, they share 
the same core domain composed of a 4 helix bundle that holds the FAD cofactor 
(Gross et al., 2004).  In both proteins, the active cysteine pair in a conserved Cys-X-
X-Cys motif is located at the N-terminus of a helix.  A second cysteine pair, essential 
for activity, and is located in an unstructured flexible region (C-terminal tail of Erv2p 
or loop of Ero1p) that can be found in at least two different conformations.  In one 
conformation, this flexible region is flipped out, and its cysteine pair oxidizes 
substrate proteins, such as Pdi1p, while becoming reduced.  In another 
conformation, the flexible region moves closer to the active site cysteine pair and the 
former cysteine pair reoxidizes the reduced cysteine pair in the flexible region.  The 
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active site cysteine pair is in close proximity to the FAD cofactor and is then 
reoxidized by the flavin, which is then reoxidized by molecular oxygen (Gross et al., 
2004; Gross et al., 2002). 
In Erv2p, a short channel lined with hydrophobic residues that leads to the N5 
nitrogen atom of FAD seems to be the potential channel through which oxygen 
interacts with the flavin cofactor (Gross et al., 2002).  No such channel has been 
found in the Ero1p structure, and this difference might suggest differences in final 
electron acceptor (Gross et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
(Next page) 
 
Figure 3.  Similarities between the structures and catalytic 
mechanisms of Erv2p and Ero1p.  The structures of Erv2p (left panel; 
PDB files 1JR8 and 1JRA) and Ero1p (right panel; PDB files 1RP4 
and 1RQ1) are shown in a side view (A) and a top view (B and C) 
using Pymol (DeLano, 2002).  The four helices composing the four 
helix bundle are colored yellow, red, green and blue.  Both cysteine 
residues of the active site and the FAD cofactor are represented in a 
ball-and-stick representation and are colored in magenta and orange, 
respectively.  (C) In Erv2p, the second pair of cysteines is provided 
by the C-terminus of the other subunit while in Ero1p the second pair 
of cysteines is located in a mobile loop.  Both the Erv2p tail and the 
Ero1p mobile loop have at least two different conformations and are 
colored in light blue.  The cysteine residues located in these regions 
are colored in light pink. 
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Sulfhydryl oxidases of the QSOX/ERV family: their role in oxidative folding 
 
Erv2p belongs to an emerging family of flavoproteins.  One of the main 
features of the members of this family is their ability to catalyze the oxidation of thiol 
substrates to disulfides, with the associated reduction of oxygen and production of 
hydrogen peroxide (Coppock et al., 2000; Francavilla et al., 1994; Lisowsky, 1992; 
Lisowsky et al., 2001; Senkevich et al., 2000b). 
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Sequence analysis reveals that the QSOX/ERV family members share a core 
domain of about 100 amino acids that includes a conserved Cys-X-X-Cys motif and 
that this family can be subdivided into two different types of proteins (Figure 4): small 
ERV-like proteins (such as Erv1p, Erv2p, ALR and E10R) that are approximately 100 
to 200 amino acids in size and the QSOX-like proteins that are about 400 to 600 
amino acids (such as Quiescin Q6 and the Sox proteins).  The latter are a fusion 
between an N-terminal thioredoxin-like domain and an ERV-like domain and seem to 
be present only in genomes of higher eukaryotes.  All eukaryotic genomes 
sequenced so far contain at least one member of the QSOX/ERV family. 
The members of this family are located in several subcellular compartments 
and are involved in a variety of different cellular processes (Coppock et al., 2000; 
Francavilla et al., 1994; Lisowsky, 1992; Lisowsky et al., 2001; Senkevich et al., 
2000b).  For example, while the mitochondrial protein Erv1p is involved in 
cytoplasmic iron-sulfur cluster assembly and mitochondrial protein import, the 
vaccinia virus protein E10R is involved in disulfide bond formation in viral proteins in 
the cytoplasm of infected cells (Lange et al., 2001; Mesecke et al., 2005; Senkevich 
et al., 2004; Senkevich et al., 2000a; Senkevich et al., 2000b).  The QSOX proteins 
are secreted proteins that may be involved in the formation of disulfide bonds in the 
extracellular space (Thorpe et al., 2002). 
 
ERV1 is required for mitochondrial disulfide bond formation 
 
ERV1 (Essential for respiration and viability 1) was first identified as a gene 
that suppresses the growth defect of the pet-ts492 (erv1-1) mutant (Lisowsky, 1992).  
It is essential for viability, for the synthesis of mitochondrial proteins such as Cox2p, 
and for oxidative phosphorylation (Lisowsky, 1992).  Furthermore, ERV1 may be 
involved in the biogenesis of mitochondria (Stein et al., 1998).  Inactivation of ERV1 
leads to the loss of the mitochondrial genome and an aberrant distribution of 
mitochondria at the two poles of the cell.  In addition, lack of the typical formation of 
crystae for some mitochondria is observed in an erv1-1 mutant at the permissive 
temperature (Becher et al., 1999; Lisowsky, 1994). 
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Figure 4.  Schematic representation of the QSOX/ERV family members.  
Signal sequences were predicted by SignalP (Bendtsen et al., 2004; Nielsen 
et al., 1997; Nielsen et al., 1998) and are shown in light blue.  Mitochondrial 
signal sequences were predicted by Mitoprot II (Claros, 1995; Claros et al., 
1996) and are shown in light orange.  The ERV domain was predicted by 
sequence similarity between the proteins using ClustalX (Thompson et al., 
1997) and the boundaries suggested in Pfam (Bateman et al., 2004) and is 
shown in green.  The TRX domain was predicted by sequence similarity to 
the thioredoxin fold using the boundaries suggested in Pfam (Bateman et 
al., 2004) and is shown in blue.  The two pairs of essential cysteines are 
represented by a triangle and their sequence is shown.  The following amino 
acid sequences were used: Sacharomyces cerevisiae Erv2p (ScErv2p, 
NCBI accession number NP_015362) and Erv1p (ScErv1p, NCBI accession 
number NP_011543), Homo sapiens ALR, (HsALR, NCBI accession number 
NP_005253), vaccinia virus E10R (vvE10R, NCBI accession number 
NP_063714) and Gallus gallus QSOX (GgQSOX, accession number 
NP_989456) 
 
Erv1p is a mitochondrial protein located in the mitochondrial intermembrane 
space (IMS).  Recent data suggest that Erv1p and Mia40p are involved in a disulfide 
cascade pathway in the intermembrane space (IMS) of mitochondria, which controls 
the import of IMS-localized proteins that contain a Cys-X3-Cys or Cys-X9-Cys motif, 
such as Tim13p and Cox17p (Mesecke et al., 2005).  Newly synthesized 
mitochondrial proteins are translocated into the IMS in an unfolded reduced form 
through the translocase of the mitochondrial outer membrane (TOM complex).  After 
translocation into the IMS, these proteins are oxidized through interaction with 
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oxidized Mia40p.  Reduced Mia40p is subsequently reoxidized via interaction with 
oxidized Erv1p, thus promoting the next round of formation of disulfide bonds in IMS 
proteins.  Erv1p transfers its electrons to oxygen via its two cysteine pairs and flavin-
bound cofactor, after which it becomes reoxidized and ready for another cycle 
(Figure 5) (Mesecke et al., 2005).  Cytochrome c is the final electron acceptor for 
Erv1p (Bihlmaier et al., 2007).  Cytochrome c transfers its electrons to cytochrome c 
oxidase, which in turn transfers its electrons to oxygen.  This interaction directly 
connects the disulfide bond formation to the respiratory chain, thus preventing the 
generation of hydrogen peroxide (Bihlmaier et al., 2007).  
In both erv1-1 and mia40-3 mutants, the levels of IMS proteins that contain a 
Cys-X3-Cys or Cys-X9-Cys motif, such as the small Tim proteins (Tim9, Tim10p, 
Tim12p and Tim13p) and Cox17p, were reduced, whereas the levels of IMS proteins 
that lack conserved cysteine signatures and proteins of the outer membrane, inner 
membrane or the matrix were not affected (Mesecke et al., 2005; Rissler et al., 2005; 
Terziyska et al., 2005).  Furthermore, the formation of a complex between Erv1p and 
Mia40p that is sensitive to reducing conditions suggests that this interaction occurs 
via their cysteines and that Mia40p accumulates in the reduced state when Erv1p is 
depleted (Mesecke et al., 2005; Rissler et al., 2005).  The fact that in both wild-type 
and erv1-1 cells, Tim10p is found in its oxidized form suggests that Erv1p does not 
directly oxidize the small Tim proteins, but rather transfers its oxidizing equivalents 
through Mia40p (Allen et al., 2005).  Moreover, cells depleted of Erv1p are DTT 
sensitive (Mesecke et al., 2005).  The presence of homologs of Mia40p and Erv1p in 
higher eukaryotes suggests that this disulfide bond formation pathway and import 
into the IMS might be conserved process. 
Erv1p is thought to be involved in the process of assembly of cytoplasmic 
iron-sulphur (Fe/S) proteins (Lange et al., 2001).  Maturation of Leu1p and Ril1p, two 
Fe/S cytosolic proteins, is impaired in an erv1-1 mutant at the restrictive temperature, 
while the maturation of mitochondrial Fe/S proteins, such as Bio2p, aconitase, and 
succinate dehydrogenase, is not.  Furthermore, the erv1-1 mutant accumulates free 
iron, a characteristic of mutants that are impaired in biogenesis of cellular Fe/S 
proteins.  In addition, overexpression of wild-type Erv1p is able to restore the 
maturation of Leu1p in an erv1-1 strain (Lange et al., 2001).  It is possible that the 
role of Erv1p in Fe/S cluster assembly is an indirect effect, since Erv1p interferes with 
the formation of the Tim complex (translocation into the inner membrane) and thus 
might interfere with transport of proteins essential for the assembly of Fe/S clusters in 
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the matrix.  The other possibility is that Erv1p is necessary for the transport of a 
component that is synthesized in the matrix but needs to be transported to the 
cytosol (Sipos et al., 2002). 
Erv1p is a mitochondrial FAD-dependent sulfhydryl oxidase that contains 
three pairs of essential cysteines.  As in Erv2p, the first cysteine pair (Cys131 and 
Cys133 in Erv1p) is located in the core domain present in all members of the 
QSOX/ERV family juxtaposed to the FAD cofactor.  It forms a conserved Cys-X2-Cys 
motif that can interact with the flavin cofactor.  The second cysteine pair (Cys30 and 
Cys33) is located in the N-terminus and is thought to receive oxidizing equivalents 
from the first pair and subsequently transfer them to the substrate protein (Hofhaus et 
al., 2003).  Finally, the third cysteine pair (Cys159 and Cys176) seems to form a 
structural bond.  All three cysteine pairs are necessary for activity in vivo and in vitro 
(Hofhaus et al., 2003).  The existence of a disulfide-linked intermediate between the 
Cys30-Cys33 pair and the active site confirms that these two pairs of cysteines 
interact during the catalytic mechanism of Erv1p.  The electron flow is as follows: 
 
dithiol substrate ?[Cys30-Cys33]subA ? [Cys130-Cys133]subB ? [FAD]subB ? O2 
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Figure 5.  Pathways of disulfide bond formation in the IMS of mitochondria 
of S. cerevisiae.  Mia40p oxidizes substrate proteins, such as Tim13p and 
Cox17p, after their translocation through the TOM complex.  Oxidized 
Mia40p is recycled by interaction with Erv1p, which in turn obtains its 
oxidizing equivalents from oxygen or from cytochrome c through its flavin-
bound cofactor. 
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Recombinant wild-type Erv1p can oxidize reduced lysozyme, DTT and 
cysteine, with apparent turnover numbers of 8.6, 52.8 and 5 min-1, respectively 
(Hofhaus et al., 2003; Hofhaus et al., 2002; Lee et al., 2000; Lisowsky et al., 2001).  
Substitution of the active site cysteines with serine abolishes the sulfhydryl oxidase 
activity towards DTT, whereas substitution of the Cys30 or Cys33 with serine only 
diminishes the activity towards DTT (Hofhaus et al., 2003). 
 
Augmenter of liver regeneration 
 
Mammalian ALR (augmenter of liver regeneration) is a homolog of ScErv1p 
and was first identified as a cytoplasmic human growth factor that was able to 
stimulate regeneration of liver after partial hepatectomy (Francavilla et al., 1994).  
Recent studies suggest that it might be involved in the formation of cytoplasmic iron-
sulphur proteins (Lange et al., 2001) and in spermatogenesis (Klissenbauer et al., 
2002).  
Two forms of ALR formed due to alternative splicing are found in hepatocytes 
(Thasler et al., 2005).  The 15 kDa shorter form consists of 125 amino acids, lacks 
the N-terminal region, and is localized to the nucleus.  The 23 kDa longer form is 205 
amino acids and is mainly located to the cytosol and mitochondrial intermembrane 
space (Thasler et al., 2005).   
Three mechanisms have been proposed by which ALR promotes liver 
regeneration.  First, during liver regeneration, ALR is secreted from hepatocytes, and 
through the interaction with a membrane receptor for ALR, activates a MAPK 
pathway, which in turn increases gene expression (Li et al., 2001).  In a second 
mechanism, intracellular ALR interacts with the Jun activation domain-binding protein 
1 (JAB1), which leads to C-jun phosphorylation and the subsequent activation of the 
activation protein-1 (AP-1) in a MAPK independent manner.  In a third mechanism, 
ALR reduces the lytic activity of liver-resident NK cells and produces a burst in 
mitochondrial metabolism (Francavilla et al., 1997).  These effects are mediated by 
the down regulation of IFN-? (as indicated by the reduction of IFN-? mRNA in rats 
after ALRp administration and by the reduction of IFN-? protein levels in liver resident 
NK cells).  Whether these signaling pathways cooperate with each other or act 
separately remains to be elucidated (Lu et al., 2002). 
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Like Erv2p and Erv1p, ALR contains 3 pairs of cysteines, two of them 
essential.  The first cysteine pair (Cys62 and Cys65 in ALR) forms a conserved Cys-
X2-Cys motif that is required for H. sapiens ALR (HsALR) activity in vitro (Lisowsky et 
al., 2001).  The crystal structure of rat ALR (rALR) has been solved, revealing that it 
possesses the same overall structure as Erv2p: a four helical bundle core domain 
containing the FAD cofactor (Wu et al., 2003).  In the case of rALR, a second 
cysteine pair is formed by the Cys15 or one subunit and the Cys124 of the other 
subunit (Farrell et al., 2005).  A comparison between Erv2p and ALR crystal 
structures and the biochemical data has defined a disulfide bond transfer mechanism 
in the ALR protein. 
 
dithiol substrate ?[Cys15/Cys124]subAB ? [Cys62-Cys65]subB ? [FAD]subB ? O2 
 
This intersubunit disulfide bond (Cys15A-Cys124B and Cys15B-Cys124A) is 
not conserved in other members of the ERV/QSOX family, and it is not required for 
dimerization of ALR (Farrell et al., 2005).  Structural modeling of human ALR 
indicates that this intersubunit disulfide bond is in close proximity to the active site 
cysteines (Farrell et al., 2005).   
Both Erv1p and mature ALR contain an extra Cys-X-X-Cys motif in the N-
terminus that might play a role in the relay mechanism (Wu et al., 2003).  As in the 
Erv2p mutants lacking the Cys176-Cys178 cysteine pair, an N-terminal truncated 
ALRp (?1-80-ALRp fused to the signal sequence of Cytb2 for proper localization to 
the intermembrane space) lacking the extra Cys-X-X-Cys motif is able to rescue 
erv1-1, but cells containing this construct are less active than the wild type ALRp or 
Erv1p in incorporation of 55Fe into cytosolic Leu1p (Lange et al., 2001).  However, as 
observed for Erv2p-Cys176A/Cys178A, recombinant ?1-73-Erv1p and ?1-81-ALRp 
still exhibit sulfhydryl oxidase activity in vitro as indicated by oxidation of reduced 
lysozyme or DTT (Hofhaus et al., 2003; Lee et al., 2000; Lisowsky et al., 2001). 
A chimera made of the N-terminal region of Erv1p (amino acid residues 1-93) 
fused to the C-terminal region of human ALR (amino acid residues 81-205) is able to 
complement the erv1? or erv1-1 growth defect, suggesting that the ALR core domain 
is able to substitute for Erv1p.  In addition, this fusion protein is localized to the IMS 
and is able to restore the assembly of cytoplasmic Fe/S clusters when expressed in 
the erv1-1 mutant. This result suggests that ALR might also be involved in assembly 
of Fe/S clusters in mitochondria (Lange et al., 2001). 
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Vaccinia virus E10R: sulfhydryl oxidase involved in cytoplasmic 
disulfide bond formation pathway 
 
One of the members of the QSOX/ERV family, a viral protein E10R, has been 
implicated in disulfide bond formation in the cytoplasm of vaccinia virus infected cells 
(Senkevich et al., 2000a).  The E10R protein is the smallest of the family, containing 
approximately 100 amino acids and only a single pair of cysteines in a Cys-X-X-Cys 
motif (Senkevich et al., 2000a).  Recent studies have shown that E10R is essential 
for vaccinia virus assembly and that its cysteine residues are required for the in vivo 
oxidation of viral proteins, such as L1R, F9L and A28L (Senkevich et al., 2004; 
Senkevich et al., 2000a; Senkevich et al., 2000b). 
Various studies have defined the pathway of disulfide bond formation in the 
cytoplasm of vaccinia virus-infected cells (Figure 6).  E10R oxidizes an adaptor 
protein A2.5L (Senkevich et al., 2002b), which contains a pair of cysteines that 
probably fulfills the function of the tail cysteines in Erv2p.  Next, A2.5L interacts with 
a glutaredoxin-like protein, G4L, that in turn oxidizes coat proteins in the cytoplasm 
(Senkevich et al., 2004; Senkevich et al., 2002a; White et al., 2002).  Based on its 
homology with ERV-like members of the QSOX/ERV family, it is thought that E10R is 
a FAD-dependent sulfhydryl oxidase and that it becomes reoxidized by transferring 
electrons to O2, forming H2O2, but no in vitro studies have been performed to directly 
confirm this. 
Various pieces of evidence confirm this pathway: 1) E10R repression 
prevents the formation of disulfide bonds in the cytoplasmic domain of virion attached 
L1R protein or the closely related F9L (Senkevich et al., 2000a), 2) the cysteines in 
the conserved Cys-X-X-Cys motif of E10R are essential for its function, and when 
these residues are mutated to Ser, the F1L and F9L proteins are reduced, 3) each 
cysteine in A2.5L is also essential for the formation of disulfide bonds in substrate 
proteins that are essential for formation of the mature virion (Senkevich et al., 2000a; 
Senkevich et al., 2000b; White et al., 2002), 4) G4L is also required for virus 
assembly and is required for the formation of disulfide bonds in L1R and F9L proteins 
and 5) Repression of E10R prevents thiol oxidation of G4L, whereas the reverse is 
not true. 
The three components of this pathway (Figure 6) are present/conserved in all 
sequenced poxviruses and are essential for vaccinia virus assembly, suggesting that 
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this is a conserved mechanism in poxvirures (Senkevich et al., 2000a; Senkevich et 
al., 2002b; White et al., 2002).  
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Figure 6.  Pathways of disulfide bond formation (oxidation) in the cytoplasm 
of vaccinia virus.  Arrows indicate flow of electrons.  The vaccinia virus L1R 
(or F9L or A28L) is oxidized by glutaredoxin homolog G4L, which in turn is 
reduced.  Reduced G4L is reoxidized by interaction with A2.5L.  A2.5L is 
reoxidized by E10R, which in turn is reoxidized by molecular oxygen, 
producing hydrogen peroxide. 
 
QSOX 
 
The Quiescin/Sox-like proteins, such as chicken sulfhydryl oxidase and 
Quiescin Q6, are secreted proteins that might be involved in the formation of disulfide 
bonds in the extracellular space (Thorpe et al., 2002).  They consist of a fusion of 
thioredoxin and ERV/ALR motifs (Hoober et al., 1999a).  Members of the QSOX 
family include the avian egg white oxidase, the rat seminal vesicle flavoprotein, and 
Quiescin Q6, a cell growth inhibitory factor.  Quiescin Q6, the best understood 
member of this family is highly induced when human fibroblasts enter reversible 
quiescence (Hoober et al., 1999a). 
QSOX are found in metazoans, such as Caenorhabditis elegans and 
Drosophila melanogaster, plants and certain protists, while Erv2-like proteins are 
found only in fungal genome (Thorpe et al., 2002).  Interestingly, Erv2p and QSOX 
proteins have not been found in the same organism (Thorpe et al., 2002). 
Furthermore, although QSOX proteins have been found in protists such as 
trypanosoma brucei, some protist genomes such as Giardia lamblia and Entamoeba 
histolytica seem to have neither QSOX nor ERV-like proteins in their genomes  
(Hoober et al., 1999a).  Although little is known about the role of the QSOX family 
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members, it has been suggested that members of this family introduce disulfide 
bonds in the extracellular medium (Thorpe et al., 2002). 
The Chicken QSOX (cQSOX) is by far the best studied sulfhydryl oxidase of 
the QSOX/ERV family.  It is a homodimeric protein containing one molecule of FAD 
per subunit (Hoober et al., 1996).  The protein cQSOX is able to oxidize a variety of 
small thiols, such as DTT, GSH, and cysteine in vitro (Hoober et al., 1996).  The 
cQSOX flavoenzyme is also able to introduce disulfide bonds in vitro to a wide variety 
of proteins and peptides, such as insulin A and B chains, lysozyme, ovalbumin, 
riboflavin-binding protein and reduced RNase, although the Km obtained for these 
substrates are significantly lower than those for small monothiols (Thorpe et al., 
2002).  This result suggests that there is little dependence on substrate molecular 
weight or isolelectric point (Thorpe et al., 2002).  It has also been reported that 
cQSOX can oxidize reduced PDI and reduced E. coli Trx (Hoober et al., 1999b; 
Hoober et al., 2002). 
 
A mechanism for substrate specificity similar to the one observed for Erv2p is 
found in chicken QSOX, which is a fusion of a thioredoxin-like domain and an ERV-
like domain (Raje et al., 2003).  Partial proteolysis studies showed that while the 
thioredoxin-like fragment or the ERV-like fragment alone has little or no activity 
toward thiol substrates, the two fragments combined exhibit substantial activity.  The 
ERV-like fragment is a dimer and probably shares the overall structure of Erv2p, 
including a flexible C-terminal tail containing the second cysteine pair (Raje et al., 
2003).  As in Erv2p, this second pair of cysteine residues in the ERV-like fragment 
confers specificity in the disulfide transfer to the redox active cysteine pair in the 
thioredoxin-like fragment.  In contrast, the rat QSOX protein is a monomeric enzyme 
(Ostrowski et al., 1980), showing that subunit communication in the dimeric avian 
enzyme may not be a prerequisite for activity (Thorpe et al., 2002). 
 
Members of the QSOX/ERV family share the same mechanism 
 
Structural and biochemical data suggest that all members of the QSOX/ERV 
family share the same catalytic mechanism.  Structural studies on Erv2p and rat ALR 
have shown that the conserved core domain is composed of a four helix bundle that 
contains the active site cysteine pair at the N-terminus of a helix (helix ?3 in the case 
of Erv2p) (Figure 7) (Gross et al., 2002; Wu et al., 2003).  Site-directed mutagenesis 
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studies showed that all members of this family require two pairs of cysteines for their 
catalytic activity in vivo or in vitro, suggesting that they might share the same catalytic 
mechanism (Hofhaus et al., 2003; Lisowsky et al., 2001; Senkevich et al., 2000b; 
Senkevich et al., 2002a; Sevier et al., 2001).  One pair of cysteines is located in the 
conserved core near the flavin cofactor, while the second pair of cysteines is located 
in a flexible region, in either the N- or C-terminal regions of the proteins, and has 
variable spacing between cysteine residues.  The latter pair of cysteines seems to be 
an electron carrier between the active site cysteines and the substrate.  After transfer 
of oxidizing equivalents to the tail cysteine pair, the active site cysteines become 
reduced.  To be recycled, the active site pair of cysteines interacts with the flavin-
bound cofactor becoming oxidized.  Subsequently, molecular oxygen or another 
electron acceptor reoxidizes the reduced flavin. 
 
 
 
A
B
 
 
Figure 7.  Erv2p (A) and rat ALR (B) share the same catalytic core.  The 
structures of Erv2p (PDB file 1JR8) and rat ALR (PDB file 1OQC) are shown 
in a side view (left panel) and a top view (right panel) using Pymol (DeLano, 
2002).  One subunit is colored in blue while the other is colored in green.  
Both cysteine residues and the FAD cofactor are represented in a ball-and-
stick representation and are colored magenta and orange, respectively. 
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PDI - Its role in disulfide bond formation 
 
PDI proteins can catalyze thiol oxidation, reduction and isomerization 
reactions; isomerization may occur directly through intramolecular rearrangement of 
through cycles or reduction and oxidation (Schwaller et al., 2003). 
To date, several homologues of PDI have been found, but the role of these 
proteins is only now being uncovered.  Each PDI-like protein consists of active (a 
domains), containing a characteristic CXXC active site motif, and inactive (b 
domains) thioredoxin-like modules.  The structure might have evolved by means of 
partial gene duplication or shuffling of common thioredoxin-like modules (Kemmink et 
al., 1997). 
PDI-family proteins differ from thioredoxin (Trx) in two main aspects: their 
redox potentials are usually higher, and the presence of domains devoid of the active 
site cysteine confers additional properties on them, such as the capacity to bind 
peptides or proteins and consequently display chaperone and isomerase activities.  It 
has been suggested that the multi-domain structure of PDI enhances and diversifies 
substrate specificity (Ellgaard et al., 2005). 
 
 
 
 (Next page) 
 
Figure 8.  Schematic representation (domain structure) of the protein disulfide 
isomerase family (PDI-related proteins) from S. cerevisiae (A) and Homo sapiens 
(B).  Signal sequences were predicted by SignalP (Bendtsen et al., 2004; Nielsen et 
al., 1997; Nielsen et al., 1998) and are shown in light blue.  Active thioredoxin-like 
domains (a domains) are represented by blue rectangles.  The cysteine residues of 
the active domains are represented by a triangle and their sequence is shown.  The 
catalytically inactive thioredoxin-like domains (b and b' domains) are shown in green, 
pink and purple, respectively.  Transmembrane regions were predicted by the 
program TMHMM 2.0 (Krogh et al., 2001; Sonnhammer et al., 1998) and are shown 
in orange.  The a and b domains boundaries were predicted by sequence similarity 
between the proteins using ClustalX (Thompson et al., 1997) and the boundaries 
suggested in Pfam  (Bateman et al., 2004).  Adapted from (Ellgaard et al., 2005). 
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Thioredoxin fold 
 
The thioredoxin fold is an ancient structural fold consisting of four stranded ?-
sheets and three flanking ?-helixes that was named after the protein in which it was 
first observed, the E. coli thioredoxin (Martin, 1995).  A variety of proteins have been 
shown to belong to the thioredoxin superfamily, such as thioredoxin, glutaredoxin, 
glutathione peroxidase (GPx), peroxiredoxin (Prx), glutathione S-transferase (GST), 
PDI and its bacterial homolog DsbA. 
The thioredoxin fold is composed of an N-terminal ??? motif and a C-terminal 
??? motif connected by a loop of residues that incorporate a third helix (Figure 9A) 
(Martin, 1995).  The ? strands from the N- and C-terminal motifs form a ?-sheet of 
parallel (?1 and ?2) and antiparallel (?3 and ?4) ?-strand pairs that is characteristic of 
the thioredoxin fold (Martin, 1995).  On one side of the ?-sheet and parallel to it are 
the helices from the N- and C-terminal motifs (?1 and ?3, respectively).  On the other 
side of the ?-sheet and opposite to the ?1 and a3 helices, the helix that connects 
both N- and C-terminal motifs is located in a perpendicular orientation (Martin, 1995). 
The core thioredoxin fold comprises about 80 residues, but each protein in 
the family contains extra residues beyond the core (Martin, 1995).  Structural and 
sequence analysis between proteins of the thioredoxin superfamily has shown that 
the thioredoxin fold can tolerate insertions at various positions without disruption of 
the overall structure (Figure 9B).  E. coli thioredoxin, DsbA and glutathione 
peroxidase contain an extra domain of around 20 to 30 residues inserted at the N-
terminus of the ? and ? domains.  Both DsbA and glutathione peroxidase have an 
additional insertion of a 40-70 amino acid helical domain or loop after the N-terminal 
motif (???) of the thioredoxin fold, while glutathione S-transferase has a whole 
domain inserted into the C-terminus of the thioredoxin fold. 
These extra domains inserted into the thioredoxin fold have been shown to 
provide these proteins with extra functionality.  For example, the insertion in DsbA 
forms a deep hydrophobic groove near the active site that seems to be important for 
substrate binding, while the extra domain in GST contributes residues that help to 
stabilize GSH and the electrophilic substrate (Martin, 1995). 
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Figure 9.  Structure of the thioredoxin fold.  (A) Thioredoxin fold of E. coli 
thioredoxin A (PDB file 2TRX) was generated using Pymol (DeLano, 2002).  
The N-terminal ??? domain is colored in blue, the C-terminal ??? domain is 
colored in red and the connecting ? helix is colored in green.  The cysteine 
residues are shown in a stick-and-ball representation and are colored in 
magenta.  Asterisks represent areas of the thioredoxin fold that can tolerate 
insertions.  (B) Structure of E. coli thioredoxin A (PDB file 2TRX) as in (A).  
In yellow are represented extra domains of thioredoxin A not found in the 
core thioredoxin fold.  Adapted from (Martin, 1995). 
 
Homologs of PDI in the yeast ER 
 
Yeast PDI (Pdi1p) was isolated by various groups using different approaches 
(Farquhar et al., 1991; Gunther et al., 1991; LaMantia et al., 1991).  It contains 5 
potential sites for Asn-linked glycosylation on Asn residues positioned at amino acid 
82, 117, 155, 174 and 425; an ER retention signal HDEL and two WCGHC motifs. 
Pdi1p is an essential protein for growth and viability that is required for the maturation 
of carboxypeptidase Y (Farquhar et al., 1991; Gunther et al., 1991; LaMantia et al., 
1991). In a glucose repression of PDI1 experiment, proCPY (p2form - 67-69 kDa) is 
accumulated (Farquhar et al., 1991; Gunther et al., 1991; LaMantia et al., 1991). 
PDI1 under the gal promoter is able to rescue pdi1? (Gunther et al., 1993). 
Under the same conditions, a deletion of the C-terminal 38 amino acids of Pdi1p is 
also able to rescue this strain. This deletion is not able to rescue a pdi1? strain under 
the ADC1 promoter (Farquhar et al., 1991; Gunther et al., 1991; LaMantia et al., 
1991).  The C-terminal domain contains the KDEL ER retention signal, so the likely 
explanation is that PDI1 must be retained in the ER to perform its function. 
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In vitro, PDI can catalyze the oxidation, reduction or isomerization of disulfide 
bonds depending upon the redox conditions of the assay and the nature of the 
substrate protein (ref in (Frand et al., 2000a)).  It is unknown which of these activities, 
if any, is the essential function of Pdi1p.  Overexpression of Pdi1p-Cys-X-X-Ser 
mutant can restore viability of pdi1? cells suggesting an essential role for Pdi1p in the 
isomerization of non-native disulfide bonds.  Futhermore, this mutant lacks 
detectable oxidase and reductase activities in vitro.  However, Pdi1p was shown to 
be involved, together with Ero1p, in the oxidation pathway. 
S. cerevisiae contains four nonessential genes with homology to Pdi1p, 
namely, MPD1 , MPD2, EUG1 and EPS1, each of which contain at least one active 
TRX-like domain (Figure 8) (Tachibana et al., 1992; Tachikawa et al., 1997; 
Tachikawa et al., 1995; Wang et al., 1999). 
 
Mpd1p 
 
Mpd1p (multicopy suppressor of PDI1 deletion) was isolated in a screen for 
multicopy suppressors of a strain lacking PDI1 (Tachikawa et al., 1995).  In contrast 
to PDI1, MPD1 is a non-essential gene.  Genetic analyses of strains lacking both 
PDI1 and its homologs indicates that Mpd1p is the only of the homologs that can fully 
compensate for the absence of Pdi1p (Norgaard et al., 2001). 
Mpd1p is a glycoprotein of 318 amino acid residues that has homology to 
Pdi1p.  It contains an N-terminal signal sequence, a C-terminal ER retention signal 
(HDEL) and a TRX-like domain that contains a Cys-X-X-Cys motif (Tachikawa et al., 
1995).  Mpd1p does not seem to have homology to the b and b' domains of PDI1 and 
its C-terminal region is not homologous to any other protein in the protein database.  
Homologs of Mpd1p have been found in fungal genomes but to date, no human 
homologs of Mpd1p have been found. 
The MPD1 promoter region contains a TATA box and a sequence related to 
the unfolded protein response (UPR).  The MPD1 gene is slightly upregulated in 
response to treatment with DTT or tunicamycin (inducers of the UPR) (Norgaard et 
al., 2003).  In contrast, MPD1 is strongly upregulated in response to PDI1 deficiency 
(Norgaard et al., 2003).  The MPD1 promoter contains both UPR response elements 
(ERES) and CERP (cis-acting element responding to PDI deficiency) (Norgaard et 
al., 2003; Tachikawa et al., 1995). 
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Mpd1p is able to suppress a PDI1 deleted strain when expressed from a high 
copy plasmid or under the control of the PDI1 promoter (Holst et al., 1997; 
Tachikawa et al., 1995).  Furthermore, a strain depleted for PDI1 is unable to process 
CPY, which accumulates in the p1 form (ER form).  But, overexpression of Mpd1p in 
Pdi1p-depleted cells restores CPY maturation (80% of the CPY becomes mature 
after 60 minutes chase) (Tachikawa et al., 1995). 
In vitro studies with recombinant Mpd1p have shown that it has weak 
reductase activity (measured by the reduction of insulin) but no chaperone activity 
(measured by the aggregation of denatured rhodanase and mastoparan binding - no 
binding) (Kimura et al., 2004).  Recombinant Mpd1p has been shown to have an 
oxidase activity when using denatured lysozyme as substrate, but its activity is 
13.8% of that of wild-type (Kimura et al., 2005). 
Mpd1p binds Mpd2p and Eps1p with KD values of 5.97x10
-5 M and 3.88 x 10-6 
M, respectively (Kimura et al., 2004; Kimura et al., 2005). Mpd1p does not affect the 
chaperone activity of Mpd2p, and Mpd2p does not affect the reductive activity of 
Mpd1p (Kimura et al., 2005).  Also, the interaction between Mpd1p and Mpd2p does 
not appear to promote isomerase activity (Kimura et al., 2004). 
Mpd1p is the only yeast PDI homolog that has been shown to be able to 
interact with Cne1p, a calnexin homolog, with a KD value of 2.27 x 10
-7 M (Kimura et 
al., 2005). 
Cne1p has no reductive activity, while Mpd1p has no chaperone activity.  The 
reductase activity of Mpd1p is increased in the presence of Cne1p (from 100% to 
115%), and the chaperone activity of Cne1p is quenched by interaction with Mpd1p 
(100% to 47%)  (Kimura et al., 2005). The inhibition of Cne1p chaperone activity by 
Mpd1p could be overcome by increasing the concentration of Cne1p, suggesting that 
the binding interface between Cne1p and Mpd1p is near the peptide binding site of 
Cne1p and that its chaperone activity requires that peptide binding site (Kimura et al., 
2005). 
Although the function of Mpd1p in the ER is unknown, it has been suggested 
to play a role in quality control in the ER.  First, Mpd1p is more similar to human 
Erp57 than to human PDI, and although Mpd1p has different domain architecture 
than human Erp57, it is thought to be its yeast counterpart (Tachikawa et al., 1997).  
Furthermore, Mpd1p interacts with Cne1p, a homolog of calnexin and calreticulin, 
two lectins known to interact with Erp57 (Kimura et al., 2005). 
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Mpd2p 
 
Mpd2p (multicopy suppressor of PDI1 deletion 2) was isolated together with 
Mpd1p in a screen for multicopy suppressors of PDI1 (Tachikawa et al., 1995).  In 
contrast with PDI1, MPD2 is a non-essential gene.  No phenotype has been found for 
the strain deleted for MPD2. 
Mpd2p is a glycoprotein with 277 amino acid residues that contains an N-
terminal signal-sequence, a C-terminal ER retention signal (HDEL) and TRX-like 
domain that contains a Cys-X-X-Cys motif (Tachikawa et al., 1997).  The active site 
sequence is similar to, but distinct from, the active site sequence of Pdi1p and Mpd1p 
(TSWCQHCK).  The C-terminal region of Mpd2 shows no homology with any other 
protein in the protein database.  No human homologs of Mpd2p have been found, 
although it has been suggested to have a C-terminal helical domain similar to the 
PDI-D family (ERp28) (personal observation). 
MPD2 can partially suppress the phenotype caused by the loss of PDI1 
function.  Overexpression of Mpd2p can suppress a yeast strain lacking PDI1 but this 
strain has a growth defect when compared to the wild-type strain (3.3 hours versus 
1.7 hours doubling time) and is sensitive to exogenous reducing agents (DTT) 
(Tachikawa et al., 1997).  Furthermore, It can rescue the CPY maturation defect of a 
pdi1? strain, although after 15 minutes chase only 60% of the CPY becomes mature 
(Tachikawa et al., 1997). The active site cysteines are required for function, since 
active site cysteine to serine mutants of Mpd2p (Mpd2-SXXS) are not able to 
suppress the growth defect of a pdi1? strain (Tachikawa et al., 1997). 
MPD2 expression is slightly induced in response to ER stress, such as 
treatment with DTT or tunicamycin (inducers of the UPR) (Norgaard et al., 2003).  
MPD2, as MPD1, also contains a CERP (cis-acting element responding to PDI 
deficiency) and is induced by deficiency of PDI1 (Norgaard et al., 2003). 
Mpd2p has reductase activity (reduction of insulin) that is extremely low 
compared to Pdi1p (Kimura et al., 2005).  Mpd2p has the highest chaperone activity 
of the yeast PDI homologs, which is 68% of that of yPdi1p and 27-fold that of hPDI 
(measured by the aggregation of denatured rhodanase and mastoparan binding with 
a KD of 2.68x10
-5) (Kimura et al., 2004; Kimura et al., 2005).  Mpd2p has oxidative 
refolding activities towards denatured lysozyme as substrate, but its activity is 16 % 
of that of wild-type (Kimura et al., 2005). 
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Mpd2p and Mpd1p interact with each other with a KD value of 5.97x10
-5, but 
Mpd1p does not affect the chaperone activity of Mpd2p, while Mpd2p does not affect 
the reductive activity of Mpd1p (Kimura et al., 2005). 
Few studies have addressed the function of Mpd2p in vivo.  The fact that 
Mpd2p can only partially complement pdi1? might reflect the fact that Mpd2p has 
only one of the activities of Pdi1p, or it might indicate that the two proteins act upon a 
different set of substrates. 
 
Eug1p 
 
Eug1p (ER protein unnecessary for growth 1) was isolated in a screen of a 
yeast genomic library for genes that hybridized to an oligonucleotide encoding the 
PDI active site sequence (Tachibana et al., 1992). 
Eug1p is an ER glycoprotein with 517 amino acid residues.  It contains an N-
terminal signal-sequence, a C-terminal ER retention signal (HDEL) and two TRX-like 
domains that contain a non-classical Cys-X-X-Ser motif (Tachibana et al., 1992).  It is 
highly similar to PDI from yeast and mammals, with the same domain organization as 
Pdi1p (Norgaard et al., 2001). 
Cells lacking the EUG1 gene do not exhibit growth defects, although a slight 
defect in the sorting of soluble vacuolar proteins CPY and proteinase A has been 
reported (Tachibana et al., 1992).  Eug1p overexpression in a pdi1? strain allowed 
growth in the absence of Pdi1p but did not suppress the phenotype of accumulation 
of proCPY in the early secretory pathway, suggesting that Eug1p cannot fully 
compensate for the lack of Pdi1p (Tachibana et al., 1992).  
The observation that a mutant Pdi1p with active sites mutated to Cys-X-X-Ser 
has almost no oxidase activity, while its isomerase activity is not affected, has lead to 
the idea that Eug1p might act as a dedicated isomerase in the yeast ER; however, its 
specific substrates are not known (Norgaard et al., 2001). 
In an in vitro assay, Eug1p exhibited a chaperone activity (measured by the 
aggregation of denatured rhodanase and mastoparan binding with a KD value of 
4.21x10-4) (Kimura et al., 2004), while its oxidative refolding activities (using 
denatured lysozyme as substrate) was only 2.16 % of that of Pdi1p (Kimura et al., 
2004). 
Eug1p and Eps1 interact in vitro with a KD value of 6.06 x 10
-6 M, but the role 
of this interaction is unknown (Kimura et al., 2005). Furthermore, the reductive 
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activity of a mixture of Eps1p and Eug1p is greater that the sum of the individual 
reductive activities of both proteins (122% vs. 0 % or 100% for the mixture, Eug1p or 
Eps1p) suggesting that Eug1p and Eps1p might work together in vivo (Kimura et al., 
2005). 
 
Eps1p  
 
Eps1p (ER-retained Pma1 suppressing) was identified in a screen for 
mutants that suppress the dominant-negative growth effect of Pma1-D378N (a 
dominant negative allele of Pma1) (Wang et al., 1999).  Eps1p is an ER type I 
transmembrane protein containing a C-terminal KKKNQD motif, which confers 
retention of transmembrane proteins in the ER (Wang et al., 1999).  It contains a 
thioredoxin domain that is facing the ER and a second Cys-X-X-Cys motif (Cys-Asp-
Lys-Cys) in a region (150-290) with no obvious sequence similarity to the disulfide 
isomerase/thioredoxin family (Wang et al., 2003). 
Overexpression of Eps1p (2μ, under its own promoter) suppresses the growth 
defect of the pdi1? strain (Wang et al., 1999).  Eps1p seems be a homolog of TMX 
(see below) (Kimura et al., 2005).  In vitro studies using denatured lysozyme as 
substrate suggest that Eps1p has no oxidative refolding activity (Kimura et al., 2005).  
Using the BIAcore system they found that Eps1p binds to Pdi1p, Eug1p, Mpd1p, 
Kar2p and Cne1p, with KD value of 7.33 x 10
-6 M, 6.06 x 10-6 M, 3.88 x 10-6 M, 1.03 x 
10-6 M, and 1.38 x 10-5 M respectively. The Eps1p-Cne1p interaction is of low affinity 
(Kimura et al., 2005). 
Characterization of deletion mutants of EPS1 showed that cells lacking EPS1 
do not show any detectable growth defects, and that there are no differences 
between the kinetics of CPY folding between the wild-type and the eps1? strain 
(Wang et al., 1999) 
Although the localization of wild-type Pma1p is not affected in eps1?, in these 
cells one can observe ER accumulation of the plasma membrane Gas1p (Wang et 
al., 1999).  Cells expressing pma1-D378N allele cannot grow even though there is a 
chromosomal copy of PMA1.  In wild-type cells, wild-type Pma1p is relatively stable 
while the pma1-D378N mutant is rapidly degraded. In eps1? cells, degradation of 
pma1-D378N is slowed, while overexpression of Eps1p leads to an increase in 
pma1-D378N degradation (Wang et al., 1999). 
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It has been shown that Eps1p is not required for CPY* degradation, while in 
eps1? mutant cells H-2Kb seems to be stabilized and its degradation is slowed 
(Wang et al., 2003).  Wild-type cells and eps1? cells do not shown significant 
differences in the secretion of wild-type lysozyme.  In contrast, secretion of a 
lysozyme mutant (lysozyme-C99A) was higher in eps1? cells (He et al., 2005).  
Furthermore, compared to wild-type cells there is an enhancement of the secretion of 
unstable proteins, such as amyloid prone chicken cystatin, in eps1? cells (He et al., 
2005).  These studies suggest that Eps1p plays a role in ERAD as a redox-sensitive 
chaperone (independent of its enzymatic function as a oxidoreductase) (He et al., 
2005). 
 
Mammalian homologs of PDI 
 
The mammalian ER contains several PDI-like proteins containing various 
combinations of active and inactive thioredoxin domains (see Table 1).  Their roles 
are just now being uncovered, and various studies suggest that they might participate 
in discrete disulfide bond formation pathways (reviewed in (Ellgaard et al., 2005)). 
For example, ERp57 interacts with the lectin-like chaperone calnexin and 
calreticulin to promote disulfide bond formation in glycoproteins, such as MHC-Class 
I.  ERdj5 contains both a J domain and a thioredoxin-like motif (Hosoda et al., 2003).  
Biochemical studies have shown that the J domain of ERdj5 specifically interacts with 
BIP in vitro and that this interaction is ATP-dependent (Cunnea et al., 2003; Hosoda 
et al., 2003). This could be a novel example of synergy between a chaperone and a 
folding enzyme (Hosoda et al., 2003). 
TMX, also a member of the mammalian PDI family, contains a 
transmembrane domain.  It has been suggested that TMX might function to help 
relieve ER stresses (Cunnea et al., 2003; Hosoda et al., 2003; Matsuo et al., 2001).  
Overexpression of TMX increases the resistance to apoptosis induced by treatment 
with brefeldin A (BFA), an inhibitor of ER to Golgi transport, but not apoptosis 
induced by agents that disrupt the intracellular calcium homeostasis, such as 
thapsigargin or the calcium ionophore A23187 (Matsuo et al., 2001).  Furthermore, 
the active site cysteines seem to be required for its function in vivo, since the 
increased resistance to apoptosis induced by treatment with brefeldin A (BFA) was 
not observed in TMX-C56S-C59S (Matsuo et al., 2001). 
 
Table 1 - Characteristics of S. cerevisiae PDI-like proteins and comparison to TrxA and DsbA from E. coli. 
 
Protein Alias NCBI 
accession 
Length 
(aa) 
Domain 
structure 
a-like domains Interactions with 
other proteins 
ER retention 
S. cerevisiae homologs  
Pdi1p Trg1 NP_009887 522 a-b-b'-a'-c -C-G-H-C- Ero1p, Kar2p, 
Eps1p, Prc1p 
HDEL 
Mpd1  NP_014931 318 a -C-G-H-C- Cne1p, Mpd2p, 
Eps1p 
HDEL 
Mpd2  NP_014553 277 a -C-Q-H-C- Ero1p HDEL 
Eug1  NP_010806 517 b0-b-b'-b'0 -C-L-H-S- 
-C-I-H-S- 
Eps1p HDEL 
Eps1  NP_012261 701 a -C-P-H-C- Pma1p, Kar2p, 
Eug1p, Pdi1p, 
Mpd1p 
KKXXX 
TM segment 
Others  
TrxA  
(E. coli) 
 AAY89720 109 a -C-G-P-C- TrxR, substrates NA 
DsbA  
(E. coli) 
 
 
CAA56736 208 a -C-P-H-C- DsbB, substrates NA 
Domains a, a' and a0 are redox active with thioredoxin fold. In contrast, b and b' domains are redox inactive with possible a thioredoxin fold (the b 
domain of hPDI has a thioredoxin-like fold although it does not contain the CXXC motif). The D domain is a unique helical domain present in the 
PDI-D family. The domain c represents a highly acidic region. NA non-applicable. 
 
 
 
 
 
 
 
 
 
 Table 2 - Characteristics of mammalian PDI-like proteins and comparison to TrxA and DsbA from E. coli. 
 
Protein Alias NCBI 
accession 
Length Domain structure a-like domains Interactions with other 
proteins 
ER retention 
H. sapiens homologs   
PDI  P4HB, 
P55 
AAH71892 508 a-b-b'-a'-c -C-G-H-C- 
-C-G-H-C- 
Ero1-L KDEL 
ERp57  GRP58, 
P58, 
ERp60, 
ERp61 
NP_005304 505 a-b-b'-a' -C-G-H-C- 
-C-G-H-C- 
calnexin/calreticulin QDEL 
ERp72 (CaBP2, 
ERP70 
NP_004902 645 c-a0-a-b-b'-a' -C-G-H-C- 
-C-G-H-C- 
-C-G-H-C- 
ND KEEL 
PDIp PDIP NP_006840 525 a-b-b'-a' -C-G-H-C- 
-C-T-H-C- 
ND KEEL 
PDIr PDIR BAA08451 519 b-a0-a-a' -C-S-M-C- 
-C-G-H-C- 
-C-P-H-C- 
ND KEEL 
ERdj5 jPDI AAN73271 793 a0-X-a-a'-a'' -C-S-H-C- 
-C-P-P-C- 
-C-H-P-C- 
-C-G-P-C- 
BIP KDEL 
ERp27  NP_689534 273 b None ND  
ERp28 ERp29 P30040 261 b-D None ND  
P5  CaBP1, 
ERp5 
NP_005733 440 a0-a-b-c -C-G-H-C- ND KDEL 
ERp46 EndoPDI NP_110437 432 a-a'-a'' -C-G-H-C- 
-C-G-H-C- 
-C-G-H-C- 
ND  
ERp44  NP_055866 406 a -C-R-F-S- 
 
 
Ero1-L RDEL 
ERp18 ERp19, 
TLP19 
NP_056997 172 a -C-G-H-C- 
I 
ND EDEL 
ERp65 PDILT AAH44936 584 a-b-b-a- -S-K-Q-S- 
-S-K-K-C- 
Ero1-L KEEL 
 
 
 Table 2 (Continued) - Characteristics of mammalian PDI-like proteins and comparison to TrxA and DsbA from E. coli. 
 
Protein Alias NCBI 
accession 
Length Domain structure a-like domains Interactions with other 
proteins 
ER retention 
H. sapiens homologs   
TMX  NP_110283 280 a -C-P-A-C ND TM segment 
TDKS 
TMX2  NP_057043 296 a -S-N-D-C ND KKDK 
TMX3  NP_061895 454 a -C-G-H-C ND TM segment 
-KKKD 
TMX4  AAQ89363 349 a -C-P-S-C- ND TM segment 
-DKGLL 
Others ND 
TrxA  
(E. coli) 
 AAY89720 109 a -C-G-P-C- TrxR, substrates NA 
DsbA  
(E. coli) 
 
 
CAA56736 208 a -C-P-H-C- DsbB, substrates NA 
Domains a, a' and a0 are redox active with thioredoxin-fold. In contrast, b and b' domains are redox inactive with possible a thioredoxin- fold (the b domain of 
hPDI has a thioredoxin-like fold although it does not contain the CXXC motif). The D domain is a unique helical domain present in the PDI-D family. The 
domain c represents a highly acidic region. 
 
 
 
 
 
 
 
35 
The Role of other factors in oxidative folding 
 
Role of glutathione in oxidative folding 
 
Whereas the redox potential of the cytosol is strongly reducing, the redox 
potential of the ER is more oxidizing due to its higher GSSG content (Hwang et al., 
1992).  Glutathione is a major source of thiols in the ER and the ratio of the 
concentration of reduced to oxidized (GSH/GSSG) in the ER is 1:1 to 3:1 (Hwang et al., 
1992).  These studies suggested that glutathione acts as a protein oxidant in the ER.  
Furthermore, oxidative refolding in vitro requires a redox buffer with a similar ratio of 
GSH/GSSG (Gilbert, 1963). 
The current model is that GSH is not required for disulfide bond formation, but 
acts as a net reductant in the ER to counteract the Ero1p-driven oxidation pathway 
(Cuozzo et al., 1999).  First, glutathione is not essential for the formation of disulfide 
bond formation, since mutants in gsh1? are able to mature CPY (Frand et al., 1998).  
Second, deletion of the GSH1 gene (which lacks ?-glutamylcysteine synthetase, the 
enzyme for the first and rate-limiting step in glutathione synthesis) not only restores 
disulfide bond formation to cells containing a mutant ERO1 allele but also causes 
oxidative protein folding to be more readily compromised by the addition of a small 
molecule oxidant (Frand et al., 1998). 
Similar experiments performed in permeabilized mammalian cells have shown 
that reduced glutathione is necessary to counteract the Ero1p-Pdi1p oxidation pathway 
(Molteni et al., 2004).  Furthermore, like GSH1 deletions mutants, glutathione-depleted 
mammalian cells (treated with an inhibitor of ?-glutamylcysteine synthetase) do not 
exhibit defects in oxidative folding or secretion (Chakravarthi et al., 2004; Frand et al., 
1998).  GSH has been shown to be required to keep ERp57 in its reduced state.  
Furthermore, mammalian cells depleted for glutathione cannot reduce ERp57 after 
oxidative stress. However, a large fraction of the glutathione in the ER forms mixed-
disulfide bonds with proteins, thus making it unclear whether reduced glutathione acts by 
maintaining thioredoxin-like reductases in their active reduced form or by directly 
reducing folding substrates (Bass et al., 2004). 
 
 
 
 
 
36 
Role of flavin  
 
FAD1 and FMN1, genes involved in the synthesis of flavin, were found to be high 
copy suppressors of the ero1-1 mutant (Tu et al., 2002).  Furthermore, the observation 
that CPY maturation is defective in the rib5? strain (deficient in production of FAD), while 
there is no observable defect in coq5? or hem1? strains (deficient in production of 
ubiquinone and heme, respectively), suggests that flavin levels influence oxidative 
folding in vivo (Tu et al, 2000).  Various other pieces of evidence suggest a role of flavin 
in the process of disulfide bond formation: 1) ero1-1 is synthetic lethal with fad1-1 
mutant, 2) the fad1-1 mutant is DTT sensitive under anaerobic conditions, 3) 
overexpression of FAD1 in ero1-1 mutants can suppress the growth defect in anaerobic 
conditions, and 4) addition of free FAD to recombinant Ero1p accelerates the formation 
of disulfides in RNAseA (Tu et al., 2002). 
All together, these data suggest that flavin might play an important role in 
disulfide bond formation under anerobic conditions.  The FAD levels in yeast vary with 
the growth condition and the growth phase (Tu et al., 2004). 
Flavin also seems to play a role in mammalian disulfide bond formation 
pathways.  In HepG2 cells, secretion of apolipoprotein B-100 (apoB) into the culture 
medium is lower in riboflavin-deficient cells compared to cells grown in normal medium 
(Manthey et al., 2005).  In addition, riboflavin deficiency causes decreased secretion and 
intracellular accumulation of IL-2 in Jurkat cells (Varsanyi et al., 2004). 
 
Disulfide bond formation in the periplasm of prokaryotes 
 
Oxidation pathway - DsbA & DsbB 
 
The oxidation pathway of gram negative bacteria such as E. coli is composed of 
two proteins, the disulfide oxidase DsbA and the membrane protein DsbB (reviewed in 
(Kadokura et al., 2003).  After transfer of its disulfide bond to a substrate protein, DsbA 
becomes reduced.  To start a new catalytic cycle, DsbA must become reoxidized.  DsbB 
reoxidizes reduced DsbA, thus becoming reduced itself.  Reduced DsbB is reoxidized by 
oxidizing equivalents provided from the respiratory chain through its quinone cofactor 
(Figure 10). 
Inactivation of either DsbA or DsbB leads to accumulation of reduced proteins in 
the periplasm of E. coli.  This, and the fact that both mutants exhibit the same 
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phenotypes (such as sensitive to dithiothreitol, benzylpenicilim and some metal ions 
such as Hg2+ and Cd2+), suggested that these two proteins were acting on the same 
pathway.  Moreover, dsbA? strains have reduced levels of proteins that contain disulfide 
bonds, such as alkaline phosphatase and ?-lactamase.  
 
Isomerization pathway - DsbC/DsbG & DsbD 
 
The fact that DsbA was found not to be a specific oxidant, and therefore could 
lead to the formation of non-native disulfides in proteins with more than 2 cysteines, 
suggested the presence of an isomerization pathway in E. coli (reviewed in (Kadokura et 
al., 2003)).  To correct the non-native disulfides formed by DsbA, E. coli possesses an 
isomerization system composed of protein disulfide isomerase DsbC or DsbG and a 
membrane protein DsbG. 
DsbC/DsbG catalyses the reoxidzation of misoxidized substrates, thus becoming 
oxidized in the process.  In turn, DsbC is reduced by DsbG protein, which gets oxidized 
in the process.  DsbG must be kept reduced in the periplasm to perform its function; thus 
it receives electrons from cytoplasmic thioredoxin. Thioredoxin is kept reduced by 
thioredoxin reductase, which uses NADPH. 
DsbC and DsbD are kept reduced in the oxidative environment of the periplasm.  
Structural and mutagenesis studies showed that while DsbC/DsbD are dimeric proteins, 
DsbA is a monomeric protein.  These studies found that turning DsbC into a monomeric 
protein allow it to be oxidized by DsbB. This elegant mechanism allows two opposite 
pathways (oxidation and isomerization) to occur simultaneously without short-circuiting 
the system. 
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Figure 10.  Pathways of disulfide bond formation (oxidation) and isomerization in the 
periplasm of E. coli. 
 
Comparison of the disulfide bond formation pathways in prokaryotes and 
eukaryotes 
 
Despite the differences between eukaryotes and prokaryotes, their disulfide bond 
formation pathways share a number of features.  The secretion of various oxidized 
proteins is affected by disruption of either DsbA or PDI (Bardwell et al., 1991; Frand et 
al., 1998). The fact that PDI is also able to complement a dsbA? mutant when targeted to 
the bacterial periplasm suggests an overlap of the biochemical activities of PDI and 
DsbA (Humphreys et al., 1995). Their main job is to oxidize substrate proteins in the ER 
and in the periplasm, respectively. 
The loss of either ERO1 or DsbB results in the accumulation of reduced Pdi1p or 
DsbA, their respective substrates (Bardwell et al., 1993; Frand et al., 1998). Both 
mutants seem to accumulate proteins in the reduced state (CPY, Gas1p in the case of 
Ero1 and alkaline phosphatase in the case of DsbB).  Both ero1-1 and dsbB? mutants 
are DTT sensitive, and defects in disulfide bond formation in both mutants are rescued 
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by addition of oxidants (diamide in the case of Ero1p and GSSG or cysteine in the case 
of DsbB).   
Both Ero1p and DsbB are membrane associated oxidoreductases that transfer 
disulfides to soluble thioredoxin-like proteins (Pdi1p/Mpd2p and DsbA respectively) 
suggesting that they are functional homologs.  Moreover, comparison of the structural 
features of both DsbB and Ero1p showed that both contain an active site cysteine pair in 
a four helix bundle containing the redox cofactor (FAD or quinone, respectively), and 
another cysteine pair located in an unstructured flexible loop that is posed to interact with 
the substrate (Sevier et al., 2005).  
The main difference between the prokaryotic and the eukaryotic disulfide bond 
formation pathways is the lack of a dedicated isomerization pathway in eukaryotes.  
Oxidation and isomerization systems in prokayotes are separate (DsbA-DsbB and DsbC-
DsbD systems), while eukaryotes have become dependent on forming disulfides by 
consolidating the oxidase and isomerization functions into one single protein. 
Why do the two pathways not exist in yeast or higher eukaryotes? The periplasm 
is more leaky to the external environment, so if bacteria used a small thiol it would be 
difficult to maintain its concentration in the periplasm.  Thus, the two separate pathways 
for disulfide bond formation and isomerization might be a necessity in bacteria. 
Although eukaryotes lack a dedicated pathway of isomerization there are still 
some interesting analogies that can be made between the two systems.  Both dsbC? and 
gsh1? mutants are rescued by reducing agents (ref in (Frand et al., 2000a)).  Reducing 
equivalents delivered to DsbC from DsbD are derived from cytoplasmic thioredoxin, 
which is linked to NADPH (ref in (Frand et al., 2000a)).  Similarly, reducing equivalents 
delivered to the ER are derived from the cytoplasm, which is linked to NADPH 
metabolism through glutathione reductase.  Although the sequence similarity of Pdi1p 
and DsbC is almost undetectable, their crystal structures suggest a similar fold. 
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Preface 
 
Chapter 2 contains two papers that have been published as: 
 
Sevier, C.S., Cuozzo, J.W., Vala, A., Åslund, F. and Kaiser, C.A. (2001) A flavoprotein 
oxidase defines a new endoplasmic reticulum pathway for biosynthetic disulphide bond 
formation. Nat Cell Biol, 3, 874-882. 
 
Gross, E., Sevier, C.S., Vala, A., Kaiser, C.A. and Fass, D. (2002) A new FAD-binding 
fold and intersubunit disulfide shuttle in the thiol oxidase Erv2p. Nat Struct Biol, 9, 61-67. 
 
 
Chapter 2 represents primarily the work of Fredrick Åslund, John W. Cuozzo, and Einav 
Gross.  Fredrick Åslund performed the screen from where ERV2 was identified and John 
W. Cuozzo did the characterization of Erv2p.  Einav Gross resolved the crystal structure 
of Erv2p. 
 
In the first paper I performed the experiments represented in Figures 2B, C and D.  In the 
second paper, I contributed to Figure 7B and C by constructing the plasmids and strains, 
and by generating preliminary results. 
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Abstract 
 
Ero1p and Pdi1p are essential elements of the pathway for the formation of 
disulfide bonds within the endoplasmic reticulum (ER).  By screening for alternative 
oxidation pathways in Saccharomyces cerevisiae, we identified ERV2 as a gene that 
when overexpressed can restore viability and disulfide bond formation to an ero1-1 
mutant strain.  ERV2 encodes a luminal ER protein of relative molecular mass 22,000.  
Purified recombinant Erv2p is a flavoenzyme that can catalyze O2-dependent formation 
of disulfide bonds.  Erv2p transfers oxidizing equivalents to Pdi1p by a dithiol-disulfide 
exchange reaction, indicating that the Erv2p-dependent pathway for disulfide bond 
formation closely parallels that of the previously identified Ero1p-dependent pathway. 
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Introduction 
 
Secreted proteins and the extracellular domains of membrane proteins often 
contain disulfide bonds that are required for proper protein folding, function and stability.  
The process of disulfide bond formation has been studied intensively by the use of 
assays for the oxidative refolding of reduced and denatured proteins such as 
ribonuclease A (Lyles and Gilbert, 1991).  Such in vitro assays have revealed the 
importance of both a source of oxidizing equivalents (usually provided by a mixture of 
oxidized and reduced glutathione) and a catalyst for disulfide formation and 
rearrangement such as protein disulfide isomerase (PDI).  In eukaryotic cells, protein 
disulfide bonds are formed as the nascent polypeptide chains of secretory proteins enter 
the lumen of the endoplasmic reticulum (ER).  The cellular pathways that provide 
oxidizing equivalents to the ER of living cells conducive for disulfide bond formation have 
recently begun to come to light. 
The product of the ERO1 gene is important in generating oxidizing equivalents in 
the ER.  ERO1 encodes an ER-membrane glycoprotein that in yeast is essential for 
viability and for the generation of disulfide bonds in secretory proteins (Cuozzo and 
Kaiser, 1999; Frand and Kaiser, 1998; Pollard et al., 1998).  ER oxidation by ERO1 
seems to be a broadly conserved mechanism, because homologues of yeast ERO1 are 
present in every eukaryote for which extensive genomic sequence data are available and 
a mammalian version of the gene can functionally complement yeast ero1 mutations 
(Cabibbo et al., 2000).  PDI is a highly abundant resident of the ER lumen that in vitro 
can catalyze either protein disulfide rearrangements or dithiol oxidation to disulfides 
according to the conditions of the assay (Gilbert, 1994).  The activity of PDI depends on 
two pairs of cysteines found in the motif Cys-X-X-Cys, which is a conserved feature of 
the oxidoreductases of the thioredoxin superfamily (Chivers et al., 1997; Martin, 1995).  
Pdi1p is essential for cell viability, and Pdi1p has been implicated in the catalysis of both 
disulfide bond formation and isomerization in vivo (Frand and Kaiser, 1999; Holst et al., 
1997; Laboissiere et al., 1995; LaMantia and Lennarz, 1993; Scherens et al., 1991). 
We have recently delineated a core pathway for disulfide bond formation in the 
yeast ER in which oxidizing equivalents flow from Ero1p to Pdi1p and then to substrate 
proteins (Frand et al., 2000).  Evidence for this pathway comes from mutational studies 
demonstrating that Ero1p is required for oxidation of the cysteine pairs of Pdi1p, and that 
Pdi1p is required for the oxidation of cysteine thiols in substrate proteins.  Direct transfer 
of oxidizing equivalents by dithiol-disulfide exchange reactions was demonstrated by the 
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capture of Ero1p-Pdi1p and Pdi1p-substrate mixed disulfides, which are the 
intermediates for these transfer reactions (Frand and Kaiser, 1999).  Finally, this 
pathway for protein disulfide formation has been confirmed by in vitro reconstitution of 
substrate protein oxidation with the use of purified Ero1p and Pdi1p (Tu et al., 2000).  
The mechanism for oxidation of Ero1p itself is not yet understood, nor has the ultimate 
physiological source of oxidizing equivalents for the ER disulfide bond formation been 
identified. 
Ero1p is required for the oxidation of intraluminal glutathione as well as for the 
oxidation of protein thiols.  However, the production of oxidized glutathione in the ER is 
not an obligatory intermediate step in protein thiol oxidation; instead, the presence of 
reduced glutathione seems to buffer the ER lumen against hyper-oxidizing conditions 
(Cuozzo and Kaiser, 1999; Frand and Kaiser, 1998).  A key observation indicating that 
glutathione effectively competes with protein thiols for oxidizing equivalents derived from 
Ero1p is that the temperature sensitivity of an ero1-1 mutant can be suppressed by 
gsh1?, a mutation that blocks the synthesis of intracellular glutathione (Cuozzo and 
Kaiser, 1999).  We have also found that a complete chromosomal deletion of ERO1 can 
be suppressed in this manner; an ero1? gsh1? double mutant will grow and form normal 
disulfide bonds (J.W.C. and C.A.K., unpublished work).  This observation indicates the 
existence of a bypass pathway for disulfide bond formation that can function 
independently of Ero1p.  We found that an ero1? gsh1? double mutant can grow under 
aerobic but not anaerobic conditions, indicating that bypass of Ero1p requires O2 as an 
ultimate electron acceptor.  Here we used an overexpression screen to identify a 
component of the presumptive bypass pathway, Erv2p, which is a luminal ER oxidase 
that can consume O2 for the production of protein disulfide bonds. 
 
Results 
 
ERV2 defines a novel pathway for disulfide bond formation 
 
To identify components of disulfide bond formation pathways that can function 
independently of ERO1, we screened for genes that when overexpressed could 
suppress the temperature sensitivity of an ero1-1 mutant.  An ero1-1 strain was 
transformed with a library of Saccharomyces cerevisiae cDNAs expressed from the 
powerful GAL1 promoter, and 50 clones were identified that could grow at the restrictive 
temperature of 37 °C from a collection of 106 transformants.  Plasmid recovered from 
these strains revealed that 45 contained cDNA of the ERO1 gene itself, whereas 5 
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plasmids contained the yeast open reading frame (ORF) YPR037C, which had 
previously been designated ERV2 because of its homology with the yeast gene ERV1 
(Figure 1A) (Stein and Lisowsky, 1998). 
We tested whether overexpression of ERV2 could suppress the lethality of a 
complete deletion of ERO1.  A heterozygous ERO1/ero1? diploid strain carrying the 
PGAL1-ERV2 plasmid was sporulated and tetrads were dissected onto galactose medium. 
The ero1? PGAL1-ERV2 spore clones could grow slowly, whereas ero1? spores that did 
not receive the plasmid could not progress beyond two or three cells. The growth of the 
ero1? PGAL1-ERV2 strain depended on ERV2 overexpression because this strain could 
not grow on glucose medium (data not shown). 
We found previously that the capacity of ero1-1 mutants for disulfide bond 
formation is compromised even at temperatures permissive for growth.  As a 
consequence, ero1-1 strains are hypersensitive to the presence of a reductant such as 
dithiothreitol (DTT) or 2-mercaptoethanol in the growth medium (Frand and Kaiser, 
1998).  Activation of a parallel pathway for disulfide bond formation would therefore be 
expected to increase the resistance of the ero1-1 strain to DTT.  Accordingly, we 
assayed a ero1-1 PGAL1-ERV2 strain for DTT resistance and found that ERV2 
overexpression conferred resistance to DTT, as shown by a decrease in the diameter of 
the zone of growth inhibition caused by DTT in a plate assay (Figure 1B). 
Finally, in the most specific test for a role of Erv2p in disulfide bond formation in 
vivo, we assayed the ability of overexpressed ERV2 to restore the capacity of ero1 
mutants to form disulfide bonds in secretory proteins.  Carboxypeptidase Y (CPY) is a 
convenient substrate for this purpose because native CPY contains five disulfide bonds 
and a failure to form these bonds causes the incompletely folded pro-CPY to accumulate 
in the ER (Jamsa et al., 1994; Simons et al., 1995).  Therefore, in an ero1-1 mutant at 
the restrictive temperature (37 °C) pro-CPY accumulates in the ER in its core-
glycosylated, unprocessed p1 form (Figure 1C, lane 1).  This is in contrast to wild-type 
cells, in which CPY is exported from the ER, progresses through the secretory pathway 
and becomes converted to the mature (m) form after cleavage by vacuolar proteases 
(Figure 1C, lane 5).  Both ero1-1 and ero1-1 PGAL1-ERV2 strains were grown in galactose 
medium at a permissive temperature of 24 °C and then shifted to 37 °C for 4 h. Under 
these conditions, the ero1-1 PGAL1-ERV2 strain accumulated much less of the p1 form of 
CPY than the ero1-1 strain as detected by immunoblotting (Figure 1C, compare lane 2 
with lane 1).  The accumulation of some p1 CPY in the ero1-1 PGAL1-ERV2 strain when 
incubated at 37 °C for 4 h indicated a partial defect in disulfide bond formation.  This 
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strain seemed eventually to adapt and to restore apparently normal efficiencies of 
disulfide bond formation, because after incubation of the ero1-1 PGAL1-ERV2 strain at 37 
°C for 20 h, conditions under which this strain continues to grow, the p1 form of CPY was 
only barely detectable (Figure 1C, lane 3).  The total amount of CPY in this strain was 
similar to that in the wild-type, demonstrating that normal CPY synthesis continues at 37 
°C and that the p1 form does not accumulate because it can be converted to mature 
CPY.  Finally, an ero1? PGAL1-ERV2 strain did not accumulate the p1 form of CPY, 
demonstrating that overproduced Erv2p had the capacity to drive native disulfide bond 
formation even in the complete absence of Ero1p (Figure 1C, lane 4).  Neither the ero1? 
PGAL1-ERV2 strain nor the ero1-1 PGAL1-ERV2 strain (at 37 °C) would grow on glucose 
medium, confirming that the suppression of the CPY trafficking defect in these strains 
depended on overexpression of ERV2 and was not the result of cryptic extragenic 
suppressor mutations (data not shown).  Taken together, the increased resistance to 
DTT and the restoration of CPY maturation that is conferred by overexpression of ERV2 
in either ero1-1 or ero1? genetic backgrounds show that overproduced Erv2p forms the 
basis of a disulfide-bond-formation pathway that can function independently of Ero1p. 
 
Erv2p is a luminal ER protein 
 
The ERV2 gene encodes a protein of predicted relative molecular weight 22,000 
(Mr 20K), containing a putative amino-terminal hydrophobic ER localization sequence. 
To examine the intracellular localization of Erv2p, a carboxy-terminal fusion to a 
hemagglutinin (HA) epitope tag was constructed.  The HA-tagged fusion protein could be 
detected by immunoblotting and was able to suppress the ero1-1 temperature-sensitive 
defect, indicating that the tagged protein was functional (data not shown).  Extracts were 
prepared from cells expressing the tagged construct, and Erv2p was followed by 
fractionation under conditions intended to reveal properties such as membrane 
localization and peripheral localization in the ER.  Erv2p could be solubilized by 
detergent (1% Triton X-100) but not by Na2CO3 at pH 11.5, indicating that Erv2p is an 
integral membrane protein and that the hydrophobic N-terminal sequence acts as both a 
signal sequence and a membrane anchor (Figure 2A). 
Immunofluorescence microscopy showed that HA-tagged Erv2p was distributed 
at the perimeter of the nucleus, coincident with the ER-resident protein Pdi1p (Figure 
2B).  The localization of Erv2p to the ER permits it to function directly at the site of 
protein disulfide bond formation.  Because Erv2p has no distinguishable ER retention 
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signal (such as an HDEL-motif), Erv2p is presumably retained in the ER by its 
transmembrane segment.  To determine the membrane topology of Erv2p, membranes 
from a medium-spin pellet fraction (see Materials and methods) were subjected to 
digestion by proteinase K in the presence and absence of Triton X-100. Erv2p-HA was 
resistant to protease digestion in the absence of detergent but was degraded in the 
presence of detergent, like the luminal ER protein Pdi1p, showing that the carboxy-
terminal domain of Erv2p-HA is luminal (Figure 2C).  To exclude the possibility that the 
C-terminal domain of Erv2p was intrinsically protease resistant, purified recombinant C-
terminal domain of Erv2p (described below) was treated with protease under the same 
conditions as those used for the membrane samples and was shown to be sensitive to 
protease in the absence of detergent (Figure 2D).  We therefore conclude that Erv2p is 
normally a type II transmembrane protein with an N-terminal membrane anchor with the 
bulk of the protein residing within the lumen of the ER. 
 
Erv2p is a flavin-binding thiol oxidase 
 
The ERV2 gene sequence shares significant homology with the yeast ERV1 
gene, encoding an essential mitochondrial matrix protein (Hofhaus et al., 1999; 
Lisowsky, 1992), the cytoplasmic human protein ALR (Augmenter of Liver 
Regeneration), which has been shown to stimulate regeneration of the liver after partial 
hepatectomy (Francavilla et al., 1994; Hagiya et al., 1994), the C-terminal domain of the 
secreted human protein quiescin Q6, a Mr-93K protein that is induced when fibroblasts 
reach senescence (Coppock et al., 1998), and cytoplasmic proteins encoded by vaccinia 
and African swine fever viruses (Lewis et al., 2000; Senkevich et al., 2000).  All four 
proteins share a Cys-X-X-Cys motif, indicative of the active site of thioredoxin-like thiol 
oxidoreductases, but no other similarity to proteins of the thioredoxin family of proteins is 
evident in this domain (Figure 3).  Importantly, the avian homologue of quiescin Q6 
(designated SOX) and Erv1p have been shown to be flavoproteins that catalyze the 
reaction (Hoober et al., 1999; Lee et al., 2000) 
 
2R-SH + O2 ? R-S-S-R + H2O2 
 
To examine the possible enzymatic activity of Erv2p, the ERV2 coding sequence 
with a C-terminal His6 tag was expressed in Escherichia coli from the T7 promoter.  
Although some full-length Erv2p could be expressed in this way, we found that a much 
greater yield of soluble protein was obtained by expression of a truncated protein 
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(designated Erv2-?N) that lacked 29 residues of the hydrophobic N terminus.  
Purification of Erv2-?N from a cytosolic extract by Ni-nitrilotriacetate (NTA) affinity 
chromatography produced a protein of Mr 20K that was of >90% purity as assessed by 
staining with Coomassie Blue after SDS-PAGE. 
Purified recombinant Erv2-?N protein was bright yellow, and spectroscopic 
analysis of the protein revealed absorbance peaks at 382 and 454 nm, indicative of a 
bound FAD moiety (Figure 4A).  We found that the yield of flavin-bound Erv2-?N (as 
determined by the ratio of Abs280 to Abs454 for the purified protein) could be improved 
about twofold if FAD was added to the E. coli growth medium during the period of protein 
induction.  The flavin moiety could be released from the protein either by boiling or by 
precipitation of the protein in trichloroacetic acid (TCA), indicating that the flavin was not 
covalently bound to the protein.  The fluorescence (excitation at 450 nm and emission at 
535 nm) of released flavin increased 4.7-fold on transfer from neutral to acidic pH; this is 
a characteristic of FAD, not FMN (Faeder and Siegel, 1973).  The FAD moiety was found 
to bind tightly to the protein, because the protein retained 98% of its FAD absorbance at 
454 nm after dialysis for 20 h.  When purified Erv2-?N was denatured in 8 M guanidinium 
chloride, the absorbance at 454 nm was identical to that of the folded protein; we 
therefore calculated the concentration of protein with bound flavin in our preparations 
from the absorption coefficient for pure flavin.  The ratio of the protein concentration of 
purified recombinant Erv2-?N and the flavin concentration (using an absorption 
coefficient of 12.5 mM-1 cm-1 at 454 nm) was 0.74, indicating that the normal 
stoichiometry of FAD binding is one FAD molecule per monomer of protein. The 
overexpressed recombinant protein is most probably not completely loaded with FAD. 
We tested the ability of purified Erv2-?N to catalyze the transfer of reducing 
equivalents from free thiols to FAD. Reduction of the bound FAD could be monitored by 
a corresponding decrease in Abs454.  The addition of 5 mM DTT to a solution containing 
4 μM Erv2-?N caused complete reduction of bound FAD (Figure 4B).  Because 5 mM 
DTT alone would not reduce FAD in solution, Erv2-?N must act as an efficient catalyst 
for the transfer of electrons from the thiol groups of DTT to the protein-associated FAD.  
The observed time lag between the moment of DTT addition and the ensuing reduction 
of FAD probably corresponds to the time that it takes for the oxidase activity to consume 
a significant quantity of the O2 in the spectrophotometer cuvette.  A similar delay in the 
DTT reduction of the FAD moiety of SOX has been observed (Hoober et al., 1999).  The 
reduced FAD produced after the addition of DTT to Erv2-?N could be re-oxidized by the 
introduction of oxygen to the solution as detected by an increase in Abs454 after the 
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addition of oxygen (data not shown).  Erv2-?N exhibited specificity for the type of thiol-
containing compound that could be coupled to FAD reduction because reduced 
glutathione at concentrations up to 100 mM did not produce detectable reduction of the 
FAD in Erv2-?N even after prolonged incubation (data not shown). 
To determine whether O2 could serve as an electron acceptor for Erv2-?N, 
consumption of soluble O2 was measured with an oxygen electrode. When Erv2-?N was 
mixed with DTT in a buffer saturated with O2, a steady decrease in the soluble O2 could 
be recorded.  In addition, the concomitant production of H2O2 could be detected by the 
peroxidase-catalyzed oxidation of o-dianisidine (data not shown).  This consumption of 
O2 and production of H2O2 depended on both DTT and Erv2-?N.  The corresponding 
oxidation of DTT was confirmed by following a decrease in the reactivity of DTT with 
Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid)) (data not shown).  The rate of DTT 
oxidation was equal within experimental error to the rate of oxygen consumption, 
indicating a stoichiometry of 1 mol of molecular oxygen consumed per mole of disulfide 
produced.  The rate of O2 consumption was saturable with increasing concentrations of 
DTT and the Km of Erv2-?N for DTT was calculated to be 6.9 mM with a turnover number 
of 239 mol O2 min
-1 per mole Erv2-?N (Figure 4C).  In concordance with the results from 
the FAD reduction assay described above, we found that the addition of glutathione to 
the enzyme did not cause a detectable increase in oxygen consumption or H2O2 
production, showing that Erv2p alone will not react with glutathione.  Overall, these 
results led to the conclusion that Erv2p can use molecular oxygen as a source of 
oxidizing equivalents for thiol oxidation in vitro. 
 
In vivo function of Erv2p 
 
Using the ability of ERV2 overexpression to suppress the temperature sensitivity 
of ero1-1 as a measure of Erv2p activity in vivo, we tested whether suppression requires 
O2.  Wild-type, ero1-1, ero1-1 PGAL1-ERV2 and ero1-1 PGAL1-ERO1 strains were incubated 
at 37 °C in an anaerobic chamber.  ERV2 was unable to rescue the ero1-1 strain 
anaerobically, whereas overexpression of ERO1 allowed the strain to grow nearly as well 
as the wild-type under the same conditions (Figure 5A).  Thus, oxygen is necessary for 
Erv2p to function in vivo as well as in vitro. 
Deletion of the ERV2 gene in the ero1-1 background significantly increases DTT 
sensitivity.  When grown with 1 mM DTT, the double mutant grows much more slowly 
than ero1-1 alone (Figure 5B).  The hypersensitivity of an ero1-1 erv2? double mutant to 
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DTT was confirmed by determining the size of the growth inhibition zone caused by DTT 
on solid medium (data not shown).  The Erv2p pathway is not essential for disulfide bond 
formation under standard growth conditions; deletion of ERV2 in a wild-type background 
does not result in a disulfide bond formation defect.  It is therefore likely that Erv2p is 
directly involved in maintaining the oxidizing conditions of the ER, although the inherent 
capacity for generation of oxidizing equivalents in the ER of endogenous Erv2p seems to 
be considerably less than that of Ero1p. 
Since the cysteine residues in the Cys-X-X-Cys motif (Cys121 and Cys124) of 
Erv2p are conserved between the Erv2p homologues, we were interested in whether 
either of these residues was essential for the activity of the protein in vivo.  The single 
mutants Cys121?Ala and Cys124?Ala and the Cys121?Ala,Cys124?Ala double 
mutant of Erv2p were generated by site-directed mutagenesis and found not to be able 
to suppress the temperature-sensitivity of the ero1-1 strain (Table 1).  All three mutant 
proteins were expressed at the same level as wild-type protein, as determined by 
immunoblotting (data not shown).  To examine the FAD binding of the mutants, all of the 
mutants were expressed in E. coli, then purified and assayed for FAD binding by 
examining their absorbance spectra.  All three mutants had absorbance maxima near 
454 nm, and the ratio of Abs454 to the total protein Abs280 was significantly higher than the 
ratio for the BSA control protein.  These results indicated that the cysteine mutants were 
able to fold normally and to bind FAD (Table 1).  The activity of each of the mutants with 
DTT was tested with the oxygen consumption assay and none of the Erv2p Cys-X-X-Cys 
mutants was found to be active in this assay.  These results demonstrate that the 
cysteine residues in the conserved Cys-X-X-Cys motif of Erv2p are required for its 
activity as an oxidase in vitro and in vivo. 
 
Trapping of Pdi1p-Erv2p mixed disulfides in vivo 
 
We next wished to examine the relationship between the oxidase activity of Erv2p 
observed in vitro and the oxidation of substrate proteins in vivo.  Other pathways for 
protein disulfide bond formation, including Ero1p-Pdi1p in the ER and DsbB-DsbA in the 
bacterial periplasm, employ a protein from the thioredoxin family of thiol oxidoreductases 
for the purpose of disulfide transfer, suggesting that Erv2p might similarly operate in 
conjunction with Pdi1p or one of the yeast PDI homologues. We therefore examined 
whether Erv2p participates in a thiol-disulfide exchange pathway with Pdi1p. 
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During the transfer of a disulfide bond, a mixed-disulfide intermediate is 
generated when a disulfide bond in the oxidized partner is attacked by a cysteine-derived 
thiolate anion in the reduced partner.  To assay for this mixed-disulfide intermediate, 
cells overproducing both Erv2p-HA and Pdi1p were labeled with [35S]methionine and 
subsequently treated with TCA to block thiol exchange and precipitate cellular proteins.  
Free thiols were then blocked with the thiol-alkylating agent N-ethylmaleimide (NEM) and 
proteins were immunoprecipitated with anti-HA under non-reducing but denaturing 
conditions.  Primary anti-HA immunoprecipitates were divided and reimmunoprecipitated 
with anti-Pdi1p or anti-HA.  The most prominent species detected on the non-reducing 
gel have Mr values of 25K and 50K. The Mr 25K species corresponds to an Erv2p-HA 
monomer, whereas the Mr 50K species corresponds to an Erv2p-HA homodimer.  
Purified recombinant Erv2-?N also forms a prominent disulfide-bonded homodimer, 
which is evident when preparations of Erv2-?N are resolved on non-reducing gels (data 
not shown).  Also evident when Erv2p-HA was immunoprecipitated from yeast extracts 
under non-reducing conditions were high-molecular-weight complexes that contained 
Pdi1p as shown by reprecipitation with anti-Pdi1p antibody (Figure 6A, lanes 1 and 2).  
On reduction with DTT, the high-molecular-weight complex resolved into two bands 
corresponding to Erv2p-HA and Pdi1p (Figure 6A, lanes 3 and 4).  These results show 
that Erv2p can engage Pdi1p in a thiol-disulfide exchange reaction in vivo. 
 
Oxidation of Pdi1p by Erv2p in vitro 
 
The expected product of a disulfide transfer between Pdi1p and Erv2p is oxidized 
Pdi1p.  Given that we had preparations of enzymatically active recombinant Erv2-?N, we 
tested the ability of pure Erv2-?N to oxidize purified Pdi1p in vitro.  Functional 
recombinant Pdi1p was prepared in a reduced state and then incubated with Erv2-?N for 
15 min at 30 °C.  At the end of the reaction, TCA was added to preserve the oxidation 
state by rapidly blocking thiol exchange, and then the oxidation state of Pdi1p was 
assessed by reaction with the thiol-conjugating reagent 4-acetamido-4'-
maleimidylstilbene-2,2'-disulphonic acid (AMS) at neutral pH.  The reduced and oxidized 
forms of AMS-modified Pdi1p were resolved by SDS-PAGE.  When reduced Pdi1p and 
Erv2-?N were mixed, Pdi1p exhibited redox changes consistent with quantitative 
disulfide bond transfer from Erv2p to Pdi1p (Figure 6B, lanes 4-6).  Reduced Pdi1p 
incubated with an excess of the oxidizing agent diamide was used as the mobility 
standard for fully oxidized Pdi1p (Figure 6B, lane 3).  The cysteine residues in the 
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conserved Cys-X-X-Cys motif of Erv2p are required for disulfide bond transfer to Pdi1p, 
because mixing the Erv2-Cys121?Ala,Cys124?Ala mutant with Pdi1p did not result in 
the oxidation of Pdi1p (Figure 6B, lane 7).  Additionally, FAD alone could not transfer 
oxidizing equivalents to Pdi1p in the absence of Erv2p (Figure 6B, lane 8). 
 
Discussion 
 
We previously identified Ero1p as a major conduit for introducing oxidizing 
equivalents into the lumen of the ER.  Here we show that an ero1? mutant can be 
bypassed by overexpression of Erv2p, indicating that Erv2p can supplant Ero1p for the 
generation of biosynthetic protein disulfide bonds in the ER.  Erv2p is an ER protein with 
an N-terminal hydrophobic membrane anchor and a luminal domain that binds FAD and 
can catalyze the formation of disulfide bonds with O2 as an electron acceptor. Parallel 
physiological experiments show that the capacity of Erv2p to drive disulfide bond 
formation in vivo in an ero1-1 mutant requires O2 and depends on two conserved 
cysteine residues within Erv2p that are necessary for thiol oxidase activity in vitro.  Erv2p 
seems to drive the oxidation of substrate proteins in vivo as part of a disulfide-bond-
formation cascade involving Pdi1p. 
The Erv2p sequence includes an N-terminal hydrophobic segment (amino acids 
10-30) that seems to be a transmembrane anchor because Erv2p fractionates with the 
membrane and resists extraction by treatment with high pH or chaotropic agents.  An 
algorithm to assess topology based on a comparison of the net charge difference 
between amino acid sequences flanking the transmembrane domain (Claros and von 
Heijne, 1994) leads to the prediction that most of Erv2p (amino acids 31-196) should 
reside within the lumen of the ER.  We confirmed this prediction experimentally by 
demonstrating that Erv2p present in an isolated microsomal membrane fraction is 
inaccessible to protease.  In parallel experiments we showed that the soluble luminal 
domain of Erv2p, when expressed in E. coli, binds tightly to FAD and uses this flavin 
cofactor to catalyze thiol oxidation.  Similar experiments, published while this manuscript 
was under review, also demonstrate that Erv2p is an FAD-linked thiol oxidase present in 
a yeast microsomal fraction (Gerber et al., 2001).  These results, in addition to the recent 
discovery that Ero1p also binds FAD (Tu et al., 2000), indicate that yeast cells contain a 
pool of FAD within the lumen of the ER that, in turn, implies the existence of a 
transporter for FAD (or FADH2) in the ER membrane.  Transporters for the nucleotide-
sugar precursors of luminal glycosylation reactions that reside in the ER or Golgi 
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membranes have been studied extensively (Hirschberg et al., 1998), but a transporter 
specific for FAD derived from these organelles has not been described.  It might be 
possible to identify this transporter biochemically by an assay for FAD transport activity 
in microsomal membrane preparations.  Alternatively, it might be possible to use Erv2p 
function as the basis for a genetic screen for FAD transport mutants. 
Figure 7 summarizes the relationships between the different pathways for 
disulfide formation and consumption that we have defined in the ER of living S. 
cerevisiae cells.  The primary pathway for introducing oxidizing equivalents into the ER 
involves two essential proteins, Ero1p and Pdi1p (Frand et al., 2000; Frand and Kaiser, 
1999).  Disulfide bonds that form within Ero1p are transferred, by a dithiol-disulfide 
exchange reaction, to the active site of Pdi1p and are then transferred to substrate 
proteins (Frand et al., 2000).  Thus, Ero1p seems to link the redox chemistry of the cell 
to the formation of disulfide bonds within the ER, whereas Pdi1p seems to act as a 
mobile carrier of oxidizing equivalents adapted for the introduction of disulfide bonds into 
substrate proteins.  We now know of two different ways of bypassing the requirement for 
Ero1p in disulfide bond formation.  The first is to decrease the overall load on the ER 
oxidation pathways.  Glutathione within the ER competes with protein thiols for the 
oxidizing equivalents generated by Ero1p; the load on the protein oxidation pathways 
presented by glutathione can be greatly decreased by blocking the cellular synthesis of 
glutathione (Cuozzo and Kaiser, 1999).  The second method of bypassing the need for 
Ero1p is to overexpress Erv2p.  Erv2p seems to participate in a disulfide bond cascade 
in parallel with Ero1p.  As expected, bypass via the Erv2p pathway is only effective 
during aerobic growth, when O2 is available as an electron acceptor for Erv2p.  The 
Erv2p pathway is not essential for disulfide bond formation under standard growth 
conditions, but in a sensitized genetic background with impaired Ero1p function we can 
detect a contribution of Erv2p to the capacity of the ER for disulfide bond formation.  
ERV2 expression is induced in cells that have entered stationary phase (Stein and 
Lisowsky, 1998), suggesting that under these conditions Erv2p might have a larger part 
in providing oxidizing equivalents to the ER. 
Ero1p and Erv2p differ in their use of electron acceptors.  Ero1p contributes to 
ER oxidation in either the presence or the absence of O2, implying that the physiological 
electron acceptor(s) for Ero1p is not O2 and does not depend on O2 for its generation. In 
the recent reconstruction of the Ero1p pathway in vitro, the oxidation of protein 
substrates by purified Ero1p and Pdi1p required a stoichiometric excess FAD (Tu et al., 
2000).  Thus, for this reaction in vitro, the source of oxidizing equivalents seems to be 
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added free FAD, implying that Ero1p becomes reoxidized by the acquisition of FAD from 
solution.  Accordingly, it is possible that in vivo Ero1p exchanges FADH2 for free FAD in 
the ER lumen and that free FAD and FADH2 shuttle between the cytosol and ER lumen.  
However, it seems unlikely that this is the normal physiological mechanism for oxidation 
of Ero1p.  The concentration of FAD in yeast cells is much less than that required for the 
oxidation of Ero1p in vitro (Gliszczynska and Koziolowa, 1998).  In addition, most 
flavoproteins bind their cofactors tightly, which precludes the use of a catalytic cycle 
based on flavin exchange with solution.  In contrast to what has been found for Ero1p, 
we show here that Erv2p binds tightly to its FAD cofactor and uses O2 as a direct and 
obligatory electron acceptor.  The Erv2p pathway therefore represents the first 
eukaryotic pathway for biosynthetic disulfide bond formation in the ER for which the 
ultimate electron acceptor has been defined. 
The physiological implications of two parallel pathways for disulfide bond 
formation in the yeast ER are not yet understood.  Our results demonstrate that Erv2p 
can transfer oxidizing equivalents directly to Pdi1p in vivo and in vitro.  However, the role 
of the four additional PDI homologues present in the yeast ER as potential substrates for 
Ero1p or Erv2p has not been fully explored.  An intriguing possibility is that Ero1p and 
Erv2p might transfer oxidizing equivalents to different PDI homologues, which in turn 
might perform specialized functions in the oxidation of different substrate proteins.  
Preliminary experiments suggest that Ero1p and Erv2p might prefer different substrates 
in that a dithiol-disulfide exchange reaction between Ero1p and Mpd2p has been 
detected (Frand and Kaiser, 1999), whereas a corresponding mixed-disulfide 
intermediate has not been detected between Erv2p and Mpd2p (data not shown).  
Although the ability to capture mixed disulfides provide strong evidence for a dithiol-
disulfide transfer reaction, the mixed-disulfide species is an evanescent intermediate and 
there is no reason to assume that the amount of mixed disulfide should be correlated 
with the overall rate of disulfide transfer between proteins.  Accordingly, a full description 
of the fluxes of disulfides from Ero1p and Erv2p to the different PDI homologues will 
probably require reconstitution of each of the possible exchange reactions in vitro and 
measurement of the corresponding kinetic constants. 
Erv2p is a member of a family of thiol oxidases that are distributed widely among 
eukaryotic organisms and their viruses (Coppock et al., 1998; Hofhaus et al., 1999; 
Hoober et al., 1999; Senkevich et al., 2000).  Although the different members of this 
family reside in a variety of cellular locations, a common mechanism for disulfide transfer 
to substrate proteins has begun to emerge.  Our results show that Erv2p can operate in 
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conjunction with Pdi1p to mediate the transfer of disulfide bonds to thiol substrate 
proteins within the yeast ER.  Recent studies on cytoplasmic disulfide bonds that form 
during the maturation of vaccinia virus particles show that the vaccinia E10R protein, 
which is homologous to Erv2p, is responsible for the oxidation of the viral G4L gene 
product, which is homologous to glutaredoxin (Senkevich et al., 2000).  The natural 
substrates for oxidation by Erv1p within the mitochondrion have not been identified. 
However, it seems possible that the TRX3 gene product, a thioredoxin targeted to the 
mitochondrial matrix, might be the oxidoreductase partner for Erv1p (Pedrajas et al., 
1999).  Similarly, the cytoplasmic ALR proteins have been shown to have protein thiol 
oxidase activity (Lisowsky et al., 2001).  It is possible that ALR uses cytoplasmic 
thioredoxin or glutaredoxin as a cofactor, but the ultimate substrate for ALR is not known.  
Finally, although a requirement for the thioredoxin-like domain of SOX in protein disulfide 
formation has not been established, it seems possible that an internal disulfide transfer 
between the ERV-like and thioredoxin-like domains is part of the mechanism by which a 
disulfide bond is ultimately transferred to a substrate protein in the extracellular space. 
The members of the QSOX/ERV family that are targeted to the secretory pathway 
can be classified into two general types, ERV-like and QSOX-like.  The ERV-like 
sequences have a hydrophobic N terminus and are about 200 amino acids in length.  
Sequences of this type can be identified in fungal genomes, including S. cerevisiae, 
Candida albicans, Botrytis cinerea and Saccharomyces pombe.  These proteins 
presumably function as thiol oxidases within the ER of their respective organisms.  ERV-
like sequences are not evident in the genomic or expressed sequence tag databases for 
multicellular eukaryotes, including Arabidopsis thaliana, Caenorhabditis elegans, 
Drosophila melanogaster and Homo sapiens.  However, these metazoan genomes all 
encode proteins with the same overall sequence organization of QSOX (including a 
signal sequence, an N-terminal thioredoxin domain and a C-terminal ERV-like domain 
with an overall length of 400-600 amino acids).  If we extrapolate from the physiological 
characterization of Erv2p presented here and the characterization of SOX as a secreted 
protein of avian egg whites, it seems that the fungi have evolved to use the ERV-like 
domain for biosynthetic protein disulfide formation within the ER, whereas multicellular 
organisms use the same domain in the context of a secreted protein for disulfide bond 
formation in the extracellular space. 
 
Material and methods 
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Strains and growth conditions 
 
YPD is rich medium with 2% glucose and YPGal is rich medium with 2% 
galactose. Some experiments were performed with YEP medium containing 2% raffinose 
and 1% galactose to induce the GAL1 promoter. To grow strains under anaerobic 
conditions, 0.002% ergosterol and 0.5% Tween 80 were added to the medium. 
Anaerobic conditions were maintained in a sealed BBL GasPak chamber with a H2 and 
CO2 generator envelope (Becton Dickinson). Minimal medium (SMM) contains either 2% 
glucose or a specified carbon source and is supplemented with 16 amino acids not 
including cysteine. 
Genotypes of the strains used in this study are listed in Table 2. The isolation and 
characterization of the ero1-1 temperature-sensitive strain (CKY559) were as described 
previously (Frand and Kaiser, 1998). 
The erv2? strain (CKY688) was constructed by transforming a wild-type strain 
(CKY8) with a linear DNA fragment containing 45 base pair segments derived from the 5' 
and 3' non-coding regions of ERV2 flanking the kanMX4 gene. This fragment was 
designed so that homologous recombination of the fragment would give a complete 
deletion of the ERV2 coding sequence. The DNA fragment was synthesized by PCR with 
Vent polymerase (New England Biolabs) and the kanMX4-containing plasmid pFA6a-
kanMX4 (Wach et al., 1994). The primers used for PCR were 5'-TTT GTA AAG AGG 
AAA GTC TGG ACA GAT TGT GCA AGG AAC GAA GGG CGT ACG CTG CAG GTC 
GAC-3' and 5'-AAA AAT TTA CTA TTA CTA TAA TTG ATT AAT GTA ATC TTT CTT 
TGT ATC GAT GAA TTC GAG CTC G-3'. Mutants containing the integrated kanMX4 
gene were selected on rich medium containing geneticin (20 μg ml-1) and were verified 
by PCR amplification of the insert sequences. 
The erv2? ero1-1 strain (CKY689) was constructed by crossing the erv2? strain 
(CKY688) to a MATa ero1-1 strain (CKY687); the resulting erv2? ero1-1 spore clones 
were identified by their temperature sensitivity and geneticin resistance. A sister spore 
clone (CKY690) of the double mutant that contained only the ero1-1 allele was used for 
comparisons of growth rate and DTT sensitivity with the double-mutant strain. 
The ero1? strain containing the PGAL1-ERV2 plasmid was constructed by 
transforming the heterozygous ERO1/ero1? diploid strain (CKY467) with PGAL1-ERV2 
(pFA11; see below). The transformants were sporulated and tetrads dissected on YPGal 
plates. Spores containing the ero1? allele and the PGAL1-ERV2 plasmid were able to grow 
slowly on galactose but not at all on glucose medium. 
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Isolation of PGAL1 -ERV2 
 
The ero1-1 mutant strain (CKY598) was transformed with a yeast cDNA library 
under the regulation of the GAL1 promoter (Liu et al., 1992). Approximately 106 colonies 
were replica-plated onto YEP plates supplemented with 2% raffinose and 1% galactose 
and incubated at 37 °C for 2 d. A total of 50 colonies that grew under these conditions 
were analyzed. Plasmid DNA was screened by PCR with primers specific for GAL1 
promoter (5'-TGC ATA ACC ACT TTA ACT-3') and ERO1 (5'-CGT GTT CAA ATA TTC 
CTT TGA-3'): 45 of the plasmid preparations gave rise to a PCR product of the size 
expected from an ERO1 insert. Five plasmids that did not encode ERO1 contained the 
yeast ORF YPR037C, ERV2; a representative plasmid was named pFA11. pFA11 was 
re-transformed into the ero1-1 strain (CKY598). This strain could grow at 37 °C on both 
minimal and rich medium containing galactose, but could not grow on glucose-containing 
medium at 37 °C. 
 
Tagging of ERV2 
 
The insert in pFA11 was amplified with the primers Gal1 (see above) and 
Erv2Coxp: 5'-ATT ACC GCG GTT AGC GGC CG CCG TGC TGT TTA GCC TCC-3' and 
was digested with BamHI and SacII and ligated to pFA11 digested with the same 
enzymes. The resulting plasmid was named pFA12. An in-frame HA tag was then ligated 
into the NotI site at the 3' end of ERV2; the resulting PGAL1-ERV2-HA construct was 
named pFA13. PGAL1-ERV2-HA from pFA13 was inserted into a centromeric plasmid 
marked with LEU2 to form pJC16. 
 
Detection of CPY, Erv2p and Pdi1p by immunoblotting 
 
For the detection of CPY, cells were cultured in SMM lacking uracil with the 
addition of 2% galactose and a total of 5 OD600 units of cells were pelleted and then 
suspended in 50 μl sample buffer (80 mM Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, 25 
mM DTT, 0.01% bromophenol blue) and boiled for 2 min. Cells were lysed by agitation 
with glass beads, an additional 50 μl sample buffer was added and the samples were 
centrifuged briefly. The equivalent of 0.75 OD600 units of cells for each sample were 
subjected to SDS-PAGE (8% gel). Immunoblotting was performed as described (Elrod-
Erickson and Kaiser, 1996), with anti-CPY (1:1,000 dilution) and horseradish-peroxidase 
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(HRP)-conjugated donkey anti-rabbit IgG (1:10,000 dilution; Amersham). Erv2p-HA 
immunoblots used monoclonal anti-HA antibody 16B12 (1:500 dilution; Covance) and 
sheep anti-mouse IgG-HRP (1:3,000 dilution, Amersham). Pdi1p immunoblots used 
polyclonal anti-Pdi1p antibody (1:1,000 dilution, a gift from T. Stevens, Eugene, Oregon) 
and donkey anti-rabbit IgG-HRP (1:10,000 dilution; Amersham). Blots were developed by 
chemiluminescence (ECL system; Amersham) and detected on a Kodak Image Station 
440. 
 
Localization of Erv2p 
 
A wild-type yeast strain (CKY263) was transformed with pFA13 encoding the HA-
tagged version of Erv2p. This strain was grown to exponential phase in SMM lacking 
uracil and containing 2% raffinose and 1% galactose; cells were suspended in 10 mM 
Tris-HCl [pH 7.5], 1 mM EDTA, 0.1 mM PMSF, and lysed with glass beads. Unlysed cells 
were removed by centrifugation at 500 g for 1 min. The resulting extract was treated with 
10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 0.1 mM PMSF containing 1% Triton X-100, 2.5 M 
urea or 0.1 M Na2CO3 [pH 11]. After incubation on ice for 1 h, the samples were 
fractionated by centrifugation at 100,000 g for 1 h. Supernatants were collected and 
mixed with sample buffer, and membrane pellets were solubilized in sample buffer at the 
same final volume as supernatants. The samples were separated by SDS-PAGE (12% 
gel) and Erv2p-HA was detected by immunoblotting. 
For the localization of Erv2p by immunofluorescence, CKY263 containing pJC16 
was grown to exponential phase in SMM lacking leucine and containing 2% galactose 
and 2% raffinose, and the cells were fixed with 1/10 culture volume of 37% 
formaldehyde. Fixed cells were treated with lyticase followed by monoclonal anti-HA 
12CA5 (1:5,000 dilution; Covance) and polyclonal anti-Pdi (1:2,500 dilution; a gift from T. 
Stevens). A secondary Alexa 488 goat anti-mouse (1:200 dilution; Molecular Probes) 
and a secondary Texas Red donkey anti-rabbit antibody (1:200 dilution; Amersham) 
were used for the detection of Erv2p-HA and Pdi1p, respectively. Staining with 4',6-
diamidino-2-phenylindole (DAPI) was used to identify the localization of the yeast 
nucleus. Images were acquired with a Nikon E800 microscope equipped with a charge-
coupled device camera (model C4742-95; Hamamatsu) and Improvision Open lab 
software. 
For protease accessibility experiments, CKY263 containing pJC16 was grown to 
exponential phase in SMM lacking leucine and containing 2% galactose and 2% 
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raffinose. Cells were converted to spheroplasts by digestion with lyticase, lysed by 
Dounce homogenization in buffer 88 (20 mM HEPES [pH 6.8], 150 mM potassium 
acetate, 250 mM sorbitol, 1 mM magnesium acetate) and centrifuged at 370 g. The 
supernatant fraction was centrifuged at 12,000 g, and the membrane fraction suspended 
in buffer 88 was used as the starting material for digestion with protease. Samples were 
treated on ice with 50 μg ml-1 proteinase K (Sigma) in the presence or absence of 1% 
Triton X-100; digestion was stopped by the addition of 40 mM PMSF. Erv2p-HA and Pdip 
were detected by immunoblotting. In parallel, samples of purified Erv2-?N were 
subjected to digestion with proteinase K under identical conditions. Digestion was 
stopped after 30 min by addition of 60 mM PMSF and Erv2-?N was detected by SDS-
PAGE and Coomassie Blue stain. 
 
Expression and purification of Erv2p 
 
The ERV2 gene was subcloned into the bacterial expression vector pET-21b(+) 
(Novagen) containing the T7 promoter and the His6 tag, using PCR to amplify the gene 
from the original library clone pFA11. To increase expression, the first 29 amino acids 
encoding the hydrophobic N-terminal signal sequence were not included in the bacterial 
expression vector. The 5' primer contains an NheI site followed by a sequence 
homologous to ERV2 bases 88-120 (5'-AAA AAA GCT AGC GAA CTA TCC ATC GCT 
ACG CCG GGC-3'). The 3' primer contains a HindIII site followed by the reverse 
complement of ERV2 bases 565-588 (5'-AAA AAA AAG CTT ACC GTG CTG TTT AGC 
CTC CTT CTC-3'). The ERV2 gene was amplified with Vent polymerase and the 
resulting PCR product was digested with NheI and HindIII and ligated into these sites in 
the pET-21b(+) vector. The resulting construct (pJC11) expressed Erv2-?N, which 
corresponded to Erv2p without the signal sequence followed by an in-frame His6 tag. 
The bacterial host BL21 was transformed with pJC11. A saturated 10 ml culture 
of this strain was diluted into 1 liter of 2 times YT plus ampicillin, grown to exponential 
phase, and the expression of Erv2-?N was induced with 1 mM isopropyl beta-D-
thiogalactoside (IPTG) for 2 h at 30 °C. To maximize loading of Erv2-?N with flavin, FAD 
(Sigma) was added to a final concentration of 10 μM at the time of induction. The cells 
were harvested in 25 ml lysis buffer (50 mM sodium phosphate [pH 8.0], 300 mM NaCl, 
10 mM imidazole, 1 mM PMSF) and were lysed by incubation for 20 min on ice with 1 
mg ml-1 lysozyme, followed by sonication. Insoluble material was removed by 
centrifugation (25,000 g for 20 min) and the cleared lysate was bound to 1 ml 50% Ni-
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NTA (Qiagen) resin by batch incubation for 1 h at 4 °C. The resin was washed with 20 ml 
50 mM sodium phosphate [pH 8.0], 300 mM NaCl, 20 mM imidazole followed by 10 ml 
50 mM sodium phosphate [pH 8.0], 300 mM NaCl, 50 mM imidazole. Bound protein was 
eluted with 50 mM sodium phosphate [pH 8.0], 300 mM NaCl, 250 mM imidazole and 
then dialyzed for 20 h against 50 mM sodium phosphate [pH 7.5], 150 mM NaCl. The 
dialyzed fractions were analyzed by staining with Coomassie Blue and were found to 
contain a major band running at a Mr of 21K, consistent with the predicted molecular 
mass of the Erv2-?N construct. 
The absorbance spectrum of Erv2-?N was recorded on a Hewlett-Packard 8452A 
diode array spectrophotometer and showed peaks characteristic of a bound flavin. The 
flavin group of recombinant Erv2-?N was further characterized by fluorescence 
spectroscopy. The bound flavin was released by boiling a sample of the protein for 5 min 
in a foil-covered tube. The boiled sample was centrifuged to remove the precipitated 
protein, and aliquots of the supernatant were diluted 1:50 into 50 mM Tris-HCl [pH 7.5] or 
10 mM HCl. The fluorescence of both samples was determined on a Hitachi F4500 
fluorescence spectrophotometer with an excitation wavelength of 450 nm and an 
emission range of 490-600 nm. The fluorescence of the acidified supernatant at 535 nm 
was 4.7-fold that of the neutral solution, which is characteristic of FAD and not FMN 
(Faeder and Siegel, 1973). 
 
Mutagenesis of ERV2 
 
Mutants of ERV2 that converted Cys121 or Cys124 to Ala were made with the 
QuikChange site-directed mutagenesis kit (Stratagene), which allowed the mutations to 
be made directly in pFA13. Complementary primers were used for each mutant 
constructed: Cys121?Ala (1), 5'-GCA GAA CTC TAT CCA GCC GGG GAA TGT TCA 
TAT C-3'; Cys121?Ala (2), 5'-GAT ATG AAC ATT CCC CGG CTG GAT AGA GTT CTG 
C-3'; Cys124?Ala (1), 5'-CTA TCC ATG CGG GGA AGC TTC ATA TCA CTT TGT AAA 
G-3'; Cys124?Ala (2), 5'-CTT TAC AAA GTG ATA TGA AGC TTC CCC GCA TGG ATA 
G-3'; both Cys residues (1), 5'-GCA GAA CTC TAT CCA GCC GGG GAA GCT TCA TAT 
CAC TTT GTA AAG-3'; both Cys residues (2), 5'-CTT TAC AAA GTG ATA TGA AGC 
TTC CCC GGC TGG ATA GAG TTC TGC-3'. The mutated plasmids were verified by 
sequencing, and the protein expression levels in each of the mutants were assessed by 
immunoblotting protein extracts from the overexpressing strains with anti-HA antibody. 
The mutants were subcloned into the pET-21b(+) vector by using the NheI and XhoI 
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sites for subsequent expression in E. coli as His6-tagged proteins without the N-terminal 
signal sequence as described above for the wild-type protein. 
 
ERV2 assays 
 
The activities of recombinant purified Erv2-?N and the active-site cysteine 
mutants were assayed by determining the rate of O2 consumption with the use of a Clark 
oxygen electrode (YSI 4004). Activity was assayed at 25 °C in an oxygen-saturated (240 
μM O2) 50 mM sodium phosphate [pH 7.5] buffer. The buffer was stirred continuously 
throughout the assay. DTT was added first; the assay was then started by the addition of 
0.17 μM Erv2-?N. Oxygen consumption rate was recorded as the decrease in oxygen 
concentration over the first 4 min after the addition of the enzyme. In control 
experiments, no non-enzymatic oxygen consumption was observed over the duration of 
the assay. 
 
Trapping mixed disulfides between Erv2-HA and Pdi1p 
 
A wild-type yeast strain (CKY263) containing plasmids encoding ERV2-HA and 
PDI1 was grown to exponential phase. Cells were radiolabeled with [35S]methionine and 
[35S]cysteine (EXPRESS, NEN) for 60 min at 30 °C in SMM lacking uracil, leucine and 
methionine but containing 3% galactose. Extracts corresponding to 40 OD600 units were 
collected by centrifugation and suspended in 10% (w/v) TCA. Cell membranes were 
disrupted by agitation with glass beads and proteins were collected by centrifugation at 4 
°C. Protein pellets were resuspended in urea sample buffer (50 mM Tris-HCl [pH 7.5], 
2% SDS, 6 M urea, 1 mM PMSF, bromophenol blue) containing 40 mM NEM (Sigma). 
The pH of the samples was adjusted by the gradual addition of 1 M Tris-HCl [pH 8] until 
samples turned blue. After incubation on ice for 15 min and at 24 °C for 10 min, samples 
were diluted 1:10 in immunoprecipitation buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 
1% Triton X-100, 1 mM PMSF) and immunoprecipitated with monoclonal anti-HA 
antibody (12CA5) as described previously (Frand and Kaiser, 1998). Immunoprecipitated 
samples were boiled for 2 min in non-reducing sample buffer, diluted in 
immunoprecipitation buffer; one-quarter was reimmunoprecipitated with anti-HA antibody 
and three-quarters of each sample was reimmunoprecipitated with anti-Pdi1p antibody. 
Before electrophoresis, 0.1 M DTT was added to one-half of each sample and all 
samples were boiled for 2 min. Samples were analyzed by SDS-PAGE (8% gel) and 
proteins were revealed with a 445si PhosphorImager (Molecular Dynamics). 
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Expression and purification of His-tagged Pdi1p  
 
Plasmid encoding wild-type, His6-tagged yeast Pdi1p without the signal sequence 
was kindly provided by J. Winther (Copenhagen, Denmark). The E. coli strain BL21(DE3) 
containing the yPDI plasmid was grown to exponential phase in Luria-Bertani medium 
containing ampicillin, and expression of Pdi1p was induced with 1 mM IPTG for 4 h at 30 
°C. Cells from 1 liter of culture were collected in 10 ml sonication buffer (50 mM sodium 
phosphate [pH 8.0], 300 M NaCl, 1 mM PMSF) and lysed by incubation for 30 min on ice 
with 1 mg ml-1 lysozyme, followed by sonication. Insoluble material was removed by 
centrifugation at 20,000 g for 20 min and by filtration through a 0.45 μm pore-size filter. 
The cleared lysate was incubated in a batch with 4 ml 50% Ni-NTA (Qiagen) resin for 1 h 
at 4 °C. The resin was loaded into a column, washed with 40 ml sonication buffer 
containing 1 mM 2-mercaptoethanol, and then with 20 ml 50 mM sodium phosphate [pH 
8.0], 300 M NaCl, 20 mM imidazole, 1 mM 2-mercaptoethanol.  Bound protein was 
eluted with 50 mM sodium phosphate [pH 8.0], 300 M NaCl, 100 mM imidazole.  
Fractions containing Pdi1p were pooled and dialyzed for 20 h against 50 mM sodium 
phosphate [pH 7.5], 150 mM NaCl. 
 
Oxidation of Pdi1p by ERV2 in vitro 
 
Purified Pdi1p was reduced by incubation with 10 mM DTT for 30 min at 30 °C.  
Reduced Pdi1p was diluted 1:100 to a final concentration of 3 μM in buffer containing 50 
mM sodium phosphate [pH 7.5], 61.5 mM NaCl, 0.8 mM EDTA.  Pdi1p samples were 
incubated for 15 min at 30 °C alone or in the presence of 1 mM diamide (Molecular 
Probes), 1, 3 or 9 μM Erv2-?N, 9 μM Erv2-?N-Cys121?Ala, Cys124?Ala or 9 μM FAD.  
Disulfide exchange reactions were quenched by the addition of an equal amount of 20% 
(w/v) TCA.  Proteins were collected by centrifugation for 10 min at 4 °C and samples 
were washed with 200 μl acetone before resuspension in 15 μl urea sample buffer with 
or without 15 mM AMS (Molecular Probes).  Proteins were solubilized by vortex-mixing 
for 15 min at 4 °C and were subsequently incubated for 15 min at 30 °C; 15 μl of 2 times 
non-reducing sample buffer was added to samples, which were boiled for 2 min and 
resolved by non-reducing SDS-PAGE (8% gel).  Pdi1p was detected by immunoblotting. 
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Table 1.  Analysis of Erv2p mutants in the conserved Cys-X-X-Cys motif. 
 
Protein Abs454/Abs280 Activity with 20 mM 
DTT (nmol O2 min
-1) 
Suppression of 
ero1-1 at 37 ˚C? 
Erv2p-WT 0.157 117 Yes 
Erv2p-C121A 0.121 0 No 
Erv2p-C124A 0.168 0 No 
Erv2p-C121A-C124A 0.122 0 No 
Albumin 0.003 0 - 
C121A, Cys121?Ala; C124A, Cys124?Ala; C121A-C124A, Cys121?Ala, Cys124?Ala double 
mutant 
 
 
Table 2.  Yeast strains used in this study. 
 
Strain Genotype Source 
CKY8 MAT? ura3-52 leu2-3,112 Kaiser lab collection 
CKY263 MATa ura3-52 leu2-3,112 GAL2 Kaiser lab collection 
CKY467 MATa/? ero1?::LEU2/ERO1 ura3-52/ura3-52 leu2-
3,112/leu2-3,112 
Kaiser lab collection 
CKY598 MATa ero1-1 ura3-52 leu2-3,112 GAL2 Kaiser lab collection 
CKY687 MATa ero1-1 ura3-52 leu2-3,112 Kaiser lab collection 
CKY688 MAT? erv2?::kanMX4 ura3-52 leu2-3,112 This study 
CKY689 MAT? ero1-1 erv2?::kanMX4 ura3-52 leu2-3,112 This study 
CKY690 MATa ero1-1 ura3-52 leu2-3,112 This study 
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Figure 1.  ERV2 overexpression restores growth, resistance to DTT, and the formation of 
disulfide bonds to an ero1-1 mutant.  (A) An ero1-1 strain (CKY598) was transformed with the 
control plasmid, pRS316, or with PGAL1-ERV2.  These strains were plated on minimal medium with 
2% galactose and were incubated at 37 °C for 4 d.  (B) The two strains used in (A) were plated as 
a lawn of 4 ? 106 cells on minimal medium with 2% galactose.  A 6-mm filter disk was placed in 
the centre of each lawn and 10 μl 0.1 M DTT was applied to the disks. The lawns were incubated 
for 2 d at the semi-permissive temperature of 30 °C.  (C) Immunoblot showing the relative 
amounts of the ER (p1) and vacuolar (m) forms of CPY in the wild-type (WT) strain (CKY263) 
containing the control plasmid pRS316, and in ero1-1 (CKY598) with either pRS316 or the PGAL1-
ERV2 plasmid. The strains were grown to exponential phase at 24 °C in YPGal and then shifted 
to the restrictive temperature (37 °C) for the indicated durations.  The ero1? PGAL1-ERV2 strain 
was grown in YPGal medium at 30 °C. CPY was detected by immunoblotting. 
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Figure 2.  Erv2p is a membrane protein located in the ER.  (A) Extract from cells overexpressing 
ERV2-HA (pFA13) was fractionated by centrifugation under the following conditions: 50 mM Tris-
HCl [pH 7.5], 1% Triton X-100, 2.5 M urea, or 0.1 M Na2CO3 [pH 11.5].  The supernatant (S) and 
pellet (P) fractions were separated by SDS-PAGE followed by detection of Erv2p by 
immunoblotting for the HA epitope.  (B) Cells overexpressing Erv2p-HA were grown to 
exponential phase and then fixed for microscopy.  Erv2p-HA and Pdi1p are revealed by 
immunofluorescence (bottom left and bottom right panels, respectively), the cell bodies are 
observed under differential interference contrast (top left panel), and the nucleus is revealed by 
staining with DAPI (top right panel).  (C) Membranes prepared from cells overexpressing Erv2p-
HA were either mock-digested or treated with 50 μg ml-1 proteinase K in the absence or presence 
of 1% Triton X-100, as indicated. Digests were terminated at the indicated times with 40 mM 
PMSF. The samples were separated by SDS-PAGE and Erv2p and Pdi1p were detected by 
immunoblotting. Proteolysis fragments of Pdi1p are indicated with asterisks.  (D) The intrinsic 
sensitivity of Erv2p to protease was shown by treatment of purified Erv2-?N with 50 μg ml-1 
proteinase K in the absence or presence of 1% Triton X-100. Erv2-?N was revealed by 
Coomassie Blue stain. A proteolysis fragment of Erv2-?N is indicated by an asterisk. 
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Figure 3.  Erv2p contains a conserved domain shared between yeast and human proteins.  The 
amino acid sequences of Erv2p, the yeast homologue Erv1p and the human proteins ALR (hALR; 
NCBI accession no. CAB87993) and quiescin Q6 (Q6; NCBI accession no. NP_002817) were 
aligned with CLUSTALX.  Conserved residues are boxed and homologous amino acids shared 
between Erv2p and at least one other sequence are shaded.  The conserved cysteine residues in 
the Cys-X-X-Cys motif, Cys121 and Cys124 in the Erv2p sequence, are indicated with asterisks. 
 
88 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(next page) 
 
Figure 4.  Erv2p is a flavin-binding thiol oxidase that consumes oxygen to form disulfide bonds.  
(A) The absorbance spectrum of 23 μM purified recombinant Erv2-?N in 50 mM sodium 
phosphate [pH 7.5] was recorded from 300 to 600 nm. The absorbance spectrum of 20 μM FAD 
in is shown for comparison.  (B) Recombinant Erv2-?N was diluted to a concentration of 4 μM in 
50 mM sodium phosphate [pH 7.5]; DTT was added to 5 mM and the change in flavin absorbance 
at 454 nm was recorded.  (C) The variation in rate of oxygen consumption (nmol O2 min
-1) by 
Erv2-?N with DTT concentration was measured by using an oxygen electrode. The concentration 
of Erv2-?N in these assays was 0.17 μM. The kinetic constants reported in the text were obtained 
from an Eadie-Hofstee plot of the data (inset). 
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Figure 5.  Erv2p uses oxygen in a pathway for thiol oxidation in vivo. (A) The ero1-1 strain 
(CKY598) containing a control plasmid, pRS316, PGAL1-ERV2 or PGAL1-ERO1, along with the wild-
type strain (CKY263) containing pRS316 were plated on YPGal medium containing ergosterol 
and Tween 80, and incubated under anaerobic conditions at 37 °C for 6 d.  (B) The ero1-1 erv2? 
(CKY689) and ero1-1 (CKY690) strains were plated on YPD medium containing 1 mM DTT and 
incubated for 2 d at 30 °C. 
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Figure 6.  Erv2p transfers oxidizing equivalents to Pdi1p via a direct thiol-disulfide exchange.  (A) 
Radiolabeled cells overproducing Erv2p-HA and Pdi1p were lysed in 10% TCA and free thiols 
were alkylated with NEM before immunoprecipitation with anti-HA under non-reducing conditions. 
The samples were reimmunoprecipitated with either anti-Pdi1p or anti-HA, as indicated. Before 
electrophoresis, half of each sample was reduced with DTT (lanes 3 and 4) and the remaining 
samples were analyzed under non-reducing conditions (lanes 1 and 2). Three times the amount 
of material was used in the anti-Pdi1p immunoprecipitations than in the anti-HA samples.  (B) 
Reduced Pdi1p (3 μM) was incubated in buffer with 50 mM sodium phosphate [pH 7.5], 61.5 mM 
NaCl, 0.8 mM EDTA, 0.1 mM DTT either alone (lanes 1 and 2) or with the following additions: 1 
mM diamide (lane 3); 1, 3 or 9 μM Erv2-?N (lanes 4, 5 and 6, respectively); 9 μM Erv2-?N-
Cys121?Ala, Cys124?Ala (lane 7) or 9 μM FAD (lane 8). All samples were incubated at 30 °C 
for 15 min before trapping of thiols with 10% TCA followed by alkylation with AMS. Samples were 
resolved by SDS-PAGE and Pdi1p was detected by immunoblotting. The reduced (red.) and 
oxidized (ox.) forms of Pdi1p are indicated. 
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Figure 7.  Pathways for thiol oxidation in the ER.  Black arrows represent the entry of free thiols 
into the ER either as cysteine residues on newly translocated polypeptides or as reduced 
glutathione (GSH), which enters the ER by an unknown mechanism.  Two different pathways 
exist for the flow of oxidizing equivalents into the ER, as represented by grey arrows.  In the first 
pathway, disulfide bonds are transferred from Ero1p to Pdi1p and then to substrate proteins.  
Ero1p itself can be oxidized in either the presence or the absence of O2 and might use FAD as a 
cofactor.  In the second pathway, Erv2p uses luminal FAD as a cofactor and is oxidized directly 
by O2. Erv2p also transfers disulfide bonds to Pdi1p before substrate oxidation. GSSG, oxidized 
glutathione. 
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Abstract 
 
Erv2p is an FAD-dependent sulfhydryl oxidase that can promote disulfide bond 
formation during protein biosynthesis in the yeast endoplasmic reticulum.  The structure 
of Erv2p, determined by X-ray crystallography to 1.5 Å resolution, reveals a helix-rich 
dimer with no global resemblance to other known FAD-binding proteins or thiol 
oxidoreductases.  Two pairs of cysteine residues are required for Erv2p activity.  The first 
(Cys-Gly-Glu-Cys) is adjacent to the isoalloxazine ring of the FAD.  The second (Cys-
Gly-Cys) is part of a flexible C-terminal segment that can swing into the vicinity of the 
first cysteine pair in the opposite subunit of the dimer and may shuttle electrons between 
substrate protein dithiols and the FAD-proximal disulfide. 
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Introduction 
 
Disulfide bonds stabilize many secreted proteins, cell-surface proteins and 
proteins residing in intracellular membrane-bound compartments.  The primary disulfide-
bond donor in eukaryotes is the endoplasmic reticulum oxidoreductin 1 protein (Ero1p) 
(Frand and Kaiser, 1998; Pollard et al., 1998).  Ero1p is an essential membrane-
associated (Frand and Kaiser, 1998) flavoenzyme (Tu et al., 2000) that directly oxidizes 
a member of the thioredoxin fold family, protein disulfide isomerase (PDI) (Frand and 
Kaiser, 1999), a soluble factor that in turn oxidizes a wide variety of target proteins 
(Noiva, 1999). 
A screen for proteins that restore viability to an Ero1p mutant when 
overexpressed in yeast uncovered Erv2p (Sevier et al., 2001).  Although Erv2p is 
normally expressed only under certain growth conditions (Stein and Lisowsky, 1998) and 
deletion of the ERV2 gene is not lethal (Stein and Lisowsky, 1998), Erv2p expressed 
under a heterologous promoter efficiently rescues the temperature-sensitive ero1-1 
mutant at the non-permissive temperature (Sevier et al., 2001).  Prior to these 
experiments, Erv2p had been recognized (Gerber et al., 2001; Stein and Lisowsky, 
1998) as a homolog of the essential for respiration and viability 1 protein (Erv1p), a 
mitochondrial FAD-binding sulfhydryl oxidase (Lee et al., 2000).  In recent years, 
additional homologs have been discovered, including a hepatotrophic growth factor 
called ALR (augmenter of liver regeneration) (Hagiya et al., 1994) and virally encoded 
enzymes that promote disulfide-bond formation in poxvirus coat proteins (Senkevich et 
al., 2000), which assemble in the reducing environment of the cell cytosol.  A domain 
homologous to Erv2p is fused to a thioredoxin-like domain in a family of proteins (Hoober 
et al., 1999a) that includes an egg white sulfhydryl oxidase (Hoober et al., 1999b) and 
Quiescin Q6, a protein that is highly expressed (Coppock et al., 1998) and secreted 
(Coppock et al., 2000) when fibroblasts enter quiescence.  Although enzymes bearing 
the ERV-like domain differ in their protein substrates, a key feature of these enzymes 
appears to be the ability to catalyze the reaction 2R-SH + O2 ? R-S-S-R + H2O2.  Thus, 
the basic sulfhydryl oxidase module of the Erv2p family can exist in a variety of 
compartmental and quaternary structural contexts to serve diverse physiological 
functions. 
The Erv2p family has unusual features for sulfhydryl oxidoreductase 
flavoproteins.  According to sequence alignments, the FAD-binding domain appears to 
comprise only ~100 residues, making it considerably smaller than typical flavin binding 
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oxidoreductases (Senkevich et al., 2000).  Furthermore, the secondary structure 
prediction for Erv2p suggested a highly ?-helical protein (Senkevich et al., 2000).  In 
contrast, classical FAD-binding folds (Fraaije and Mattevi, 2000) and the thioredoxin fold 
contained within other known endoplasmic reticulum (ER) (Kemmink et al., 1996; 
Kemmink et al., 1999) and bacterial periplasmic (Martin et al., 1993; McCarthy et al., 
2000) thiol oxidoreductases are mixed ?/? structures.  Finally, FAD-binding thiol 
oxidoreductases that have been studied in depth, such as thioredoxin reductase, 
glutathione reductase and dihydrolipoamide dehydrogenase, use NADH (or NAD+) as a 
substrate, whereas the Erv2p family uses O2 as an electron acceptor.  For the above 
reasons, Erv2p-like proteins differ from the flavoprotein families as currently described 
(Massey, 1995; van Berkel et al., 1999). 
 
Results and discussion 
 
Crystallization of the Erv2p thiol-oxidase module 
 
To begin to elucidate the mechanism of the newly described class of disulfide 
bond donor enzymes to which Erv2p belongs and to further our understanding of the 
origin of the disulfide-rich environment of the ER, we determined the structure of Erv2p 
by X-ray crystallography.  Erv2p retains its N-terminal signal sequence in vivo and 
remains fixed in the ER membrane (Sevier et al., 2001).  For crystallization, we 
expressed a soluble fragment of Erv2p, called Erv2-?N, which lacks the signal sequence 
and begins at Glu30 (Figure 1).  The first crystals obtained were found to be 
proteolytically cleaved to a shorter fragment beginning in the vicinity of Thr67, as 
determined by N-terminal peptide sequencing of the major degradation product in the 
crystallization stock solution.  Data were collected to 2.0 Å resolution from these crystals, 
which were of space group P21 with unit cell dimensions a = 53.6 Å, b = 66.8 Å, c = 60.4 
Å and ? = 91.4°, and four molecules per asymmetric unit. 
To increase the reproducibility of crystallization, a limited proteolysis step was 
added to the Erv2-?N purification procedure.  Cleavage with thermolysin removed an N-
terminal fragment, leaving a protease-resistant domain.  The predominant N-terminal 
residue of this stable product was Leu71, and the molecular weight obtained by mass 
spectrometry was 13,395 ± 10 Da.  This mass is consistent with Ser187 being the C-
terminal residue of the protease-resistant domain (Figure 1), which gives a calculated 
mass of 13,390 Da.  This fragment spans the region of high sequence homology with 
other proteins of the family and will be referred to as Erv2-core (Erv2-c). 
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The protease-resistant fragment Erv2-c was compared by circular dichroism (CD) 
spectroscopy to Erv2-?N. Both intact and truncated enzymes gave CD spectra typical of 
highly helical proteins (Figure 2).  Subtraction of the spectrum for Erv2-c from that of 
Erv2-?N yielded a difference spectrum typical of an irregular structure.  The lack of fixed 
secondary structure and the extreme protease sensitivity of the N-terminal 40 residues of 
Erv2-?N suggest that this region is flexible.  Thus, Erv2-c comprises the structural core 
of the Erv2p protein.  The FAD bound to Erv2-c is sensitive to reduction by 
concentrations of dithiothreitol (DTT) that do not reduce free flavin, demonstrating that 
Erv2-c is catalytically active (data not shown). 
Erv2-c crystals nucleated poorly but grew rapidly under a variety of conditions 
when seeded from existing crystals. Data were collected to 1.5 Å from a crystal of space 
group P21, unit cell dimensions a = 47.6 Å, b = 45.2 Å, c = 53.8 Å and ? = 100.2°, with 
two molecules per asymmetric unit.  Crystals were grown with SeMet in place of the 
single methionine residue in the domain, and phases were obtained by multiwavelength 
anomalous dispersion (MAD).  The structure built into the MAD electron density maps of 
Erv2-c was used in molecular replacement to provide phases for diffraction data from the 
crystal of degraded Erv2-?N.  The structures were then refined independently for each 
crystal form. 
 
New fold for FAD binding proteins 
 
In total, six copies of the Erv2p protomer were observed between the two crystal 
forms, distributed as two dimers in the crystals grown from the Erv2-?N preparation (one 
is shown in Figure 3) and one dimer in the crystals of Erv2-c.  Most of Erv2-c is 
structurally similar in all six protomers; the region between Asp75 and Tyr174 has an 
average root mean square (r.m.s.) deviation of 0.30 Å for backbone atoms.  This region 
contains a four-helix bundle (helices ?1–?4) and an additional single turn of helix (?5) 
packed perpendicular to the bundle (Figure 3C).  The ?4 helix (Arg142-Tyr159) crosses 
?3 at an angle of ~50°, which is typical of helix-crossing angles in globular proteins but 
not in four-helix bundles (Kamtekar and Hecht, 1995).  The ?3 helix (Gly122-Lys134) is 
at an ~30° angle to ?2, and ?4 makes an ~20° angle with ?1.  The C terminus of ?4 
splays out from the N terminus of ?1, and FAD binds between these helices (Figure 3C).  
The ?1 and ?2 helices (Asp75-Ala94 and Pro102-Leu118, respectively) are nearly 
antiparallel to one another and form the dimer interface by packing against the 
symmetry-related helices at an angle of ~55°.  The dimer interface is hydrophobic with a 
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contact area of ~700 Å2, and the hydrophobic nature of 10 residues in the interface is 
conserved among homologs. 
A search using DALI (Holm and Sander, 1996) for folds similar to that of Erv2p 
returned relatively weak matches with other four-helix bundle proteins.  The three 
highest-scoring proteins were the transmembrane subunit c of ATP synthase (PDB 
accession code 1C17, Z-score 4.5, r.m.s. deviation 2.9 Å over 76 residues), cytochrome 
c' (1CPQ, Z-score 4.1, r.m.s. deviation 4.1 Å over 81 residues) and myohemerythrin 
(2MHR, Z-score 3.9, r.m.s. deviation 3.4 Å over 71 residues).  The first match is likely to 
arise from the fortuitous convergence of topology and helix-helix crossing angles in two 
proteins that are otherwise unrelated (ATP synthase subunit c helices are much longer 
and are membrane-imbedded).  Cytochrome c' and myohemerythrin are more similar to 
Erv2-c in that they are soluble and bind cofactors.  Furthermore, cytochrome c' is 
involved in electron transport and myohemerythrin transports oxygen, whereas Erv2p 
transfers electrons from sulfhydryl groups to oxygen.  However, Erv2p helix ?3 aligns 
very poorly to cytochrome c' and myohemerythrin, and Erv2p appears to be an atypical 
member of the four-helix bundle fold family.  To our knowledge, Erv2p is the first FAD-
binding protein found to belong to the 'all ?' fold class. 
 
Key structural and functional residues in the fold 
 
Among proteins that are related by homology to Erv2p (Senkevich et al., 2000), 
conserved residues are predominantly in the FAD-binding site.  For example, the lack of 
an amino acid side chain at Gly82 accommodates the flavin.  The invariant Trp86 packs 
against the si face of the isoalloxazine ring and is in position to make a hydrogen bond to 
the hydrocarbon tail of the FAD flavin unit.  The conserved Tyr119 packs against the re 
face of the FAD. His153 packs between Trp86 and the adenine ring of the FAD, and is 
also poised to interact with a FAD phosphate group. Residue 165 is either a Tyr or a Phe 
residue in all family members, and the side chain of this residue backs the adenine on 
the opposite face from His153.  This series of aromatic residues, with intercalation of the 
isoalloxazine ring and adenine portions of the FAD, mimics base stacking in 
polynucleotides (Figure 4). 
The only other non-Cys amino acid, aside from Trp86, that is invariant in all 
family members is Asn157. This residue is in position to make hydrogen bonds from its 
side chain NH2 group to N7 of the FAD adenine moiety and to the side chain of Asn154.  
In addition, Asn147 makes water-mediated contacts via its side chain carbonyl group to 
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the AMP phosphate group of the FAD and to a hydroxyl group in the flavin unit of the 
FAD.  The FAD assumes a roughly semicircular structure so that the ribose and 
phosphates remain exposed to solvent while the two ends of the cofactor are buried 
(Figure 4). 
Of the six Cys residues in Erv2p, only the two in the active-site Cys-X-X-Cys 
motif are conserved in every known family member.  The Erv2p Cys-Gly-Glu-Cys 
sequence, like the Cys-X-X-Cys motif in thioredoxin, is found at the N terminus of a helix 
- in this case, ?3 - and these Cys residues are disulfide-bonded to each other (Figure 5).  
Similar to Escherichia coli thioredoxin reductase (Kuriyan et al., 1991), but different from 
glutathione reductase (Schulz et al., 1978), the Erv2p active site Cys residues are on the 
re face of the FAD isoalloxazine ring (Figure 5).  Erv1p, Erv2p and ALR, but not quiescin 
or the viral enzymes, share a second Cys pair found at positions 150 and 167 in Erv2p.  
These Cys residues form a disulfide bond near the adenine portion of the FAD and fix 
the short C-terminal helix ?5 against the side of helix ?4 (Figure 3B and C). 
 
Erv2p structure suggests a disulfide relay mechanism 
 
The final two Cys residues of Erv2p, Cys176 and Cys178, are disulfide bonded to 
each other in the C-terminal tail of the enzyme.  Disulfide bonds between Cys residues 
separated by a single amino acid are extremely rare, with only a few examples in the 
protein structure database.  For example, a disulfide bond is found within a Cys-Ser-Cys 
sequence in a Mengo encephalomyelitis virus coat protein (Krishnaswamy and 
Rossman, 1990) and within a Cys-Asp-Cys sequence in a thermostable serine protease 
(Smith et al., 1999).  As determined biochemically, but not yet crystallographically, a 
Cys-X-Cys sequence involved in coordination of zinc in the inactive form of the heat 
shock protein Hsp33 forms a disulfide bond (Barbirz et al., 2000) upon conversion to the 
active chaperone conformation (Jakob et al., 1999; Graumann et al., 2001).  Equilibrium 
constants for formation of small disulfide bonded loops are lower for Cys-Xm-Cys motifs 
when m equals one than for any other value of m from zero to five (Zhang and Snyder, 
1989).  Site-directed mutation of the thioredoxin active site from Cys-Gly-Pro-Cys to Cys-
Ala-Cys produced an ineffective reducing agent that tended to form dimers when 
oxidized, thereby avoiding closure of the 11-membered ring, which would be formed 
upon disulfide bonding between the Cys residues of Cys-Ala-Cys (Gleason et al., 1990).  
When strained disulfide bonds form, they become good oxidizing agents; a disulfide 
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bond in the Erv2p Cys-Gly-Cys sequence is expected to transfer readily to substrate 
protein dithiols. 
Although residues after Ser179 in the Erv2-c structure could not be traced in the 
electron density maps, the region from Asp175 to Ser179, including the disulfide bond 
between Cys176 and Cys178, was clearly observed in either of two conformations 
(Figure 6).  In three of the six copies of the protomer (both chains in one dimer and one 
chain of another dimer), this C-terminal tail swings away from the dimer interface, and 
the Cys-Gly-Cys region packs back against the ?5 helix of the same protomer.  In the 
remaining three molecules, the tail extends away from the ?5 helix and lies across the 
active site of the opposite subunit in the dimer.  The C? atom of Cys178 approaches 
within ~4 Å of the C? of Cys121 (as opposed to 14 Å in the alternate conformation), and 
a mere change in the side chain torsion angles of these residues would permit formation 
of a disulfide bond between them (Figure 6, inset). 
An intersubunit disulfide bond was detected between Erv2p protomers in vivo.  
When an epitope-tagged version of Erv2p was immunoprecipitated from yeast cells 
under denaturing, non-reducing conditions, bands corresponding to Erv2p monomer and 
dimer were apparent after electrophoresis on a non-reducing SDS-PAGE gel (Figure 
7A).  Addition of DTT prior to electrophoresis converted all of Erv2p to the monomeric 
species, confirming that the upper band represents disulfide bonded Erv2p protomers 
(Figure 7A). 
To determine which Cys residues are required for the formation of the 
intersubunit disulfide bond, we constructed mutant forms of the enzyme containing Cys-
to-Ala substitutions.  A disulfide-linked dimer of Erv2p was not detected when Cys121 or 
both Cys176 and Cys178 were mutated (Figure 7B, lanes 2 and 7), confirming that these 
Cys residues are necessary for the formation of an intersubunit disulfide bond.  The 
individual replacement of either Cys176 or Cys178 with Ala did not significantly alter the 
amount of disulfide-linked dimer formed, suggesting that the C-terminal tail has sufficient 
conformational flexibility to allow either Cys176 or Cys178 to form a disulfide with 
Cys121 (Figure 7B, lanes 5 and 6). 
A simple test of the activity of Erv2p mutants in vivo is their ability, when 
overexpressed, to suppress the temperature sensitivity of an ero1-1 mutant (Sevier et 
al., 2001).  Each of the individual Cys mutants was placed under control of the powerful 
GAL1 promoter and tested for the ability to suppress the lethality of ero1-1 at the 
restrictive temperature.  The PGAL1-ERV2 plasmid bearing a wild-type copy of Erv2p 
restored growth to the ero1-1 mutant at 37 °C (Sevier et al., 2001).  However, none of 
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the Cys mutants expressed to approximately the same levels from the same plasmid, 
including single mutants in the Cys-Gly-Cys sequence, had the capacity to suppress 
ero1-1, showing that they lack activity in vivo (Figure 7C).  The wild-type enzyme may 
function by accepting electrons from target proteins to open the Cys-Gly-Cys disulfide, 
which is reoxidized by shuttling electrons to the FAD-proximal Cys-Gly-Glu-Cys disulfide. 
 
Secondary Cys-Xn-Cys motifs in Erv2p homologs 
 
Although Erv2p is the only member of the family with a Cys-X-Cys motif, a similar 
disulfide shuttle may occur between Cys pairs in other homologs.  Sequence alignments 
reveal that the quiescin family has a second conserved Cys-X-X-Cys sequence 
(Coppock et al., 1998) in a position comparable to the Cys-Gly-Cys of Erv2p.  
Furthermore, Erv1p, like Erv2p, has been observed to form disulfide bonded dimers (Lee 
et al., 2000).  Erv1p and ALR have second Cys-X-X-Cys motifs N-terminal, rather than 
C-terminal, to the primary Cys-X-X-Cys active site.  The N-terminal region of Erv1p (Lee 
et al., 2000), but not that of Erv2p (Gerber et al., 2001), is necessary for the formation of 
dimers.  In Erv1p, 50 residues separate the N-terminal auxiliary Cys-Arg-Ser-Cys 
sequence from the beginning of helix ?1.  These 50 residues are rich in Gly and Ser and 
are predicted to have little secondary structure, indicating that they could easily span the 
30 Å between the active site of the opposite protomer and the N terminus of helix ?1.  
Although Ero1p is not homologous to Erv2p and its structure is unknown, the Ero1p 
protein may operate by a similar disulfide-shuttle mechanism.  Ero1p has two pairs of 
conserved Cys residues, one of which interacts directly with PDI and the other of which 
reoxidizes the PDI-interacting pair (Frand and Kaiser, 2000). 
 
Mechanisms for interaction with substrate proteins 
 
Much effort has focused on understanding the role of the residues in the 
immediate vicinity of the active site Cys residues on the redox properties of thiol-disulfide 
oxidoreductases (Chivers et al., 1997).  However, attention is now turning to issues such 
as steric exclusion of substrates by the tertiary and quaternary structural contexts of Cys-
Xn-Cys motifs.  For example, the bacterial periplasmic protein DsbC, which normally acts 
in reduced form to isomerize disulfides and avoids oxidation by the DsbB protein, instead 
becomes oxidized by DsbB and in turn acts as a disulfide oxidase when mutated to 
destroy its dimerization interface (Bader et al., 2001).  No changes in the vicinity of the 
active site were necessary.  Furthermore, two thioredoxin folds may not be able to 
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interact with one another, for steric reasons, to accomplish intermolecular dithiol-disulfide 
exchange (Katzen and Beckwith, 2000).  Although the Erv2p active site disulfide is not in 
a thioredoxin fold, it is at the N terminus of a helix, and its local geometry is similar to that 
of the DsbA and thioredoxin active sites (r.m.s. deviation ~0.25 Å for Cys-X-X-Cys 
backbone atoms).  Erv2p may naturally oxidize ER enzymes with thioredoxin folds 
(Sevier et al., 2001), and substrates that are sterically unable to access the Cys-Gly-Glu-
Cys region of Erv2p may instead interact with the Cys-Gly-Cys in the C-terminal tail.  The 
flexibility of the region containing Cys176 and Cys178 in Erv2p, as indicated by the 
protease sensitivity of the polypeptide chain at neighboring residues and the multiple 
conformations observed crystallographically, may further facilitate transfer of oxidizing 
equivalents to substrate dithiols.  Erv2p can also oxidize lysozyme, a test substrate 
lacking a thioredoxin fold (Gerber et al., 2001); whether the C-terminal Cys pair is 
required for this activity remains to be determined.  In general, the structure and redox 
properties of adaptor Cys-Xn-Cys motifs could tailor the thiol oxidase of the ERV module 
activity to the particular substrates and physiological functions of each enzyme in the fold 
family. 
 
Material and methods 
 
Protein expression and purification 
 
The ERV2 coding region, lacking the first 29 amino acids, was inserted into the 
pET-21b(+) (Novagen) expression vector.  The resulting Erv2-?N construct was 
transformed into BL21(DE3) pLysS (Novagen) cells. Single colonies were inoculated 
either into M9-ZB medium containing 4% (w/v) glucose or into LB.  All cultures contained 
100 mg l-1 ampicillin and 30 mg l-1 chloramphenicol.  Cells were grown at 37 °C to an 
optical density of OD600 = 0.7-0.9, isopropyl-?-D-thiogalactoside (IPTG) and FAD were 
added to a final concentration of 0.5 mM and 10 μM, respectively, and the culture was 
shifted to 30 °C for a further 3-6 h.  Cells were harvested by centrifugation and lysed by 
sonication in lysis buffer (20 mM KPO4 [pH 7.4], 500 mM NaCl and 10 mM ?-
mercaptoethanol) supplemented with 50 μM FAD.  Cell debris and membranes were 
sedimented by centrifugation, and the supernatant was applied at 4 °C to nickel affinity 
beads (Qiagen) preequilibrated with lysis buffer.  After shaking gently overnight, the 
mixture was loaded onto a column and washed with 10 column volumes lysis buffer 
supplemented with 25 mM imidazole.  Protein was eluted with 10 ml of 20 mM KPO4 [pH 
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7.4], 500 mM NaCl, 10 mM ?-mercaptoethanol and 300 mM imidazole.  The protein was 
further purified by hydroxyapatite chromatography eluted with increasing phosphate.  
Fractions containing Erv2-?N were then pooled and dialyzed against 25 mM NaCl and 
10 mM Tris-HCl [pH 8.0]. To obtain Erv2-c, the dialyzed protein was incubated with 
thermolysin (10 μg enzyme per 0.7 mg of protein) for 30 min at room temperature, and 
the protease-resistant domain was further purified by DEAE chromatography.  The 
eluted protein was pooled and dialyzed against 25 mM NaCl and 10 mM Tris-HCl [pH 
8.0], and concentrated by centricon (Amicon) to 19 mg ml-1, as determined 
spectroscopically in 6 M guanidine-HCl and 10 mM NaPO4 [pH 6.8], assuming an 
extinction coefficient of 21,980 at 280 nm. 
 
Circular dichroism 
 
CD was performed on an Aviv model 202 spectropolarimeter.  Protein was 
dialyzed against a solution containing 2 mM citrate [pH 6.1], 2 mM KPO4 [pH 6.8], 2 mM 
boric acid and 10 mM NaCl.  Samples were diluted in the same buffer such that the 
absorbance at 454 nm was identical for Erv2-?N and Erv2-c and corresponded to 10 μM 
FAD.  Spectra were recorded in a 1 mm pathlength cuvette at 25 °C. 
 
Crystallization and structure determination 
 
Small yellow crystals (~0.07 ? ~0.07 ? ~0.07 mm3) were grown from the Erv2-?N 
preparation by hanging drop vapor diffusion over a well containing 0.1 M cacodylic acid 
[pH 6.2], 50 mM MgCl2 and 32% (w/v) PEG 8000.  For Erv2-c, initial crystals of poor 
morphology were grown over a well solution containing 0.1 M cacodylic acid [pH 6.2], 10 
mM CoCl2 and 22% (w/v) PEG 8000.  Large crystals could be grown by seeding from 
these crystals into a variety of conditions.  Crystals for data collection were grown in 0.1 
M cacodylic acid [pH 6.2], 10% (v/v) dimethyl sulfoxide (DMSO), 15% (v/v) glycerol and 
10% (w/v) PEG 1000.  Crystals were transferred to a 1:1 mixture of mineral oil and 
Parabar oil (Exxon) before flash freezing.  Diffraction data were collected to 2.0 Å (Erv2-
?N preparation) and 1.5 Å (Erv2-c) resolution at 120 K on an RU-H3R generator 
(Rigaku, Tokyo) equipped with a RaxisIV detector (Rigaku) and osmic mirrors.  Phasing 
was performed by MAD using a SeMet derivative of Erv2-c prepared according to 
published protocol (Van Duyne et al., 1993), except that 10 μM FAD was added to the 
media at the time of induction, and the cells were allowed to grow for 3 h more before 
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harvesting.  SeMet-containing crystals were grown under similar conditions to the native 
crystals.  Data for phasing were collected at 100 K on the ESRF ID14 4 beamline at 
three wavelengths around the selenium absorption edge (Table 1). All native and MAD 
data were processed and scaled using DENZO and SCALEPACK (Otwinowski and 
Minor, 1997).  Heavy atoms sites were located, and phasing was performed with SOLVE 
(Terwilliger and Berendzen, 1999).  The noncrystallographic symmetry operator for the 
Erv2-c crystals was determined using polarrfn (1994) and GETAX (Vonrhein and Schulz, 
1999).  The Erv2-c structure was built using O (2000), and an Erv2-c dimer was used as 
the molecular replacement search model in AMoRe (Navaza, 1994) to provide phases 
for the cleaved Erv2-?N crystals.  Structure refinement was done using the 
Crystallography and NMR System (Brünger et al, 1998) without noncrystallographic 
symmetry restraints.  A comparison of the Erv2p active site disulfide with Cys-X-X-Cys 
motifs in proteins of known structure was accomplished using SPASM (Kleywegt, 1999). 
 
Construction and analysis of Cys mutants 
 
Mutants of ERV2 that converted Cys to Ala were made with the QuikChange site 
directed mutagenesis kit (Stratagene) using ERV2-HA in a URA3-marked plasmid as 
template.  The mutated plasmids were verified by sequencing. PGAL1-ERV2 plasmids 
containing wild-type or mutant ERV2-HA were transformed into the yeast strain CKY598 
(MATa GAL2 ura3-52 leu2-3,112 ero1-1).  Strains were grown in synthetic minimal 
media (SMM) minus uracil and methionine with 2% (w/v) galactose and 2% (w/v) 
raffinose to exponential phase.  Cell proteins were radiolabeled with [35S]methionine and 
cysteine (EXPRESS, NEN) for 60 min at 25 °C.  Samples were collected by 
centrifugation and suspended in 10% (w/v) trichloroacetic acid (TCA).  Cell membranes 
were disrupted by agitation with glass beads and proteins collected by centrifugation at 4 
°C.  Protein pellets were resuspended in sample buffer (80 mM Tris-HCl [pH 6.8], 2% 
(w/v) sodium dodecyl sulfate, 10% (v/v) glycerol, 1 mM phenylmethylsulfonyl fluoride 
(PMSF) and 0.01% (w/v) bromophenol blue) containing 40 mM N-ethylmaleimide (NEM, 
Sigma).  The pH of the samples was adjusted by addition of 1 M Tris-HCl [pH 8.0], until 
samples turned blue.  Samples were incubated for 15 min at 4 °C, followed by 10 min at 
25 °C and 2 min at 100 °C.  Samples were diluted 10-fold in IP buffer (50 mM Tris-HCl 
[pH 7.4], 150 mM NaCl, 1% (v/v) Triton X-100 and 1 mM PMSF) and incubated with HA 
antibody 12CA5 (Covance).  Immune complexes were collected with protein A-
sepharose (Pharmacia), washed twice in IP buffer and once in IP buffer minus detergent, 
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and solubilized in sample buffer.  Samples were resolved on a 10% SDS-PAGE gel and 
proteins were visualized with a 445si PhosphorImager (Molecular Dynamics). 
 
Coordinates. Coordinates have been deposited in the Protein Data Bank (accession 
codes 1JR8 for Erv2-c and 1JRA for Erv2-?N). 
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Table 1.  Crystallographic and refinement statistics. 
 
Data collection 
Crystal Native 1 Native 2 MAD ?1 MAD ?2 MAD ?3 
Resolution (Å) 2.0 1.5 2.8 2.8 2.8 
Wavelength (Å) 1.54 1.54 0.9797 0.9794 0.9393 
completeness (%)a 99.8 (98.3) 99.4 (98.2) 99.9 (100) 98.9 (99.4) 99.7 (100) 
Rsym
a 0.082 
(0.461) 
0.047 
(0.265) 
0.042 
(0.054) 
0.032 
(0.046) 
0.041 
(0.048) 
<?>/<?>a 21.7 (4.5) 32.0 (6.2) 34.1 (24.1) 33.9 (24.4) 34.3 (25.8) 
Redundancya 5.3 (4.8) 3.6 (3.7) 3.6 (3.7) 3.6 (3.7) 3.7 (3.8) 
Overall figure meritb   0.52, 0.88   
      
Refinement      
Number of 
reflections 
Reflection 1 Reflection 2    
     Working 26,812 33,466    
     Free 1,995 2,517    
Rwork
c 0.196 0.208    
Rfree
c 0.233 0.233    
R.m.s. deviations      
     bonds (Å) 0.008 0.006 Å    
     angles (˚) 1.21 1.78    
Number of atoms      
     Protein 3,448 1,724    
     Water 292 283    
     FAD 212 106    
a Numbers in parentheses correspond to the highest resolution shell (2.9-2.8 Å for MAD data, 
2.07-2.00 Å for Native 1 and 1.55-1.50 Å for Native 2) 
b Figure of merit from SOLVE (Terwilliger and Berendzen, 1999) and after solvent flattening and 
non-crystallographic symmetry averaging with DM (Kleywegt, 1999). 
c Rwork, free = ?||Fo| - |Fc||/|Fo|, where the Rwork and Rfree are calculated using the working and free 
reflection sets, respectively.  The free reflections (7% of the total) were held aside throughout 
refinement.  
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Figure 1.  Sequence and secondary structure of Erv2p.  The section of Erv2p corresponding to 
the structure determined crystallographically is shown in white lettering on a black background. 
Residues not present in the structure are in black on a white background.  Black dots highlight 
every 10th residue.  Helices are indicated by rods under the sequence, and disulfide bonds are 
shown by dotted lines between Cys residues.  Bent arrows indicate the N terminus of the 
expression construct Erv2-?N, which extends to the natural C terminus of the protein, and the 
limits of the thermolysin-cleaved fragment Erv2-c.  Different preparations of Erv2-c had either 
Leu71 or Met72 as the predominant N-terminal residue. 
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Figure 2.  CD of Erv2-?N and Erv2-c.  The CD signal as a function of wavelength is displayed for 
Erv2p lacking only the signal sequence (Erv2-?N; filled circles) and for thermolysin-cleaved 
enzyme (Erv2-c; open circles) at the same concentration.  Both spectra are typical for highly 
helical proteins.  The difference between these two spectra (inset) is indicative of random coil, 
demonstrating that the regions of Erv2p absent from the crystallographic study lack regular 
secondary structure. 
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Figure 3.  Structure of Erv2p. (A) Stereo diagram of the Erv2-?N dimer viewed down the 
approximate two-fold symmetry axis.  Every 10th residue in one protomer is indicated by a dot and 
labeled according to its position in the full Erv2p sequence. This figure was generated using 
MOLSCRIPT (Kraulis, 1991).  (B) A ribbon diagram of the dimer in the same orientation as in the 
stereo diagram shows one protomer in red and the second in blue.  Cys side chains are illustrated 
in ball-and-stick representation and numbered.  The two FAD molecules bound by the dimer are 
shown as balls and sticks.  The N and C termini of each chain is labeled “N” and “C,” respectively.  
This and the following structure figures were generated with RIBBONS (Carson, 1997).  (C) View 
down the four-helix bundle of one subunit with helices labeled ?1-?5 according to their positions 
from N terminus to the C terminus along the polypeptide chain.  
 
118 
 
 
 
 
A
B
 
 
 
 
 
 
 
 
Figure 4.  FAD binding site.  (A) A ribbon diagram of the polypeptide backbone with some side 
chains and the bound FAD shown explicitly in ball-and-stick representation. The bent 
conformation of the FAD buries the isoalloxazine ring and adenine portions of the cofactor while 
keeping the intervening regions surface exposed.  (B) The ribbon trace of the polypeptide 
backbone has been removed in this panel so that the residues involved in aromatic ring stacking 
with the FAD can be identified. 
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Figure 5.  Electron density map in the vicinity of the Erv2p active site.  A combined simulated 
annealing omit map calculated with CNS (Brünger et al., 1998) is displayed at 1.2 ? around the 
final model for the Erv2-c crystals.  The Tyr-Pro-Cys-X-X-Cys motif is conserved among Erv1p, 
Erv2p, and ALR. In contrast, the residues corresponding to the Xs are highly variable, and these 
positions are surface-exposed.  Electron density for the side chain of Glu123 is almost entirely 
lacking, indicating that this amino acid is flexible.  
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Figure 6.  Erv2p flexible C-terminal tail.  The four molecules in the asymmetric unit of the crystals 
grown from the original Erv2-?N preparation were superposed to compare the orientations of the 
C-terminal regions containing the Cys-Gly-Cys sequence.  In this crystal, one of the four C-
terminal tails packs against the neighboring active site.  The arrow indicates the significant 
conformational differences between the superposed molecules.  Shown in the inset is a model of 
an intersubunit disulfide bond constructed by changing the ?1 side chain torsion angles of Cys178 
and Cys121 to decrease the sulfur-sulfur bond distance between these residues to 2.03 Å.  
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Figure 7.  Cys residues required for disulfide bond formation between Erv2p protomers and for 
Erv2p function in vivo.  Cells overproducing wild-type or Ala-substitution mutants of Erv2p-HA 
were labeled with [35S]methionine and then lysed in 10% TCA to block disulfide exchange.  Free 
thiols were alkylated with NEM prior to immunoprecipitation with HA antibody.  (A) Wild-type 
Erv2p exists in monomeric and dimeric forms when resolved under non-reducing conditions, 
whereas the protein is entirely monomeric after reduction with 0.1 M DTT.  (B) Comparison of the 
Cys mutants resolved under non-reducing conditions.  (C) An ero1-1 strain (CKY598) was 
transformed with the control plasmid, pRS316, with PGAL1-ERV2 or with PGAL1-ERV2 bearing Cys 
mutations.  The failure of the Cys mutants to suppress the growth defect of ero1-1 was shown by 
incubation at 37 ˚C for 2 d on minimal medium with 2% (w/v) galactose. 
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Chapter Three 
 
 
 
Structural determinants of substrate access to the disulfide 
oxidase Erv2p 
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Preface 
 
Chapter 3 represents primarily my own work and has been published as: 
 
Vala, A., Sevier, C.S. and Kaiser, C.A. (2005) Structural determinants of substrate 
access to the disulfide oxidase Erv2p. J Mol Biol, 354, 952-966. 
 
Carolyn S. Sevier contributed with Figure 7C. 
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Summary 
 
Erv2p is a small, dimeric FAD-dependent sulfhydryl oxidase that generates 
disulfide bonds in the lumen of the endoplasmic reticulum.  Mutagenic and structural 
studies suggest that Erv2p uses an internal thiol-transfer relay between the FAD-
proximal active site cysteine pair (Cys121-Cys124) and a second cysteine pair (Cys176-
Cys178) located in a flexible, substrate accessible C-terminal tail of the adjacent dimer 
subunit.  Here, we demonstrate that Cys176 and Cys178 are the only amino acids in the 
tail region required for disulfide transfer and that their relative positioning within the tail 
peptide is important for activity.  However, intragenic suppressor mutations could be 
isolated that bypass the requirement for Cys176 and Cys178.  These mutants were 
found to disrupt Erv2p dimerization and to increase the activity of Erv2p for thiol 
substrates such as glutathione.  We propose that the two Erv2p subunits act together to 
direct the disulfide transfer to specific substrates.  One subunit provides the catalytic 
domain composed of the active site cysteine residues and the FAD cofactor, while the 
second subunit appears to have two functions: it facilitates disulfide transfer to 
substrates via the tail cysteine residues while simultaneously shielding the active site 
cysteine residues from nonspecific reactions. 
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Introduction 
 
Disulfide bond formation is often an essential step in the folding and assembly of 
extracellular proteins (Frand and Kaiser, 2000; Sevier and Kaiser, 2002).  Recent studies 
have defined two pathways for disulfide bond formation in the endoplasmic reticulum 
(ER) of Saccharomyces cerevisiae.  In both pathways, protein substrates are oxidized 
through thiol-disulfide exchange with protein disulfide isomerase (Pdi1p).  Pdi1p, which 
has been reduced in the process of substrate oxidation, can be reoxidized by the 
membrane-associated flavoenzyme Ero1p, which itself can be oxidized by molecular 
oxygen or an anaerobic electron acceptor (Frand and Kaiser, 1998; Frand and Kaiser, 
1999; Pollard et al., 1998; Tu et al., 2000).  Alternatively, Pdi1p can be reoxidized 
independently of Ero1p by the sulfhydryl oxidase Erv2p (Sevier et al., 2001). 
Erv2p belongs to the QSOX/ERV family of FAD-dependent thiol oxidases that 
can couple the oxidation of substrate thiols to disulfides with the reduction of oxygen to 
hydrogen peroxide (Coppock et al., 2000; Francavilla et al., 1994; Lisowsky, 1992; 
Lisowsky et al., 2001; Senkevich et al., 2000b; Thorpe et al., 2002).  This family includes 
the small ERV-like proteins, which share a conserved core domain of about 100 amino 
acids including a conserved Cys-X-X-Cys motif (where X is any amino acid), and the 
larger QSOX proteins, which contain an ERV-like domain fused to a thioredoxin-like 
domain.  Most eukaryotic genomes appear to encode at least one member of the ERV 
family; however, the presence of an ERV-like protein located within the ER appears to be 
unique to fungi.  Conversely, QSOX proteins have been identified only in metazoans, 
and genes encoding these proteins are absent from the sequenced fungal genomes. 
Members of the QSOX/ERV family have been localized to a variety of subcellular 
compartments and are involved in several cellular processes (Coppock et al., 2000; 
Francavilla et al., 1994; Lisowsky, 1992; Lisowsky et al., 2001; Senkevich et al., 2000b).  
The ERV-like proteins Erv1p and ALR are mitochondrial proteins that participate in the 
assembly of cytoplasmic iron-sulphur proteins (Lange et al., 2001), whereas the ERV-like 
protein E10R is a small vaccinia virus protein that uses the glutaredoxin-like protein G4L 
to transfer disulfides to viral coat proteins in the cytoplasm of infected cells (Senkevich et 
al., 2004; Senkevich et al., 2000a; Senkevich et al., 2002; White et al., 2002).  The 
QSOX proteins chicken sulfhydryl oxidase and Quiescin Q6 are secreted proteins that 
are likely to be involved in the formation of disulfide bonds in the extracellular space 
(Thorpe et al., 2002). 
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Erv2p is a homodimeric protein with two catalytic domains, each composed of a 
four-helix bundle holding an FAD cofactor in close proximity to the active site cysteine 
pair (Cys121-Cys124).  In addition, a second cysteine pair (Cys176-Cys178) located in a 
flexible C-terminal region is also required for activity in vivo (Gross et al., 2002).  
Structural and biochemical data indicate that Erv2p transfers disulfide bonds to substrate 
proteins by a shuttle mechanism.  The following steps for disulfide formation and transfer 
have been deduced, but their reaction order has not yet been determined: (i) transfer of 
electrons from the active site cysteine pair to FAD leads to the formation of a disulfide 
bond at the active site, (ii) through an intermolecular disulfide exchange reaction the 
disulfide bond at the active site is transferred to the cysteine residues located in the C-
terminal tail of the other subunit in an Erv2p dimer, and (iii) the disulfide bond in the tail 
can be transferred to thiol-containing substrates such as Pdi1p (Gross et al., 2002).   
This disulfide shuttle mechanism is probably shared by all members of the 
QSOX/ERV family (Sevier and Kaiser, 2002).  Mutagenic studies in Erv1p, human ALR 
and vaccinia virus E10R show that the active site cysteine pair, located within a 
conserved catalytic core, is required for activity in vitro and in vivo (Hofhaus et al., 2003; 
Lisowsky et al., 2001; Senkevich et al., 2004; Senkevich et al., 2000a; Senkevich et al., 
2000b; Sevier et al., 2001).  This pair reacts with a second pair of cysteine residues 
located near either the N or C terminus.  In the case of Erv1p, a second cysteine pair 
located in an N-terminal domain was shown to be required for activity in vivo and in vitro 
(Gross et al., 2002; Hofhaus et al., 2003).  Interestingly, the vaccinia virus protein E10R 
contains only one pair of cysteine residues but interacts with an adaptor protein, A2.5L, 
which contains a pair of cysteine residues that probably fulfills the function of the tail 
cysteine residues in Erv2p.  Each cysteine in A2.5L is essential for the formation of 
disulfide bonds in substrate proteins (Senkevich et al., 2000a; Senkevich et al., 2000b; 
White et al., 2002). 
Despite the fact that the major ER oxidase Ero1p does not share obvious 
sequence similarity with Erv2p, the two proteins appear to have a common structure and 
mechanism (Gross et al., 2004).  Both Ero1p and Erv2p proteins share the same four 
helix bundle arrangement containing the FAD cofactor and the active site cysteine pair 
as catalytic domain (Gross et al., 2004).  In addition to an active site cysteine pair, both 
proteins require a second pair of cysteine residues for activity (Frand and Kaiser, 2000; 
Gross et al., 2002).  For both proteins the second cysteine pair is located in a relatively 
unstructured peptide exposed at the surface of the protein that appears to be able to 
engage in thiol-disulfide exchange with both the active site cysteine pair and thiols of 
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substrate proteins.  We have suggested previously that the internal disulfide relay 
mechanism may determine the selectivity of substrates by both proteins (Gross et al., 
2004; Gross et al., 2002).  Here we focus on the role of the subunit providing the C-
terminal tail in conferring substrate specificity to Erv2p.  By mutational studies we show 
that the latter subunit performs both a positive function to shuttle disulfide bonds to 
substrate proteins via the C-terminal peptide and a negative function to restrict relatively 
non-specific access of thiol compounds to the cysteine residues at the active site. 
 
Results 
 
Intragenic complementation of erv2 mutations 
 
Two key results provide evidence for a relay of oxidizing equivalents between the 
Cys121-Cys124 pair from one subunit and the Cys176-Cys178 pair of the adjacent 
subunit.  First, these two pairs of cysteine residues are required for activity in vivo, and 
second, Cys121 and Cys176 or Cys178 are necessary for the formation of a disulfide-
linked form, which is an intermediate of the reaction of the active site cysteine and the 
tail cysteine residues from the adjacent subunit (Gross et al., 2002). 
As an explicit test of the ability of the active site cysteine residues from one 
subunit to functionally react with the tail cysteine residues of a different subunit we co-
expressed a Cys121-Cys124 mutant (Erv2p-C121A-C124A) and a Cys176-Cys178 
mutant (Erv2p-C176A-C178A) in an ero1-1 erv2? strain.  When co-expressed, two 
different Erv2p mutants should form three different dimeric species: two homodimers of 
Erv2p-C121A-C124A or Erv2p-C176A-C178A, and a heterodimer of Erv2p-C121A-
C124A and Erv2p-C176A-C178A.  Co-expression of Erv2p-C121A-C124A and Erv2p-
C176A-C178A was able to suppress the growth defect of the temperature-sensitive ero1-
1 mutant at the non-permissive temperature (Figure 1).  This intragenic complementation 
of erv2 cysteine mutants shows that Cys121-Cys124 from one subunit can work together 
with Cys176-Cys178 from the other subunit of a dimer to produce a functional enzyme.  
As shown previously, strains individually expressing Erv2p-C121A-C124A or Erv2p-
C176A-C178A were unable to suppress the ero1-1 growth defects (Figure 1) (Gross et 
al., 2002; Sevier et al., 2001).  This result emphasizes that Erv2p catalytic domain 
requires components from both subunits.  We will focus on the C-terminal tail and further 
study its role in disulfide transfer. 
 
Cys176 and Cys178 are the only tail residues essential for Erv2p activity 
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The Erv2p tail region, defined structurally as the C-terminal segment beginning 
after the last ?-helix of Erv2p (residues 171 to 196) is weakly conserved among the 
Erv2p fungal orthologs, yet only the Cys-Gly-Cys motif is conserved completely (Figure 
2).  Because previous studies suggested that the C-terminal tail of Erv2p confers 
specificity to its interaction with substrates (Gross et al., 2002), we conducted site-
directed mutagenesis of the tail and examined the effect on substrate oxidation.  We 
individually mutated each of the amino acids from 171 to 183 to alanine, and determined 
that only the Erv2p-C176A and Erv2p-C178A mutants were not active in vivo (data not 
shown).  In addition, the C-terminal tail contains many charged residues that we 
individually mutated to alanine (K184A, R185A, E189A, K190A, E191A, K193A and 
H195A).  All of these mutants were active in vivo, and only the E191A mutation caused 
even a partial growth defect (data not shown). 
We then generated a nested set of truncation mutants across the tail region 
(Figure 3A) and tested these mutants for their ability to suppress the growth defect of an 
ero1-1 strain at the restrictive temperature.  Only Erv2p truncation mutants that 
contained the tail cysteine residues (Erv2p-D182Stop, Erv2p-S187Stop and Erv2p-
A192Stop) were active, while mutants lacking one or both tail cysteine residues (Erv2p-
L171Stop, Erv2p-C176Stop and Erv2p-G177Stop) were inactive (Figure 3B).  Erv2p-
D182Stop, Erv2p-S187Stop and Erv2p-A192Stop mutants also displayed intersubunit 
disulfide-linked intermediates under denaturing conditions (Figure 3C).  Interestingly, the 
majority of the Erv2p-G177Stop mutant protein was found in a disulfide-linked 
conformation, suggesting that a second cysteine normally plays a role in resolving the 
mixed disulfide between the tail and the active site cysteine residues.  Alternatively, it is 
possible that the observed increase in the amount of disulfide-linked dimer in this 
truncation mutant is due to increased accessibility of Cys176 in the absence of the distal 
portion of the tail. 
 
Erv2p activity depends on the spacing between Cys176 and Cys178  
 
Studies with Cys-Xn-Cys peptides have shown that the number of residues 
between two cysteine residues affects the rate of the thiol-disulfide exchange reaction 
and that peptides containing only one residue between cysteine residues form a 
relatively unstable disulfide bond (Zhang and Snyder, 1989).  These studies of model 
peptides suggest that the Cys-Gly-Cys arrangement of the Erv2p tail cysteine residues 
should create a relatively unstable disulfide bond, potentially facilitating the efficient 
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transfer of oxidizing equivalents to substrate proteins (Gross et al., 2002; Woycechowsky 
and Raines, 2003).  The spacing between the cysteine residues of the second cysteine 
pair in other members of the QSOX/ERV family is variable.  The second cysteine pair 
appears in a Cys-X2-Cys motif in Erv1p, ALR and Quiescin Q6, in a Cys-X3-Cys motif in 
the viral A2.5L protein, and in a Cys-X4-Cys motif in Erv1p from Arabidopsis thaliana. 
By adjusting the spacing between the Erv2p tail cysteine residues we expected to 
alter the redox characteristics of the Cys176-Cys178 pair and thus perhaps interfere with 
disulfide transfer either between the active site cysteine and the tail cysteine residues, or 
between the tail cysteine residues and the substrate protein.  For this purpose, we either 
removed the glycine between the tail cysteine residues (Erv2p-G177?) or inserted 
alanine residues between the tail cysteine residues (Erv2p-CGAnC, where n varies from 
one to four) (Figure 4A).  Erv2p tolerated spacing of two, three or four residues between 
the tail cysteine residues but lost activity when we deleted the glycine residue between 
the tail cysteine residues (Erv2p-G177?) or increased the spacing between the tail 
cysteine residues to five amino acids (Erv2p-CGA4C) (Figure 4B).  The activity of these 
Erv2p mutants did not correlate with the predicted changes in the equilibrium constant 
for loop formation based on in vitro studies with model peptides (Zhang and Snyder, 
1989). 
A disulfide-linked form of Erv2p was detected by SDS-PAGE under non-reducing 
denaturing conditions for each of these mutants (Figure 4C), suggesting that the spacing 
between the tail cysteine residues does not affect the ability of the tail cysteines to 
interact with the active site cysteine residues.  Because we can still capture Erv2p-
CGA4C and Erv2p-G177? in the disulfide-linked conformation, the inactivity of these 
mutants in vivo may result from either a particularly energetically unfavorable disulfide 
bond in these tail mutants or a constraint that causes resolution of the mixed disulfide 
bond between the active site cysteine and the tail cysteine to occur relatively slowly.  
Consistent with this latter possibility, kinetic studies of disulfide rearrangements with 
model peptides showed that Cys-Cys and Cys-Ala5-Cys peptides are slow to undergo 
either oxidation or reduction reactions (Zhang and Snyder, 1989). 
 
Erv2p activity depends on the position of Cys176 and Cys178 within the tail 
 
Finally, we examined the effect of the distance between the active site cysteines 
and the tail cysteine residues on Erv2p activity by shortening the C-terminal tail by 
deleting residues before the tail cysteine pair (Figure 5A).  Amino acids preceding 
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Cys176 in the tail (Asp173, Tyr174, and Asp175) were deleted to generate the Erv2p-
(DYD)? mutant, which was inactive in vivo and failed to form disulfide-linked 
intermediates (Figure 5B and 5C).  However, when we reintroduced two or three alanine 
residues at this position, creating Erv2p-(DYD)?+2A and Erv2p-(DYD)?+3A, the activity 
and the ability to form disulfide-linked intermediates was restored (Figure 5B and 5C). 
Taken together, these mutagenesis studies show that Cys176 and Cys178 are 
the only residues in the C-terminal tail region required for Erv2p activity.  Our data 
indicate two important factors for the cysteine residues in the tail to function in vivo: (i) 
the tail cysteine residues have to be separated by a peptide segment of an appropriate 
length for a disulfide bond to form between and (ii) the tail cysteine residues have to be 
separated from the body of Erv2p by a peptide tether sufficiently long to give access of 
the tail cysteine residues to the active site of the other subunit in the dimer. 
 
Identification of intragenic suppressors of Erv2p tail cysteine mutants 
 
To better understand how accessibility of substrates to the active site is 
controlled, we designed a screen for intragenic suppressors of a nonfunctional mutant 
with both tail cysteine residues mutated to alanine.  Random PCR mutagenesis was 
performed on ERV2-C176A-C178A, and the resulting plasmids generated by in vivo gap 
repair were screened for their ability to bypass the need for the tail cysteine residues by 
allowing growth of an ero1-1 erv2? strain.  Sequencing of 24 candidate suppressors 
revealed that each contained more than one mutation.  However, all of the suppressor 
mutants had at least one mutation in the ?2 helix: K107N (1 clone), K107E (1 clone), 
F111S (10 clones), F111V (1 clone) and F111L (2 clones), L114S (5 clones), F115S (1 
clone), L118R (2 clones) and P120A (2 clones). 
To identify individual point mutations with suppressor activity we tested three 
single mutants (F111S, L114S, and P120A) and found that each by itself was sufficient 
for the restoration of Erv2p activity in the absence of the tail cysteine pair (Figure 6A).  
These three mutants were also active in vivo when the Erv2p tail was truncated 
immediately after Cys176 yet required a functional Cys121-Cys124 pair for activity 
(Figure 6B and data not shown).  Overexpression of the three intragenic suppressors 
decreases the sensitivity of ero1-1 cells to the reducing agent dithiothreitol (DTT; data 
not shown) as does overexpression of wild-type Erv2p (Sevier et al., 2001).  Constructs 
expressing the three intragenic suppressor mutants or wild-type Erv2p complemented an 
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ero1? mutant, while those expressing an Erv2p mutant lacking the tail cysteine residues 
did not (data not shown). 
The Phe111, Leu114 and Pro120 residues are located in the Erv2p dimer 
interface (Figure 6C), a region characterized by hydrophobic contacts between the ?1 
and ?2 helices of both subunits (Gross et al., 2002).  To test whether elimination of these 
hydrophobic residues precludes dimer formation, we expressed and purified recombinant 
Erv2p wild-type and Erv2p variants (Erv2p-C176A-C178A, Erv2p-F111S-C176A-C178A 
and Erv2p-L114S-C176A-C178A) in Escherichia coli.  We were unable to purify Erv2p-
P120A-C176A-C178A due to its insolubility.  After purification, all the recombinant 
proteins exhibited the characteristic absorbance peaks for bound FAD at 352 and 454 
nm, and showed sulfhydryl oxidase activity as determined by the initiation of oxygen 
consumption and reduction of bound FAD by thiol substrates (data not shown). 
In equilibrium analytical ultracentrifugation experiments, recombinant wild-type 
Erv2p and Erv2p-C176A-C178A each reached sedimentation equilibrium for a protein of 
a molecular weight of 41 kDa, a value close to that expected for a homodimeric protein 
(Table 1).  In contrast, addition of the F111S or L114S mutation caused the mutant 
lacking the tail cysteine residues to sediment with a molecular weight of 22 or 23 kDa, 
respectively, suggesting that the intragenic suppressor mutants are monomeric proteins 
(Table 1). 
In thermal denaturation experiments, recombinant wild-type Erv2p and Erv2p-
C176A-C178A have a melting temperature of 59.2 ˚C and 56.5 ˚C, respectively, while 
the Erv2p-F111S-C176A-C178A has a lower melting temperature of 46.7 ˚C (Figure 7).  
The relative instability of monomeric Erv2p-F111S-C176A-C178A mutant indicates that 
molecular contacts at the dimer interface of the wild-type protein contribute to overall 
stability.   
 
Monomeric Erv2p has decreased substrate selectivity 
 
The Erv2p crystal structure suggests that the active site cysteine residues in the 
Erv2p dimer conformation are partially buried in the dimer interface, underneath the tail 
of the other subunit (Gross et al., 2002).  To test whether thiol substrates have greater 
access to the active site cysteine residues in the monomeric form of Erv2p, we used the 
catalytic reduction of bound FAD in the presence of various thiol substrates as a 
measurement of in vitro sulfhydryl oxidase activity (Figure 8A).  The observed time lag 
between the addition of Erv2p and the moment of reduction of bound FAD corresponds 
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to the time that is necessary to consume the oxygen in the cuvette and is correlated with 
the amount of thiol used.  We used a range of small thiol substrates, including the dithiol 
substrates DTT and (±)-trans-1,2-bis(2-mercaptoacetamido)cyclohexane (BMC), and the 
monothiol substrates cysteine, homocysteine, N-methylmercaptoacetamide (NMA), 
reduced glutathione (GSH) and ?-mercaptoethanol (?-ME).  Using an assay based on 
FAD bleaching we found that most thiol substrates (except for DTT and BMC) were not 
sufficiently soluble to derive Km or Vmax values.  For example, Figure 8B shows that 
enzyme saturation when GSH was used as a substrate does not occur at the solubility 
limit of GSH (about 250 mM). 
Comparison of the sulfhydryl oxidase activity of these proteins revealed higher 
reaction rates when using dithiols as substrates (Table 2).  When we compared the 
activity of the recombinant proteins toward the dithiol substrates, we observed that they 
could oxidize the small dithiol DTT but have lower activity toward the bulkier dithiol 
substrate BMC (Table 2).  The same relationship was observed for the monothiol 
substrates tested, with the exception of ?-ME (Table 2).  Of all the monothiols tested, ?-
ME has the highest pKa value and thus probably has the least thiolate form at 
physiological pH. 
Erv2p-C176A-C178A and Erv2p-C176Stop mutants could oxidize the small 
substrate DTT but have limited activity toward the bulkier substrates BMC, GSH and 
cysteine (Table 2 and data not shown).  The addition of an intragenic suppressor 
mutation to the Erv2p-C176A-C178A mutant allowed this protein to oxidize a broader 
range of substrates (Table 2).  The Erv2p-F111S-C176A-C178A had wild-type level 
activity toward all the monothiol substrates tested except GSH, which was twofold higher 
(Figure 8A, 8B and Table 2). 
DTT is a strong reducing agent that is small enough to react directly with the 
Cys121-Cys124 pair.  For each protein, the rate of O2 consumption was highest with 
DTT as substrate (Table 2).  Thus, we used the activity toward DTT as the standard for 
the intrinsic activity of each mutant protein.  For all other substrates tested, the rates of 
O2 consumption were highest for the Erv2p-F111S-C176A-C178A mutant.  This result 
emphasizes that the intragenic suppressor mutants is less specific than wild-type Erv2p, 
tail mutant or the truncation mutant.  From these in vitro experiments, we conclude that 
substrate accessibility to the active site is determined by steric occlusion by the adjacent 
subunit in a dimer.   
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Monomeric Erv2p mutants can oxidize Pdi1p in the absence of tail cysteine 
residues 
 
We have previously shown that Erv2p is able to transfer oxidizing equivalents to 
Pdi1p in vitro (Sevier et al., 2001).  To test whether the intragenic suppressor mutations 
alter this property of Erv2p, we reduced 4 μM of recombinant Pdi1p and incubated it with 
300 nM of Erv2p or its mutant variants at 30 ˚C.  At various time points, an aliquot of the 
reaction mixture was TCA precipitated and the oxidation state of Pdi1p was determined 
by reaction with AMS, an alkylating agent that will react only with free cysteine residues.  
After AMS treatment, the samples were resolved by non-reducing SDS-PAGE.  As a 
mobility standard for oxidized Pdi1p we incubated reduced Pdi1p with 1 mM diamide.  
Both Erv2p-C176A-C178A and Erv2p-C176Stop mutants did not oxidize Pdi1p, yet the 
Erv2p-F111S-C176A-C178A suppressor mutant reoxidized recombinant Pdi1p faster 
than wild-type Erv2p (Figure 8C).  This result supports the idea that the active site 
cysteine pair in Erv2p-F111S-C176A-C178A is more accessible to bulkier substrates 
than in the wild-type. 
The reaction of Erv2p with Pdi1p in vitro is much slower than the reaction of 
Erv2p with small-molecule thiols, raising the question of whether Pdi1p is a 
physiologically relevant substrate of Erv2p.  It is possible that other as yet unidentified 
ER protein(s) are the preferred substrate of Erv2p in vivo or that our in vitro assay for 
oxidation of Pdi1p lacks an important component. 
 
Discussion 
 
The mechanism by which Erv2p generates a disulfide bond that can be 
transferred to thiol substrates has been deduced from structural data, mutagenesis 
studies, and biochemical assays (Gross et al., 2002; Sevier et al., 2001).  A central 
feature of this mechanism, which Erv2p appears to share with other members of the 
family of QSOX/ERV proteins and the structurally related ER oxidase Ero1p, is a second 
pair of cysteine residues that can shuttle disulfide bonds from the active site to thiols of 
substrate proteins (Gross et al., 2004; Hofhaus et al., 2003; Thorpe et al., 2002).  In this 
manuscript we describe mutagenesis studies on Erv2p to define the features of the C-
terminal tail in the vicinity of the second cysteine pair that allow efficient disulfide 
shuttling between the active site and in vivo substrates.  In addition, we employed a 
genetic suppression strategy to explore the structural constraints that prevent substrate 
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thiols from directly gaining access to the active site disulfide bond in the absence of 
cysteine residues in the C-terminal tail.   
Mutagenesis of the Erv2p tail cysteine residues shows that they are required for 
activity and for the formation of the catalytically important intrasubunit disulfide-linked 
intermediate (Gross et al., 2002).  By extensive mutagenesis of the C-terminal tail we 
show here that the most important features of the tail are the presence of two cysteine 
residues spaced appropriately such that a disulfide bond can form between them and 
positioned with a long enough flexible tether to engage in dithiol-disulfide exchange with 
the active site cysteine pair.  Although the identity of other individual residues in the tail 
are not essential for the ability of Erv2p to suppress an ero1-1 mutation in vivo, we 
cannot rule out the possibility that more subtle aspects of Erv2p function may be 
influenced by specific molecular recognition of the tail peptide.   
 
Specificity conferred by the disulfide relay 
 
Mutants that lack a cysteine pair in the C-terminal tail of Erv2p, such as Erv2p-
C176A-C178A, exhibit greatly decreased capacity for protein disulfide bond formation in 
vivo.  Nevertheless, such mutants should still be capable of forming a disulfide bond at 
the active site, and we wished to determine how access of thiol substrates to the active 
site is determined.  Accordingly, we performed a screen for intragenic suppressor 
mutants that could oxidize substrates in vivo without relaying disulfides through the tail 
cysteine pair.  The suppressor mutations that we isolated lie in the hydrophobic interface 
between subunits of the Erv2p dimer and convert Erv2p into a monomeric form 
bypassing the need for disulfide shuttling through the C-terminal tail by giving thiol 
substrates direct access to the active site cysteine residues.   
Assays of purified Erv2p for the ability to oxidize different thiol-containing 
substrates in vitro show that wild-type Erv2p can readily oxidize the small, powerful 
reducing agent DTT.  In addition, wild-type Erv2p can oxidize bulkier substrates more 
representative of the physiological substrates of Erv2p present in the ER, such as GSH 
or Pdi1p.  Mutants lacking tail cysteine residues are slightly more active than the wild-
type enzyme for oxidation of DTT, showing that this relatively small substrate can react 
with the active site without an active disulfide shuttle.  In contrast to wild-type, the 
mutants lacking tail cysteine residues have greatly decreased activity for GSH and Pdi1p 
oxidation, showing that a disulfide shuttle is needed for oxidation of these substrates.  
Finally, the suppressor mutant exhibits restored activity for GSH and Pdi1p.  The 
 
138 
monomeric mutant of Erv2p has about one third the activity towards DTT (normalized to 
absorbance of the enzyme-bound FAD).  Thermal denaturation experiments have shown 
that the suppressor mutant has a melting point about 10 ˚C lower than wild-type, 
indicating that the monomeric enzyme is intrinsically less stable than the native dimeric 
enzyme and this instability could account for the lower specific activity for reaction with 
DTT.  Monomeric Erv2p has greater activity with GSH as a substrate than the wild-type 
enzyme, consistent with the greatly increased accessibility of the active site cysteine 
residues.  Figure 9 uses the crystal structure of Erv2p to illustrate the relative 
accessibility of the active site cysteine residues for wild-type Erv2p, a truncation of the C-
terminal tail (Erv2p-C176Stop), and monomeric Erv2p.   
Specificity in the disulfide transfer reactions that occur in the ER must be tightly 
controlled to prevent crosstalk between the oxidation and the isomerization pathways, 
since unregulated activity might lead to activation or inactivation of proteins (Sevier and 
Kaiser, 2002).  It is also important to regulate the activity of oxidoreductases in the ER, 
since their activity may generate reactive oxygen species as an unwanted byproduct 
(Harding et al., 2003). 
Mutational analysis suggests that the subunit contributing with the C-terminal tail 
governs Erv2p substrate selection in two different ways.  In one sense the cysteine pair 
in the tail acts positively in the transfer of disulfide bonds to substrates.  An attractive 
possibility is that this relatively unstructured region of Erv2p has evolved to interact 
efficiently with Pdi1p by displaying properties similar to nascent polypeptide chains that 
are in the process of folding (Gross et al., 2004).  In this way, Erv2p may optimize 
transfer of disulfides to the preferred catalyst of biosynthetic disulfide bonds.   
In another sense, the tail along with the neighboring structure of the Erv2p 
monomer act negatively to restrict access of substrates to the active site, thus limiting 
the extent to which disulfides are transferred nonspecifically to bulk thiols within the ER, 
including glutathione.  Truncations that removed the C-terminal tail (Erv2p-C176Stop and 
Erv2p-L171Stop) are inactive in vivo suggesting that residues from the opposing subunit 
bury the active site cysteine residues in this mutant.  A truncation that removed the entire 
C-terminal tail (Erv2p-L171Stop) appeared to be unable to fold properly, since this 
mutant formed insoluble aggregates when expressed as recombinant protein (data not 
shown).  However, Erv2p-C176Stop could fold into an enzymatically active dimer, and 
this mutant expressed as a recombinant protein could oxidize DTT but exhibited low 
activity for oxidation of bulkier substrates similar to the substrate specificity of Erv2p-
C176A-C178A point mutants.  Thus, even for dimeric proteins for which most of the C-
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terminal tail has been deleted the active site is not as accessible to substrates such as 
GSH as it is in the monomeric form of Erv2p. 
 
Generality of the disulfide relay mechanism 
 
Besides Erv2p and members of the QSOX/ERV family, several thiol oxidases, 
such as Ero1p, DsbB and high MW thioredoxin reductase (TrxR) (Gross et al., 2004; 
Sandalova et al., 2001) appear to have evolved a similar mechanism of transfer to 
substrate proteins: a cysteine pair located in a flexible region that mediates electron 
transfer between the substrate and the active site cysteine pair, which is located near a 
redox cofactor.  However, this auxiliary cysteine pair can be located in the N or C 
terminus, either in the same subunit or in a different subunit, or as in the case of E10R, 
in a different protein. 
A combination of structural, biochemical and mutagenesis studies show that 
there are striking similarities between the catalytic domains and disulfide transfer 
mechanisms of Erv2p and Ero1p (Gross et al., 2004; Gross et al., 2002).  First, both 
require two pairs of cysteine residues for activity (Frand and Kaiser, 2000; Gross et al., 
2002; Sevier et al., 2001).  Second, both transfer disulfides from a buried FAD-proximal 
active site cysteine pair to Pdi1p via a second pair of cysteine residues located in an 
unstructured flexible region (Gross et al., 2004; Gross et al., 2002).  This second pair of 
cysteine residues is located in a C-terminal tail in Erv2p and in a loop in Ero1p, and their 
structures suggest that these regions restrict substrate access to the active site cysteine 
pair (Gross et al., 2004; Gross et al., 2002).  Like the Erv2p tail mutant, Ero1p lacking the 
second pair of cysteine residues (Ero1p-C100A-C105A) is incapable of forming disulfide 
bonds in vivo (Frand and Kaiser, 2000).  Second-site suppressors of Ero1p-C100A-
C105A seem to displace the loop, giving direct access to the active site cysteine 
residues (Sevier and Kaiser, 2005).  As observed for Erv2p, these mutants are able to 
oxidize both small and large substrates, while Ero1p-C100A-C105A is only able to 
efficiently oxidize small substrates such as DTT (Sevier and Kaiser, 2005).  Transfer 
between two pairs of cysteine residues seems to be an important mechanism used by 
Erv2p and Ero1p to control substrate specificity by directing the transfer of disulfides to 
specific substrates and thus preventing reduction of both proteins by reduced GSH, 
which is abundant in the ER. 
A similar mechanism for substrate specificity is found in chicken QSOX, which is 
a fusion of a thioredoxin-like domain and an ERV-like domain (Raje and Thorpe, 2003).  
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While the thioredoxin-like fragment or the ERV-like fragment alone has little or no activity 
toward thiol substrates, the two fragments combined exhibit substantial activity.  The 
ERV-like fragment is a dimer and probably shares the overall structure of Erv2p, 
including a flexible C-terminal tail containing the second cysteine pair (Raje and Thorpe, 
2003).  As in Erv2p, this second pair of cysteine residues in the ERV-like fragment 
confers specificity in the disulfide transfer to the redox active cysteine pair in the 
thioredoxin-like fragment. 
High molecular mass TrxR and glutathione reductase are closely related 
reductases that exhibit distinct substrate specificities.  A clear structural difference 
between the enzymes that may explain the marked preference of TrxR for thioredoxin 
rather than oxidized glutathione as a substrate is the presence of an extra C-terminal tail 
that has been shown to contain a second redox-active cysteine pair.  Although the 
residues involved in GSH binding are conserved in both structures, high molecular mass 
TrxR is unable to reduce GSSG (Sandalova et al., 2001).  Structural data suggest that 
the presence of the C-terminal tail of the high molecular mass TrxR prevents interaction 
of GSSG with the active site cysteine residues by blocking access to them, thus 
conferring specificity (Sandalova et al., 2001). 
Mercuric ion reductase (MerA), a flavoenzyme involved in Hg(II) detoxification in 
bacteria, is a homodimer that catalyzes the transfer of electrons from NADPH to 
substrates via FAD and two pairs of cysteine residues, located in different subunits.  
Interestingly, a MerA mutant containing a mutated C-terminal cysteine pair is inactive in 
vivo, and yet it retains activity in vitro.  MerA-C557A-C558A is able to reduce small HgX2 
substrates but is impaired in the reduction of larger substrates, which may be unable to 
access the active site cysteine residues (Engst and Miller, 1998; Engst and Miller, 1999).  
In the case of MerA, this internal transfer between two pairs of cysteine residues is 
important for the activity of this protein since all of the cellular Hg(II) seems to be 
associated with thiols, such as cysteine and GSH. 
This flexibility in the transfer may allow these different proteins to perform in 
different locations or to perform diverse biological functions by acting upon different 
substrates.  More importantly, the specificity in electron transfer obtained by this shuttle 
mechanism might allow for a better discrimination among different substrates, thus 
preventing inappropriate oxidation of substrates that are not on the pathway for formation 
of biosynthetic disulfide bonds. 
 
Materials and methods 
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Media and yeast strains 
 
All yeast strains used in this study have the genetic background of S288C.  
Cultures were either grown in rich medium (1% Bacto yeast extract and 2% Bacto-
peptone containing either 2% dextrose (YPD) or 2% galactose (YPGal) as carbon 
sources) or minimal media (0.67% nitrogen base without amino acids supplemented with 
16 amino acids not including cysteine) containing 2% galactose and 2% raffinose (SMM 
Gal/Raf).  The isolation and characterization of the ero1-1 mutant (CKY598) and the 
construction of an erv2? strain (CKY688) were described previously (Frand and Kaiser, 
1998; Sevier et al., 2001).  CKY899 (MATa GAL2 ero1-1 erv2?::kanMX ura3-52 leu2-
3,112) was constructed by crossing an erv2? strain (CKY688) to an ero1-1 GAL2 strain 
(CKY598). 
 
Plasmid construction 
 
The plasmids used in this study are listed in Table 3.  The construction of ERV2 
Cys to Ala mutants was described previously (Gross et al., 2002; Sevier et al., 2001).  A 
version of ERV2-C121A-C124A lacking an epitope tag (pAV36) was constructed by 
ligating a MluI fragment from ERV2-C121A-C124A-HA tagged (pJC15) to the same site 
in pFA11 (Gross et al., 2002; Sevier et al., 2001).  To generate pAV106, a 738 bp 
BamHI-SacII fragment of pAV36 was placed under the GAL1 promoter in a pRS315-
based plasmid.  The other mutants of ERV2 were made using the QuikChange site 
directed mutagenesis kit (Stratagene) using pFA11 as template.  The forward primers 
used for the site-directed mutagenesis are listed in Table 4.  All mutated plasmids were 
verified by sequencing. 
To construct ERV2 truncation mutants, the ERV2 gene was amplified from pFA11 
by PCR with a primer from the GAL1 promoter (Gal1) and one of the following primers: 
SacII-*-I170, SacII-*-D175, SacII-*-C176, SacII-*-S181, SacII-*-V186 or SacII-*-E191.  
The PCR products were cloned into BamHI-SacII restriction sites of pRS316 vector 
containing the GAL1 promoter.  The 3' untranslated region of ERV2 was subcloned into 
these vectors using the SacII site. 
ERV2 wild-type, ERV2-C176A-C178A and ERV2-F111S-C176A-C178A 
suppressor mutant lacking the first 29 amino acids encoding the hydrophobic N-terminal 
signal sequence and containing an N-terminal His6 tag were constructed using NdeI-Erv2 
and Erv2-BamHI primers.  The resulting fragments were subcloned into the bacterial 
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expression vector pET-14b (Novagen) using the NheI and BamHI sites.  The ERV2 
mutant truncated at residue 176 (ERV2-C176Stop) was subcloned into pET-14b using 
NdeI-Erv2 and Erv2-C176Stop-BamHI primers. 
 
Radiolabeling and immunoprecipitation 
 
Radiolabeling and immunoprecipitation of Erv2p was done as described 
previously (Gross et al., 2002).  Briefly, strains overexpressing Erv2p or mutant alleles 
were grown in SMM Gal/Raf lacking uracil and methionine to about 1 ? 107 cells/ml.  
Cells were suspended in the same medium at 1 ? 108 cells/ml and labeled with 
[35S]methionine and cysteine (EXPRESS, NEN) for 60 min at room temperature.  Cells 
were then suspended in 10% (w/v) TCA and lysed with glass beads.  Protein pellets 
were then incubated in sample buffer (80 mM Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, 
1 mM phenylmethylsulfonyl fluoride (PMSF), 0.01% bromophenol blue) containing 40 
mM N-ethylmaleimide (Sigma) for 15 min at 4 ˚C followed by 10 min at room 
temperature.  Cell extracts were suspended in 1 ml IP buffer (50 mM Tris-HCl [pH 7.4], 
150 mM NaCl, 1% Triton X-100 and 1 mM PMSF) and pre-adsorbed with fixed 
Staphylococcus A cells (Sigma) before incubation with Erv2p antibody.  Immune 
complexes were collected with protein A-Sepharose (Pharmacia), washed in IP buffer 
containing 0.1% SDS, washed in IP buffer without detergent, and solubilized in sample 
buffer.  Samples were analyzed by 12% SDS-PAGE and visualized with a 445si 
PhosphorImager (Molecular Dynamics). 
 
Erv2p antibody production 
 
Erv2p lacking the first 29 amino acids and containing a C-terminal His6 tag was 
purified as described previously (Sevier et al., 2001).  The protein was separated by 
SDS-PAGE and used to prepare polyclonal antibodies in rabbits by standard protocols at 
Covance. 
 
Isolation of ERV2-C176A-C178A intragenic suppressors 
 
PCR mutagenesis of ERV2-C176A-C178A (pAV41) was performed as described 
previously (Muhlrad et al., 1992).  pAV41 was amplified using AmpliTaq Gold (Perkin 
Elmer) in the presence of 0.65 mM or 0.25 mM MnCl2 and 0.2 mM dATP (one fifth of the 
normal concentration) using the Gal1 and Erv2mut3 primers (Table 4). 
 
143 
CKY899 was co-transformed with the resulting randomly mutagenized PCR 
fragment and gapped pAV41 (cut with BamHI and StuI).  Transformants were plated on 
SMM minus uracil plates and then replica plated in SMM Gal/Raf minus uracil plates at 
24 ˚C and 37 ˚C.  Plasmids from colonies that suppress the growth defect of CKY899 
cells at 37 ˚C were obtained at a frequency of 3 or 4 colonies per 100 colonies tested.  
These plasmids were tested by retransformation and positive clones were sequenced. 
 
Protein expression and purification 
 
ERV2 wild-type and mutant allele expression plasmids were transformed into E. 
coli BL21(DE3) Gold pLysS cells (Novagen).  Single colonies were inoculated into LB 
supplemented with 80 mg l-1 ampicillin and 30 mg l-1 chloramphenicol.  Cultures were 
grown at 30 °C to an OD600 of 0.5-0.6, and isopropyl ?-D-thiogalactoside (IPTG) and FAD 
were added to a final concentration of 0.4 mM and 10 μM, respectively.  After 4 h of 
induction at 30 ˚C, cells were harvested by centrifugation and lysed by French press in 
lysis buffer (50 mM NaH2PO4 [pH 8], 350 mM NaCl and 10 mM imidazole with EDTA-free 
protease inhibitor cocktail).  Insoluble material was sedimented by centrifugation and the 
supernatant was applied to a HiTrap Chelating HP column (Amersham Biotech) pre-
equilibrated with lysis buffer. 
The resin was washed with lysis buffer and with wash buffer (50 mM NaH2PO4 
[pH 8], 300 mM NaCl and 20 mM imidazole).  The bound protein was eluted with a 
gradient of 20 mM to 250 mM imidazole in 50 mM NaH2PO4 [pH 8], 300 mM NaCl.  The 
fractions containing Erv2p were then dialyzed for at least 16 h against 50 mM NaH2PO4 
[pH 8], 150 mM NaCl.  The samples used for the determination of the molecular weight 
were further purified in an anion exchange HiTrap Q column (Amersham Biotech).  The 
protein eluted from the HiTrap Chelating HP column (Amersham Biotech) was pooled 
and dialyzed against 20 mM Tris-HCl [pH 8].  The sample was applied to the HiTrap Q 
column and eluted with an increasing NaCl concentration.  The fractions containing 
Erv2p were then dialyzed for at least 16 h against buffer A (50 mM KH2PO4 [pH 8], 150 
mM KCl).  All proteins were > 95% pure after the HiTrap Q column.  Concentration of the 
protein samples was estimated using a molar extinction coefficient of 12.5 mM cm-1 at 
454 nm (Sevier et al., 2001). 
 
Protein molecular mass determination 
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Protein samples were centrifuged in an optima XL-A centrifuge (Beckman-
Coulter) using a 60 Ti rotor.  For all protein samples absorbance readings at 280, 285 
and 290 nm were taken.  His6-Erv2p at 10, 7 and 5 μM in buffer A was centrifuged at 25 
˚C at 9,000, 12,000 and 16,000 rpm.  His6-Erv2p-C176A-C178A at 13, 8 and 6 μM in 
buffer A was centrifuged at 25 ˚C at 12,000 and 16,000 rpm.  His6-Erv2p-F111S-C176A-
C178A at 11, 7 and 5 μM and His6-Erv2p-L114S-C176A-C178A at 11, 6 and 3 μM in 
buffer A were centrifuged at 25 ˚C at 12,000, 16,000 and 24,000 rpm.  Absorbance 
measurements were made at 4 h intervals until equilibrium was reached (usually 24 h).  
Data were fit to a one-species model by the least squares method to determine the 
molecular weights (McRorie and Voelker, 1993). 
 
Thermal denaturation assay 
 
Thermal stability of Erv2p, Erv2p-C176A-C178A and Erv2p-F111S-C176A-
C178A was studied by circular dichroism (CD) spectroscopy.  CD spectra were recorded 
on an AVIV model 60CD spectropolarimeter (Aviv Associates, New Jersey) with a 1 mm 
pathlength cuvette.  The proteins were at 12.5 μM in 50 mM NaH2PO4 [pH 8] and the 
ellipticity at 222 nm was measured from 4-90°C with an increased stepwise (1 °C/ min) 
and a 1 min equilibration at each temperature and a 20 s averaging time at each 
wavelength.  Also, renaturation experiments (from 90 ˚C-4 ˚C) were carried out to ensure 
reversibility.  The change in ellipticity at 222 nm was plotted against the temperature and 
the thermal denaturation midpoints (Tm) were interpolated. 
 
Activity assay 
 
Activity was also assayed by measuring the change in absorbance at 454 nm.  
The protein samples, at a final concentration of 3.75 μM, were added to a reaction 
mixture containing 50 mM NaH2PO4 [pH 8], 150 mM NaCl, 5 mM EDTA, and various 
concentrations of thiol substrates and absorbance changes were monitored at 454 nm.  
Thiol substrates were freshly prepared in buffer, pH was adjusted to pH 8 with NaOH 
and were standardized using 5,5'-dithio-bis(2-nitrobenzoic acid) (DNTB).  The rates of 
bleaching were expressed as the amount of oxygen consumed per amount of time 
necessary to reduce half of the concentration of bound FAD (measured by a decrease in 
absorbance at 454 nm) per amount of Erv2p.  In this assay, we observed a time lag 
between the addition of Erv2p and the moment of reduction of bound FAD.  This delay in 
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the reduction of bound FAD corresponds to the time that is necessary to consume 90% 
of the oxygen in the cuvette and is correlated with the amount of thiol used. 
 
Pdi1p oxidation in vitro 
 
His6-tagged yeast Pdi1p lacking the signal sequence was purified as described 
previously (Sevier et al., 2001).  Purified Pdi1p was reduced by incubation with DTT-
immobilized beads (BioVectra) for 1 h at room temperature.  Samples containing 4 μM 
Pdi1p either alone or in combination with 1 mM diamide, 300 nM wild-type or mutant 
alleles of Erv2p or 300 nM FAD were incubated at 30 ˚C with intermittent mixing for up to 
30 min.  At different times, protein samples were precipitated with an equal volume of 
20% (w/v) TCA and centrifuged for 15 min.  The pellet was washed with cold acetone 
and suspended in urea sample buffer (50 mM Tris-HCl [pH 7.5], 2% SDS, 6 M urea, 1 
mM PMSF, 0.01% bromophenol blue) with or without 15 mM 4-acetomido-4'-
maleimidylstilbene-2,2'-disulphonic acid (AMS, Molecular Probes).  Protein samples 
were incubated at 4 ˚C for 15 min and at 30 ˚C for 10 min.  The samples were boiled for 
2 min and were analyzed by 8% SDS-PAGE and immunoblotting.  Yeast Pdi1p antibody 
(gift from Tom Stevens, University of Oregon, Eugene) was used at 1:10,000 and 
horseradish peroxidase-conjugated secondary antibody (Amersham Biosciences) was 
used at 1:10,000.  Reduced Pdi1p protein concentrations were determined by the BCA 
protein assay (Sigma) using BSA as standard. 
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Table 1.  Molecular mass of His6-Erv2p and His6-Erv2p mutants. 
 
Protein 
Calculated Molecular 
Mass (kDa) a 
Predicted Molecular Mass 
(kDa) 
His6-Erv2p 41.3 ± 0.1 21.2 
His6-Erv2p-C176A-C178A 41.0 ± 0.1 21.1 
His6-Erv2p-F111S-C176A-
C178A 
22.3 ± 0.1 21.0 
His6-Erv2p-L114S-C176A-
C178A 
23.0 ± 0.1 
21.0 
a Equilibrium analytical centrifugation of 7 μM His6-Erv2p (16,000 rpm, 25 ˚C), 8 μM of His6- 
Erv2p-C176A-C178A (16,000 rpm, 25 ˚C), 7 μM of His6-Erv2p-F111S-C176A-C178A (24,000 
rpm, 25 ˚C) and 6 μM of His6-Erv2p-L114S-C176A-C178A (24000 rpm, 25 ˚C). 
 
 
 
 
Table 2.  Rate of O2 consumption of His6-Erv2p and His6-Erv2p mutants. 
 
  Rate of O2 consumption (10
2 nmol O2 per sec per nmol of Erv2p)
a 
Thiol 
substrate 
Mr
 b His6-Erv2p 
His6-Erv2p-C176A-
C178A 
His6-Erv2p-F111S- 
C176A-C178A 
DTT 152 99 ± 7.7 (100) 122 ± 7.8 (100) 34 ± 1.8 (100) 
BMC 256 41 ± 3.3 (41) 22 ± 1.1 (18) 19 ± 2.1 (56) 
NMA 208 17 ± 0.7 (17) 13 ± 0.6 (11) 19 ± 0.4 (56) 
Cysteine 240 16 ± 2.4 (16) 2.9 ± 0.2 (3) 15 ± 1.0 (44) 
Homocysteine 268 4.2 ± 0.2 (4) 1.9 ± 0.2 (2) 4.3 ± 0.2 (13) 
?-ME 154 3.6 ± 0.1 (4) 1.8 ± 0.1 (2) 3.3 ± 0.3 (10) 
GSH 613 2.2 ± 0.2 (2) <0.9c (<1) 4.6 ± 0.2 (14) 
a Rates of O2 consumption were obtained using 5 mM dithiol substrates or 50 mM monothiol 
substrates.  The average value ± standard deviation of at least three independent assays is 
presented. The activity relative to that of DTT (in percentage) is shown in parentheses. 
b Molecular weight of the oxidized form (g/mol) 
c Assays in which there was no decrease in absorbance at 454 nm after 2 h. 
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Table 3.  Plasmids used in this work. 
 
Name Description Markers 
Source or 
Reference 
pFA11 PGAL1-ERV2 CEN, URA3 Sevier et al., 2001 
pJC15 PGAL1-ERV2-C121A-C124A-HA3 CEN, URA3 Gross et al., 2002 
pAV36 PGAL1-ERV2-C121A-C124A CEN, URA3 This study 
pAV106 PGAL1-ERV2-C121A-C124A CEN, LEU2 This study 
pAV41 PGAL1-ERV2-C176A-C178A CEN, URA3 Gross et al., 2002 
pAV364 PGAL1-ERV2-L171Stop CEN, URA3 This study 
pAV363 PGAL1-ERV2-C176Stop CEN, URA3 This study 
pAV437 PGAL1-ERV2-G177Stop CEN, URA3 This study 
pAV365 PGAL1-ERV2-D182Stop CEN, URA3 This study 
pAV366 PGAL1-ERV2-S187Stop CEN, URA3 This study 
pAV367 PGAL1-ERV2-A192Stop CEN, URA3 This study 
pAV70 PGAL1-ERV2-CC CEN, URA3 This study 
pAV71 PGAL1-ERV2-CGAC CEN, URA3 This study 
pAV92 PGAL1-ERV2-CGA2C CEN, URA3 This study 
pAV93 PGAL1-ERV2-CGA3C CEN, URA3 This study 
pAV94 PGAL1-ERV2-CGA4C CEN, URA3 This study 
pAV268 PGAL1-ERV2-(DYD)? CEN, URA3 This study 
pAV404 PGAL1-ERV2-(DYD)?+2A CEN, URA3 This study 
pAV403 PGAL1-ERV2-(DYD)?+3A CEN, URA3 This study 
pAV161 PGAL1-ERV2-F111S-C176A-C178A  CEN, URA3 This study 
pAV283 PGAL1-ERV2-L114S-C176A-C178A CEN, URA3 This study 
pAV176 PGAL1-ERV2-P120A-C176A-C178A CEN, URA3 This study 
pAV284 PGAL1-ERV2-F111S-C121A-C124A CEN, URA3 This study 
pAV377 PGAL1-ERV2-F111S-C176Stop CEN, URA3 This study 
pJC11 ERV2 (1-22?)-His6 AMP Sevier et al., 2001 
pET-14b E. coli  His6-fusion vector AMP Novagen 
pAV79 His6-ERV2 AMP This study 
pAV87 His6-ERV2-C176A-C178A AMP This study 
pAV88 His6-ERV2-C176Stop AMP This study 
pAV276 His6-ERV2-F111S-C176A-C178A AMP This study 
pAV319 His6-ERV2-L114S-C176A-C178A AMP This study 
pAV287 His6-ERV2-P120A-C176A-C178A AMP This study 
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Table 4.  Primers used in this study. 
 
Primer Sequence 
G177Del1 5?- GAGGACTACGATTGTTGTAGTGACAGCGAC-3? 
G177insAla1 5?- GACTACGATTGTGGAGCATGTAGTGACAGCGAC-3? 
G177ins2Ala1 5'- GACTACGATTGTGGAGCAGCATGTAGTGACAGCGAC-3' 
G177ins3Ala1 5'- GACTACGATTGTGGAGCAGCAGCATGTAGTGACAGCGAC-3' 
G177ins4Ala1 
5'-GACTACGATTGTGGAGCAGCAGCAGCATGTAGTGACAGCGAC-
3' 
?(D173toD175)1 5'- GCTACCATCCTGGAGTGTGGATGTAGTGAC-3' 
del(DYD)2Ala1 5'- GCTACCATCCTGGAGGCTGCTTGTGGATGTAGTGAC-3' 
del(DYD)3Ala1 5'- GCTACCATCCTGGAGGCTGCTGCTTGTGGATGTAGTGAC-3'  
F111S1 5'- GAGAAACTGCACACGTCTATTGGGTTGTATGCA-3' 
L114S1 5'- CACACGTTTATTGGGTCTTATGCAGAACTCTAT-3' 
P120A1 5'- TATGCAGAACTCTATGCATGCGGGGAATGTTCA-3' 
Gal1 5?- TGCATAACCACTTTAACT-3? 
SacII-*-I170 5?- AAAACCGCGGTTAGATGGTAGCACAGTCATATAT-3? 
SacII-*-D175 5?- AAAACCGCGGTTAATCGTAGTCCTCCAGGATGGT-3? 
SacII-*-C176 5'- AAAACCGCGGTTAACAATCGTAGTCCTCCAGGAT-3' 
SacII-*-S181 5?- AAAACCGCGGTTAGCTGTCACTACATCCACAAT-3? 
SacII-*-V186 5?- AAAACCGCGGTTACACGCGTTTACCGTCGCTGTC-3? 
SacII-*-E191 5?- AAAACCGCGGTTACTCCTTCTCGAGAGACACGCG-3? 
NdeI-Erv2 5'- AAAAAACATATGGAACTATCCATCGCTACGCCGGGC-3' 
Erv2-BamHI 5'- AAAAGGATCCTCAACCGTGCTGTTTAGCCTCCTT-3' 
Erv2-C176Stop-
BamHI 
5'- AAAAGGATCCTTAATCGTAGTCCTCCAGGATGGT-3' 
Erv2mut3 5?- ATTAAGTTGGGTAACGCC-3? 
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Figure 1.  Evidence of electron transfer between pairs of cysteine residues.  An ero1-1 erv2? 
mutant strain (CKY899) was transformed with either pRS316 (empty vector), or plasmids 
expressing wild-type ERV2 or ERV2 cysteine mutants as indicated.  The resulting strains were 
tested for growth on YPGal at the restrictive (37 ˚C) and permissive (24 ˚C) temperatures for 
ero1-1. 
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Figure 2.  Conservation of the C terminus of Erv2p among fungal species.  Multiple sequence 
alignment of the C-terminal half of Erv2p, among fungal species using ClustalX (Thompson et al., 
1997).  This segment shows both the conserved active site (Cys121-Cys124) and tail (Cys176-
Cys178) cysteine pairs.  The cysteine residues are colored in a dark grey. Light grey boxes show 
blocks of conserved residues with more than 70% identity.  Abbreviations of the species names 
are as follows: Scer, Saccharomyces cerevisiae; Sbay, Saccharomyces bayanus; Smik, 
Saccharomyces mikatae; Skud, Saccharomyces kudriavzevii; Spar, Saccharomyces paradoxus; 
Ecun, Encephalitozoon cuniculi; Cgra, Candida glabrata; Sklu, Saccharomyces kluyveri; Klac, 
Kluyveromyces lactis; Scas, Saccharomyces castellii; Calb, Candida albicans; Dhan, 
Debaryomyces hansenii; Anid, Aspergillus nidulans; Fgra, Fusarium graminearum; Ylip, Yarrowia 
lipolytica; Mgri, Magnaporthe grisea; Ncra, Neurospora crassa; Umay, Ustilago maydis; Egos, 
Eremothecium gossypii; and Afum, Aspergillus fumigatus. 
 
  
 
LRSFILLFARLYPCGECASHFQGHLKKYPPQVSSRNAAAGWGCFIHNEVNTMLGKPEFDCNNIGDFYDCGCAEDEKAAG------HKDKSQAASRGVPQKKDHEGDATTPVEIHKEP
LHTFLHLLAELYPCGECSVHFVSWLKKLPPQTSSRSAAATWGCSIHNKVNLYLGKPAYDCSKILEDYDCGCGDDAAAG-------------SLKVSVHTERPQGG------------
LRSFFYTFAQLYPCGECARHFQQLIRELPPQVGSRKGASNWLCVVHNEVNKSLGKPEFACDKLDESYDCGCRDDPTKLKS-------ATVTQTSKLLAATPTTTSQVLTPIA-----
LKTYIQLFARLYPCGDCASHFQKLLKKYPPQTSGRNAAAGWACFVHNEVNKRLKKEQFDCNKIGDFYDCGCGDEGAKKA------GEAGAG-AEVKTETKKGEDLKMD---------
LKTYIQLFARLYPCGDCASHFQQLLKKYPPQVSSRNAAAGWACFVHNQVNQRLKKPEFDCVKIGDFYDCGCGDDKKKKE------GDAGGDEKALQVQEKKKE--------------
LKNYIYLFSQVYPCGECAEHFQKLLAKFPPQVSSRNTASQWACYVHNQVNERLGKEIFDCNNVGEHYKCGCAEDEEGGE-------KKEEDSDIMEPMEDDFTFGLKLDENE-----
LETFMHLFARLYPCGQCAEHFRKLLAQYPPQTSSRNAAAGWLCFAHNIVNERVHKPLFDCENIGDFYDCGCGD-KDKKG------GVEGVAGEGPDQELHKH---------------
LHSYIYLFARLYPCGECASHFQGHLKQYPPQVSSRNAAAGWGCFIHNEVNAMLGKPAFDCNKIGDFYDCGCGDEEEES-------EGSGSNSGHKTAPRESSFGDDTISPVEISREP
LDQYIHLFAQVYPCGDCARHFQGLLAKYPPQIKSRKTAALWGCHMHNKVNERLEKPEYDCTTILEDYDCGCGSDEKEDDKTLGNENIEHLRSIKVNEKEESPQLGG-----------
LENYIHLFAQVYPCGDCARHFTKLLAKHPPQTKNRKTAALWGCYVHNIVNEKLNKPEYDCTTILEDYDCGCGDDEKEKDYTLKGESMDHLRQIKIDSKKDK-QRGG-----------
LKTFVQLYAELYPCGECSYHFVKLIEKYPVQTSSREAAAMWGCSVHNMVNTVLKKKQYDCTKILEDYDCGCG------------------------PDTKPKT--------------
LREFLYLYAELYPCGECSYHFVKMLKKYPPQVASRTTAALWGCHIHNLVNDHLEKPRYDCNTILEDYDCGCTDENGNID--------PSLKMNKVTLNKEEKQLG------------
LNMFIQLYAELYPCGECSYHFVKMLQKYPPQTSSRTTAALWGCHIHNIVNEYLGKPEYDCATILKDYDCGCGDENGKID--------DDLKLNKVSIEKEGKQGG------------
LKTFLELYAELYPCGECAYHFVKLMDKYPPQTSSRTAAALWGCHVHNIVNEYLKKPEYDCSTILEDYDCGCGDTSVK--------------NNKVTVEKEGRQHG------------
TLSFIHLLSSVFPCGECTKHFQKLLSDYPPRVGSNEEFKTWLCEVHNVVNRRLGKTVVDCRTVDEIWDCGCEA--------------------------------------------
LSTFIGLYAELYPCGECSYHFVKLIEKHPVQTSSRTAAAMWGCHIHNKVNEYLKKEIYDCATILADYDCGCSDSDG----------------KRVSLEKEAKQLG------------
LDTFIKLYAELYPCGECSYHFVKLIEKFPIQTSSRTAAAMWGCHMHNKVNEYLKKEIYDCATILEDYDCGCSGDDG----------------KKVSLDKEGKQLG------------
LSTFIELYAELYPCGECSYHFVKLIKKHPVQTSSRTAAAMWGCHMHNKVNEYLNRDIYDCATILEDYDCGCSGEDG----------------KRVTVEKEAKQLG------------
LATFIELYAQLYPCGECSYHFVKLIEKYPIQTSSRTAAAMWGCHIHNKVNEFLKKDIYDCATILADYDCGCSDGDG----------------KRVSLEKEAKQLG------------
LHTFIGLYAELYPCGECSYHFVKLIEKYPVQTSSRTAAAMWGCHIHNKVNEYLKKDIYDCATILEDYDCGCSDSDG----------------KRVSLEKEAKQHG------------
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Figure 3.  In the tail, only Cys176 and Cys178 are required for activity.  (A) Scheme representing 
residues in the Erv2p tail (residues 171 through 196).  The numbers in subscript indicate the 
residues that were mutated to a stop codon, and the tail cysteine residues are colored grey.  (B) 
The ero1-1 mutant (CKY598) containing either pRS316 (empty vector) or various truncated 
mutant alleles of Erv2p were plated onto YPGal and grown at 24 ˚C or 37 ˚C for 4 d.  (C) ero1-1 
erv2? mutants (CKY899) containing either pRS316 (empty vector), wild-type Erv2p, or various 
truncated mutant alleles of Erv2p were labeled with [35S]methionine and alkylated with NEM prior 
to immunoprecipitation with Erv2p antibody.  A cross-reacting band not related to Erv2p is marked 
by an asterisk. 
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Figure 4.  The position of Cys176 and Cys178 relative to the Cys121-Cys124 cysteine pair is 
important for disulfide transfer.  (A) Scheme representing residues in the Erv2p tail (residues 171 
through 196).  The tail cysteine residues are colored grey, and inserted residues are underlined.  
(B) The ero1-1 mutant (CKY598) containing either pRS316 (empty vector) or mutant alleles of 
ERV2 were plated onto YPGal and grown at 24 ˚C and 37 ˚C for 4 d.  (C) Radiolabeling and 
immunoprecipitation with Erv2p antibody of ero1-1 erv2? cells (CKY899) containing pRS316 
(empty vector), wild-type ERV2, or erv2 mutants as indicated.  A cross-reacting band not related 
to Erv2p is marked by an asterisk. 
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Figure 5.  Localization of Cys176 and Cys178 relative to Cys121-Cys124 is important for disulfide 
transfer.  (A) Scheme representing residues in the Erv2p tail (residues 171 through 196).  The 
residues underlined are the additional amino acid residues inserted back into the Erv2p-(DYD)? 
mutant.  (B) The ero1-1 mutant (CKY598) containing either pRS316 (empty vector) or various 
mutant alleles of ERV2 were plated onto YPGal and grown at 24 ˚C and 37 ˚C for 4 days.  (C) 
ero1-1 erv2? cells (CKY899) containing pRS316 (empty vector), wild-type ERV2 or erv2 mutants 
were labeled with [35S]methionine and immunoprecipitated with Erv2p antibody.  A cross-reacting 
band not related to Erv2p is marked by an asterisk. 
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Figure 6.  Intragenic suppressors of the cysteine tail mutant.  (A) and (B) The ero1-1 mutant 
(CKY598) containing either pRS316 (empty vector) or various mutant alleles of ERV2 were plated 
in rich medium containing 2% galactose at 24 ˚C and 37 ˚C for 4 d.  (C) Structure of Erv2p 
showing the location of the residues identified as intragenic suppressors represented using 
Rasmol (Sayle and Milner-White, 1995).  The FAD molecules are represented in a ball and stick 
representation.  The cysteine residues are colored yellow and the residues obtained in the screen 
are shown in space-filling representation.  Phe111, Leu114 and Pro120 are located in the dimer 
interface. 
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Figure 7.  Thermal denaturation curves for Erv2p wild-type and mutant variants.  Thermal stability 
of 12.5 μM recombinant His6-Erv2p (?), His6-Erv2p-C176A-C178A (?), and His6-Erv2p-F111S-
C176A-C178A (?) assayed by circular dichroism.  The fraction of unfolded protein was plotted as 
a function of the temperature. 
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Figure 8.  Erv2p intragenic suppressors have different substrate specificities.  (A) Absorbance 
changes at 454 nm for 3.75 μM wild-type His6-Erv2p (?) or His6-Erv2p-F111S-C176A-C178A (?) 
with 50 mM glutathione as a substrate.  (B) Rate of reduction of bound FAD, measured by the 
decrease in absorbance at 454 nm, for 3.75 μM recombinant His6-Erv2p (?), His6-Erv2p-F111S-
C176A-C178A (?), His6-Erv2p-C176A-C178A (?) and His6-Erv2p-C176Stop (?) measured as a 
function of glutathione concentration.  (C) Pdi1p re-oxidation by His6-Erv2p, His6-Erv2p-F111S-
C176A-C178A, His6-Erv2p-C176A-C178A and His6-Erv2p-C176Stop mutants in vitro.  Reduced 4 
μM Pdi1p was incubated in the presence of 300 nM FAD, 300 nM of wild-type or mutants of 
Erv2p, or 1 mM diamide.  At the indicated time points, an aliquot was withdrawn, samples were 
TCA precipitated, and free thiols were trapped by alkylation with AMS.  Reduced (red) and 
oxidized (ox) forms of Pdi1p are indicated. 
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Figure 9.  Crystal-structure of Erv2p showing accessibility of the active site cysteine residues.  
The wild-type dimeric form of Erv2p (A), and deduced structures of Erv2p-C176Stop (B), and 
Erv2p-F111S-C176A-C178A (C) are displayed in space-filling representation using Pymol 
(DeLano, 2002).  The active site cysteine residues for subunits labeled as dark blue are shown in 
red.  The other subunit of the dimer is represented in light blue for wild-type and Erv2p-C176Stop, 
and the cysteine residues in the C-terminal tail of wild-type are shown in pink. 
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Chapter Four 
 
 
 
Further mutagenic studies performed in Erv2p 
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Preface 
 
Additional pieces of data have been generated by me and have been included as an 
appendix to Chapter 3.  In this chapter, I also extrapolate the data obtained for Erv2p to 
the QSOX/ERV family. 
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Results 
 
An additional pair of cysteines seems to be required for Erv2p activity in vivo 
 
In chapters 2 and 3, the roles of two conserved cysteine pairs in the catalytic 
mechanism of Erv2p are discussed.  Additionally, Erv2p, Erv1p and ALR contain a third 
conserved pair of cysteines (Cys150 and Cys167 in Erv2p) that forms a disulfide bond 
between helix ?4 and the C-terminal helix ?5 (helix before the flexible tail).  In the Erv2p 
and rat ALR (rALR) crystal structures this disulfide bond is near the adenine moiety of 
the FAD (Gross et al., 2002; Wu et al., 2003).  In the rALR crystal structure, Cys91-
Cys108 (corresponding to Cys150 and Cys167 in Erv2p) are in contact with the FAD 
ligand such that the oxygen of Cys91 forms a hydrogen bond with N6 of the adenine 
moiety (Wu et al., 2003).  It has been suggested that this disulfide bond may be 
important for positioning the tail cysteine residues in close proximity to the conserved 
Cys-X-X-Cys motif in the other subunit and/or for stability of cofactor binding to the 
protein (Dym and Eisenberg, 2001; Gross et al., 2002). 
In order to determine the role of this disulfide bond in the disulfide transfer 
between subunits in Erv2p we created Cys to Ala mutants of these two residues (Erv2p-
C150A and Erv2p-C167A).  This pair of cysteines is required for activity in vivo as these 
mutants do not suppress the growth defect of ero1-1 cells at the restrictive temperature 
(Figure 1A).  Similarly, the corresponding pair of cysteines in Erv1p (Cys159 and 
Cys176) is also required for activity in vivo, since Cys to Ser mutants of these residues 
are unable to suppress the erv1? or the erv1-1 temperature-sensitive mutant at the 
restrictive temperature (Hofhaus et al., 2003). 
The observation that Erv2p-C150A and Erv2p-C167A are still able to form a 
disulfide-linked dimer suggests that in these mutants the Cys121 and Cys176 or Cys178 
are still able to interact (Figure 1B).  Recombinant Erv2p-C150A and Erv2p-C167A were 
soluble but did not absorb light at the FAD characteristic peaks (data not shown) 
suggesting that these residues are probably involved in FAD binding.  The same is 
observed for recombinant Erv1p-C159S mutant, which has lower affinity towards FAD 
(Hofhaus et al., 2003), suggesting that Cys to Ala/Ser mutations of these cysteine 
residues cause instability of the FAD. 
 
The tail of Erv2p is consisted mainly of charged residues 
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Sequence analysis of the C-terminal regions of Erv2p and fungi orthologs 
revealed that these regions are poorly conserved, that they can adopt various lengths 
and that the only common feature is the large number of charged residues (Figure 2).  
To analyze the role of the charged residues in the tail of Erv2p, we individually mutated 
these residues to alanine.  The Erv2p charged residue mutants were able to suppress 
the growth defect of ero1-1 at the restrictive temperature, suggesting that they were still 
active.  Erv2p-E191A was the only mutant that had a slight growth defect (Table 1). 
 
Altering Gly177 to a negatively charged residue affects Erv2p activity 
 
It is well established that redox properties of protein thiol-disulfide 
oxidoreductases are strongly influenced by amino acid residues in close proximity to the 
redox-active cysteines (Chivers et al., 1997).  The properties of the amino acids between 
cysteine residues affect the propensity of those cysteine residues to be in a reduced or 
oxidized state (Bessette et al., 2001).  Analysis of the Cys-X-Cys motif in Erv2p and its 
fungal orthologs reveals that the residue between the tail cysteines (Gly177) is extremely 
conserved (Figure 2).  To address the role of the Gly177, we mutagenized this residue to 
other amino acid residues.  From the set of mutants studied, only Erv2p mutants where 
Gly177 was mutated to negatively charged residue had a slight defect in the ability to 
suppress the growth defect of ero1-1 at the restrictive temperature (Table 2). 
 
Cys121 of the active site cysteine pair is attacked by Cys176 
 
To further address the role of the spatial localization of the cysteine residues of 
the Cys-X-Cys motif we added one to three alanine residues to the Erv2p-(DYD)? mutant 
before and after Gly177 (Figure 3A and Table 3).  These mutants were still inactive and 
were still unable to transfer disulfide bonds through the tail, as suggested by the lack of a 
disulfide-linked intermediate (Figure 3B and C and Table 3).  These results suggest that 
in the Erv2p-(DYD)? context, the Cys176 needs to be located near the active site 
cysteine pair for transfer to occur.  It is also possible that in these mutants, the cysteine 
residue interacting with the active site cysteine is not facing the active site cysteine pair, 
thus not allowing the interaction to occur. 
 
Intragenic suppressors of the tail cysteines mutants are monomers 
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In a screen for Erv2p mutants that were able to catalyze disulfide transfer without 
relaying through the tail cysteine we isolated three mutations (F111S, L114S and 
P120A).  These residues lie in the dimer interface, a region characterized by 
hydrophobic contacts between the ?1 and ?2 helices of the two subunits (Gross et al., 
2002).  The location of these residues suggested that these mutations convert the 
protein into a monomer, thus allowing direct access to the active site cysteines.  To 
determine whether Erv2p-F111S-C176A-C178A was a monomeric protein, we 
expressed and purified Erv2p wild-type and Erv2p variants (Erv2p-C176A-C178A and 
Erv2p-F111S-C176A-C178A) in Escherichia coli.  After purification, all the recombinant 
proteins exhibited the characteristic absorbance peaks for bound FAD at 352 and 454 
nm and showed sulfhydryl oxidase activity (see below). 
The purified proteins were analyzed by gel filtration in a Sephadex-200 column.  
Figure 4A shows the elution volume of Erv2p wild-type, Erv2p-C176A-C178A and Erv2p-
F111S-C176A-C178A.  A standard curve was generated with proteins of known 
molecular weight.  The observed elution volumes correspond to apparent molecular 
weights of 47.7, 43.9 and 35.8 kDa for Erv2p wild-type, Erv2p-C176A-C178A and Erv2p-
F111S-C176A-C178A, respectively (Figure 4 B).  Erv2p wild-type and Erv2p-C176A-
C178A showed a different behavior, suggesting that Erv2p wild-type has a more 
compact structure.  Due to the difference in behavior of Erv2p wild-type and Erv2p-
C176A-C178A proteins we decided to perform equilibrium analytical centrifugation 
studies (see Chapter 3) 
 
Intragenic suppressor mutations do not rescue an Erv2p-C150A or Erv2p-C167A 
or Erv2p-C150A-C167A double mutant or an Erv2p-L171Stop mutant 
 
It has been suggested that the Cys150-Cys167 disulfide bond tethers the C-
terminal ?5 helix to the core of the protein, thus positioning the tail cysteine residues 
near the active site cysteine pair (Gross et al., 2002).  Based on this, we expected that 
the addition of intragenic suppressor mutations to an Erv2p-C150A, Erv2p-C167A or 
Erv2p-C150A-C167A would suppress the ero1-1 growth defect.  Surprisingly, the Erv2p-
F111S-C150A, Erv2p-L114S-C150A and Erv2p-P120A-C150A were still inactive (Table 
4 and data not shown).  This data is consistent with the idea that these residues are 
important for flavin binding. 
While the addition of the intragenic suppressor mutations to Erv2p-C176Stop 
restored the activity, the addition of these mutations does not rescue an Erv2p-L171Stop 
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mutant (Table 4).  This inability to suppress could result from an overall instability of the 
protein due to the removal of helix ?5.  Consistent with this result, we were unable to 
purify Erv2p-L171Stop mutant. 
 
Intragenic suppressor mutations are conserved in QSOX/ERV family 
 
All the residues tested that cause Erv2p-C176A-C178A to become a monomeric 
protein are conserved among the QSOX/ERV family.  The residue Phe111 is conserved 
between Erv2p, Erv1p and human and rat ALRp.  In Erv2p or Erv1p-like fungal orthologs 
70% of the aligned sequences have a Phe corresponding to the position 111 in Erv2p.  
The other sequences contain either a Tyr or a Leu.  The residue Leu114 is conserved in 
Erv2p and rat ALR.  In Erv2p-like homologs this residue is almost always a Leu except in 
2 cases where is a Ser or Thr.  In Erv1p-like fungi orthologs this residue is a Leu or Ile.  
Pro120 is conserved in Erv2p, Erv1p, human and rat ALR and E10R but not in Quiescin 
Q6.  In both Erv2p-like and Erv1p-like fungi orthologs this residue is always a Pro. 
 
Sulfhydryl oxidase activity of Erv2p 
 
Erv2p catalyzes the oxidation of thiols to their corresponding disulfides, 
consuming oxygen and producing hydrogen peroxide.  During oxidation of thiol 
substrates, the Cys121-Cys124 pair is reduced.  The reoxidation of this pair is 
associated with the reduction of bound-FAD.  In turn, reduced FAD is then reoxidized by 
oxygen, with a concomitant production of hydrogen peroxide.  The sulfhydryl oxidase 
activity of Erv2p wild-type and mutant alleles can be determined by monitoring O2 
consumption, by measuring the reduction of bound FAD or by measuring the formation 
of oxidized substrate. 
During the oxidation of a substrate, a mixed disulfide intermediate between Erv2p 
and the thiol of the substrate is formed.  In the case of the oxidation of a dithiol substrate, 
a second thiol from the substrate is in close proximity and facilitates the release of the 
oxidized substrate.  In the case of a monothiol substrate, another thiolate group has to 
be brought close to react (bi-molecular reaction).  Because the mixed disulfide 
intermediate is unstable, the free thiolate group from Erv2p can attack, releasing reduced 
substrate.  This difference in the mechanism typically leads to lower activities towards 
monothiols. 
The kinetics of thiol/disulfide exchange reaction are influenced by many factors, 
including the redox potential, that determine the propensity of a thiol to be in the reduced 
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or the oxidized state and by the thiol's acid dissociation constant (pKa).  Near 
physiological conditions, the lower the pKa of a thiol, the more thiolate form will be 
present to initiate the thiol/disulfide exchange reaction (Chivers et al., 1997). 
Wild-type Erv2p was able to oxidize all small thiol substrates tested (Table 5).  As 
expected, higher reaction rate was observed when using dithiols as substrates than 
when using monothiols.  Recombinant Erv2p wild-type oxidizes dithiothreitol (DTT) faster 
than (±)-trans-1,2-bis(2-mercaptoacetamido)cyclohexane (BMC, Table 6).  This result is 
consistent with the lower redox potential of DTT when compared to BMC (-0.33 V and -
0.24 V, respectively).  When we compared the oxidation of 50 mM of monothiol 
substrates by Erv2p wild-type, we observed that the rate of oxidation of cysteine and N-
methylmercaptoacetamide (NMA) is the highest, followed by ?-mercaptoethanol and 
homocysteine.  The lowest rate of oxidation was observed for gluathione (GSH, Table 5).  
This result cannot be explained by redox potential alone and is probably due to a 
combination of the redox potential and pKa of the thiols. 
As discussed previously in Chapter 3, Erv2p-C176A-C178A and Erv2p-C176Stop 
mutants are able to oxidize the small substrate DTT but have limited activity toward the 
bulkier substrates BMC, GSH and cysteine (Table 5). The addition of an intragenic 
suppressor mutation to the Erv2p-C176A-C178A mutant allowed this protein to oxidize a 
broader range of substrates (Table 5). The Erv2p-F111S-C176A-C178A had wild-type 
level activity toward all the monothiol substrates tested except GSH, which was two-fold 
higher (Table 5). 
 
Discussion 
 
Structural data and mutational studies have suggested an intermolecular disulfide 
relay mechanism for Erv2p.  The active site pair of cysteines (Cys121-Cys124), located 
near the FAD cofactor, transfers oxidizing equivalents from the FAD to the tail pair of 
cysteines (Cys176-Cys178) that, in turn, relays the disulfides obtained from the former 
cysteine pair to the substrate proteins, such as Pdi1p.  Various evidence lead to the 
proposed mechanism: (i) two pairs of cysteines (Cys121-Cys124 and Cys176-Cys178) 
are required for Erv2p activity in vivo, as demonstrated by the inability of these mutants 
to suppress the growth defect of an ero1-1 strain at the restrictive temperature (ii) 
Cys121, Cys176 or Cys178 are required for the intramolecular transfer of disulfides 
between the active site cysteines and the tail cysteines, as seen by the absence of a 
disulfide-linked dimer for Erv2 mutants that contain a Cys121, Cys176 or Cys178 
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mutated to alanine (iii) these two pairs of cysteines are close together in the crystal 
structure and we can model an interaction between Cys178 and Cys121 of the other 
subunit by rotating the ?1 side chain torsion angles of these residues. 
The following steps for Erv2p catalytic mechanism have been deduced but their 
reaction order has not yet been determined: (i) transfer of electrons from the active site 
cysteine pair (Cys121-Cys124) to FAD leads to the formation of a disulfide bond at the 
active site, (ii) through an intermolecular disulfide exchange reaction, the disulfide bond 
at the active site is transferred to the cysteines located in the C-terminal tail of the other 
subunit of Erv2p dimer, and (iii) the disulfide bond in the tail is transferred to thiol-
containing substrates, such as Pdi1p (see Figure 5A). 
 
Erv2p and members of the in the QSOX/ERV family seem to share the same 
disulfide relay mechanism 
 
All members of the QSOX/ERV family contain two pairs of cysteines that are 
required for activity, suggesting that members of this family share the same disulfide 
shuttle mechanism as Erv2p.  Mutagenic studies performed in Erv1p and human ALR 
(hALR) show that two pairs of cysteines are required for activity in vivo and in vitro: an 
FAD-proximal active site cysteine pair and another cysteine pair located in a flexible 
region (that in the case of Erv1p and hALR is located at the N-terminus) (Hofhaus et al., 
2003; Lee et al., 2000).  As seen for Erv2p, the capture of disulfide-linked intermediates 
of Erv1p and hALR suggest that these two pairs of cysteines interact with each other 
during catalysis.  This intermediate is absent when the N-terminal cysteine pair has been 
mutated to serine (Hofhaus et al., 2003; Lisowsky et al., 2001).  The vaccinia virus 
homolog, E10R, contains only one pair of cysteines that is important for activity, as 
determined by the inability of these mutants to rescue virus replication and to oxidize 
L1R (Senkevich et al., 2000).  These cysteine residues form a mixed disulfide 
intermediate between E10R and A2.5L, that has been shown to be required for disulfide 
bond formation (Senkevich et al., 2002).  A2.5L contains a pair of cysteines that probably 
fulfills the function of the tail cysteines in Erv2p. 
Truncation of the N-terminal regions of Erv1p and ALR, which contain the second 
pair of cysteines and are functionally homologous to the C-terminal tail of Erv2p, 
suggests that Erv1p and ALR require a second cysteine pair for disulfide transfer 
(Hofhaus et al., 2003; Lee et al., 2000).  As observed in Erv2p, mutation of Cys30 and 
Cys33 in the N-terminal region of Erv1p or an N-terminal truncation of Erv1p (Erv1p-?1-
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72) prevents the formation of the disulfide-linked Erv1p intermediate (Hofhaus et al., 
2003; Lee et al., 2000).  Similarly, a disulfide linked intermediate is not observed in an N-
terminal truncation of ALR (ALR-?1-80) (Lisowsky et al., 2001). 
Varying the spacing between two cysteines affects the likelihood of disulfide bond 
formation by changing the rate of thiol-disulfide exchange (Zhang and Snyder, 1989).  
Accordingly, Erv2p-G177?, Erv2p-CGA2C and Erv2p-CGA4C mutants are inactive or 
slightly defective, although the tail cysteines in these mutants are still able to interact with 
the active site cysteines.  The Erv2p tail cysteine pair is in a Cys-X-Cys motif, while other 
members of the QSOX/ERV family have a Cys-Xn-Cys, where n can be two (Erv1p, ALR 
and quiescin Q6) or four (Arabidopsis thaliana Erv1p).  Interestingly, we were unable to 
find Erv2p homologs that have a Cys-Xn-Cys motif where n equals zero, three or five.  It 
is possible that the difference in spacing between cysteines in the QSOX/ERV family 
reflects divergence in the redox properties of this cysteine pair, which has evolved either 
to confer specificity or to permit each protein to function in its specific environment.  On 
the other hand, these variations in spacing may simply indicate robustness in the tail 
cysteine motif. 
The C-terminal tail regions of Erv2p, the N-terminal regions of Erv1p and their 
fungal orthologs contain several hallmarks of unstructured regions: they are poorly 
conserved, can adopt various lengths and have an abundance of charged residues 
(Figure 2 and data not shown).  The function of this unstructured region might be inferred 
from that of Ero1p, a protein that shares a similar disulfide shuttle mechanism (Gross et 
al., 2004).  Ero1p transfers disulfides from a buried active site cysteine pair to Pdi1p via 
a second pair of cysteine located in an unstructured region (Frand and Kaiser, 1999).  It 
has been suggested that Pdi1p recognizes this region because it mimics its unfolded 
substrates (Gross et al., 2004).  Thus, it is possible that the Erv2p and Erv1p tails are 
also recognized by their substrate because they are unstructured.  Another possibility is 
that the large number of charged residues might facilitate protein-protein interactions 
with the substrate (Zhu and Karlin, 1996).  Also, it is possible that these regions have 
diverged to either allow these proteins to act in slightly different conditions or adapt to 
different substrates. 
 
Transfer between two pairs of cysteines confers specificity in the disulfide 
transfer  
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Various evidences presented in Chapter 3 suggest that Erv2p tail sterically 
excludes larger substrates from reacting with the active site cysteine pair and that the 
Cys176-Cys178 pair is important for relaying disulfides from the buried active site 
cysteine pair to substrate proteins: (i) mutants lacking the tail cysteines (Erv2p-C176A-
C178A and Erv2p-C176Stop) are unable to promote disulfide bond formation in vivo, (ii) 
addition of F111S to the previous mutants turns Erv2p into a monomeric form now able 
to promote disulfide bond formation in vivo, (iii) Erv2p-C176A-C178A and Erv2p-
C176Stop are able to oxidize small substrate in vitro, but are unable to oxidize larger 
substrates such as GSH or Pdi1p, while Erv2p-F111S-C176A-C178A is able to oxidize 
small and large substrates. 
The mutations that convert Erv2p into a monomeric form bypass the need for 
disulfide shuttling through the tail by giving thiol substrates direct access to the active 
site cysteines (see Figure 5 for the proposed differences between substrate oxidation by 
dimeric and monomeric forms of Erv2p) 
Erv1p is able to oxidize lysozyme, DTT, and cysteine but not GSH (Hofhaus et 
al., 2003; Hofhaus and Lisowsky, 2002; Lee et al., 2000), but no studies have addressed 
the role of the tail cysteines in conferring specificity to the disulfide transfer.  By analogy 
to Erv2p, it is plausible that the N-terminal cysteine pair of Erv1p may confer substrate 
specificity.  Like the Erv2p truncation mutant, an N-terminal truncation of Erv1p (Erv1p-
?1-72) is inactive in vivo (Lisowsky, 1996), but this could be due to mislocalization of the 
mutant protein, which lacks the mitochondrial signal sequence, and not a direct result of 
the absence of the cysteine pair in the N-terminus.  In vitro, the Erv1p-?1-72 rate of 
oxidation of lysozyme is slightly lower than that of wild-type (Lee et al., 2000; Lisowsky et 
al., 2001).  The observation that Erv1p-?1-72 is also able to oxidize DTT at a rate similar 
to wild-type, while Erv1p-C30S and Erv1p-C33S mutants have a reduced activity towards 
DTT (Hofhaus et al., 2003), suggests that the active site pair in Erv1p-?1-72 is more 
accessible than in wild-type, which seems likely given that this truncation is larger than 
the truncations performed in the Erv2p tail.  Thus, we expect that recombinant Erv1p-
C30S and Erv1p-C33S would not efficiently oxidize lysozyme or GSH but that Erv1p-?1-
72 would. 
 
Specificity conferred by the disulfide transfer reaction 
 
Besides Erv2p and members of the QSOX/ERV family, several other thiol 
oxidases, such as Ero1p, DsbB, TrxR appear to have evolved a similar mechanisms of 
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transfer between two pairs of cysteines to control substrate specificity, directing the 
transfer of disulfides to specific substrates. 
We observe that the Erv2p suppressor mutant is more active towards GSH than 
the tail cysteine mutant or wild-type, suggesting that the tail prevents random oxidation of 
thiols by blocking the active site cysteine pair.  Also, studies on Erv1p, chicken QSOX 
and Ero1p have shown that these proteins are unable to oxidize GSH (Hofhaus and 
Lisowsky, 2002; Hoober et al., 1996; Sevier and Kaiser, 2006).  Furthermore, E10R 
infected cells seem to have the same GSH/GSSG ratio as non-infected cells, suggesting 
that E10R cannot use GSH in vivo.  Unfortunately, we were unable to measure 
differences in oxidized glutathione in strains overexpressing Erv2p wild-type and Erv2p 
suppressor mutant, but this could be due to sensitivity of the method. 
Interestingly, the mutation that renders Erv1p temperature-sensitive (Phe124Ser) 
is on a helix that forms the dimer interface of Erv1p (Lisowsky, 1994).  We speculate that 
this mutation precludes Erv1p dimerization and also changes its substrate specificity, 
allowing it to oxidize a wider range of substrates. 
 
Materials and methods 
 
Media and yeast strains 
 
All strains used in this study are isogenic to S288C.  Cultures were grown either 
in rich medium (1% Bacto yeast extract and 2% Bacto-peptone (YP) containing either 
2% dextrose (YPD) or 2% galactose (YPGal) as carbon sources) or in minimal media 
(0.67% nitrogen base without amino acids supplemented with 16 amino acids not 
including cysteine) containing 2% galactose and 2% raffinose (SMM Gal/Raf).  The 
isolation and characterization of the ero1-1 mutant (CKY598) were described previously 
(Frand and Kaiser, 1998).  The construction of an erv2? strain (CKY688) was described 
previously (Sevier et al., 2001).  The MATa GAL2 ero1-1 erv2?::kanMX ura3-52 leu2-
3,112 (CKY899) was constructed by crossing erv2? strain (CKY688) to an ero1-1 GAL2 
strain (CKY598).  The resulting diploid was sporulated and tetrads dissected in YPD. 
 
Plasmid construction 
 
The plasmids used in this study are listed in Table 7.  The ERV2 cysteine, ERV2-
Gly177 and ERV2 charged residues mutants were made using the QuikChange site 
directed mutagenesis kit (Stratagene) using pFA11 as template (Gross et al., 2002; 
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Sevier et al., 2001).  The ERV2-(DYD)? spacing mutants were made using the 
QuikChange site directed mutagenesis kit (Stratagene) using pAV268 as template.  The 
ERV2 suppressor mutants in different backgrounds were made using the QuikChange 
site directed mutagenesis kit (Stratagene) using pAV41, pAV36, pAV37, pAV363 and 
pAV364 as templates.  The forward primers used for the site-directed mutagenesis are 
listed in Table 8.  The mutated plasmids were verified by sequencing, and the protein 
expression levels in each of the mutants were assessed by immunoprecipitation from the 
CKY598 strain overexpressing these plasmids using the Erv2p antibody as described 
below. 
Erv2p wild-type, Erv2p-C150A and Erv2p-C167A mutants lacking the first 29 
amino acids encoding the hydrophobic N-terminal signal sequence and containing an N-
terminal His6 tag were constructed using NdeI-Erv2 and Erv2-BamHI primers.  The 
resulting fragments were subcloned into the bacterial expression vector pET-14b 
(Novagen) using the NheI and BamHI sites.  The ERV2 mutant truncated at residue 176 
(ERV2-C176Stop) or 171 (ERV2-L171Stop) was subcloned into pET-14b using NdeI-
Erv2 and Erv2-C176Stop-BamHI or Erv2-L171Stop-BamHI primers, respectively. 
 
Radiolabeling and immunoprecipitation 
 
Radiolabeling and immunoprecipitation of Erv2p was done as described 
previously (Gross et al., 2002).  Briefly, strains overexpressing Erv2p or mutant alleles 
were grown in SMM Gal/Raf lacking uracil and methionine to about 1 ? 107 cells/ml.  
Cells were resuspended in the same medium at 1 ? 108 cells/ml and labeled with 
[35S]methionine and cysteine (EXPRESS,  NEN) for 60 min at room temperature.  Cells 
were then resuspended in 10% TCA and lysed with glass beads.  Protein pellets were 
then incubated in sample buffer (80 mM Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 0.01% bromophenol blue) containing 40 mM N-
ethylmaleimide (Sigma) for 15 min at 4 ˚C followed by 10 min at room temperature.  Cell 
extracts were resuspended in 1 ml IP buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% 
Triton X-100 and 1 mM PMSF) and preadsorbed with fixed Staphylococcus A cells 
(Sigma) before incubation with Erv2p antibody.  Immune complexes were collected with 
protein-A-sepharose (Pharmacia), washed in IP buffer containing 0.1% SDS and then 
washed in IP buffer without detergent and finally solubilized in sample buffer.  Samples 
were analyzed by 12% SDS-PAGE and visualized with a 445si PhosphorImager 
(Molecular Dynamics). 
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Erv2p antibody production 
 
An E. coli BL21(DE3) strain (Novagen) was transformed with pJC11 (Sevier et 
al., 2001).  Erv2p lacking the first 29 amino acids and containing a C-terminal His6 tag 
was purified as described previously (Sevier et al., 2001).  The protein was separated by 
SDS-PAGE and used to prepare polyclonal antibodies in rabbits by standard protocols at 
Covance. 
 
Protein expression and purification 
 
ERV2 wild-type and mutant alleles expression plasmids were transformed into E. 
coli BL21(DE3) Gold pLysS cells (Novagen).  Single colonies were inoculated into LB 
supplemented with 80 mg l-1 ampicillin and 30 mg l-1 chloramphenicol.  Cells were grown 
at 30 °C to an OD600 of 0.5-0.6, and isopropyl ?-D-thiogalactoside (IPTG) and FAD were 
added to a final concentration of 0.4 mM and 10 μM, respectively.  After 4 hours of 
induction at 30 ˚C, cells were harvested by centrifugation and lysed by French press in 
lysis buffer (50 mM NaH2PO4 [pH 8], 350 mM NaCl and 10 mM imidazole with EDTA-free 
protease inhibitor cocktail).  Insoluble material was sedimented by centrifugation and the 
supernatant was applied to a HiTrap Chelating HP column (Amersham Biotech) pre-
equilibrated with lysis buffer. 
The resin was washed with lysis buffer and with wash buffer (50 mM NaH2PO4 
[pH 8], 300 mM NaCl and 20 mM imidazole).  The bound protein was eluted with a 
gradient of 20 mM to 250 mM imizadole in 50 mM sodium phosphate [pH 8.0], 300 mM 
NaCl.  The fractions containing Erv2p were then dialyzed for at least 16 h against 50 mM 
sodium phosphate [pH 8], 150 mM NaCl. 
The samples used for the determination of the molecular weight were further 
purified in an anion exchange HiTrap Q column (Amersham Biotech).  For this, the 
eluted protein from the affinity column was pooled and dialyzed against 20 mM Tris-HCl 
[pH 8].  The sample was applied to the HiTrap Q column and eluted with an increasing 
NaCl concentration.  The fractions containing Erv2p were then dialyzed for at least 16 h 
against 50 mM KH2PO4 [pH 8], 150 mM KCl (Buffer A).  All proteins were > 95% pure 
after the HiTrap Q column.  Concentration of the protein samples was estimated using a 
molar extinction coefficient of 12.5 mM cm-1 at 454 nm (Sevier et al., 2001). 
 
Gel filtration 
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Analytical gel filtration of Erv2p variants was performed on a Superdex 200 PC 
3.2/20 (Amersham Biosciences) in 50 mM sodium phosphate [pH 8], 150 mM NaCl and 
2 mM DTT.  A low molecular weight gel filtration calibration kit (Amersham Biosciences) 
was used to generate the standard curve in order to obtain the apparent molecular 
weights for the Erv2p variants. 
 
FAD reduction assay 
 
The protein samples, at a final concentration of 3.75 μM, were added to a 
reaction mixture containing 50 mM sodium phosphate [pH 8], 150 mM NaCl, 5 mM 
EDTA, and various concentrations of thiol substrates and absorbance changes were 
monitored at 454 nm.  Thiol substrates were prepared fresh in buffer and were 
standardized using 5,5'-dithio-bis(2-nitrobenzoic acid) (DNTB).  The rates of bleaching 
are expressed as the amount of oxygen consumed per amount of time necessary to 
reduce half of the concentration/signal of bound FAD (measured by a decrease in 
absorbance at 454 nm) per amount of Erv2p.  In this assay, we observed a time lag 
between the addition of Erv2p and the moment of reduction of bound FAD.  This delay in 
the reduction of bound FAD corresponds to the time that is necessary to consume the 
90% of oxygen in the cuvette and is correlated with the amount of thiol used. 
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Table 1.  Erv2p C-terminal tail charge residues mutants. 
 
Erv2p allele 
Suppression of ero1-1 growth defect at 
37 ˚Ca 
Vector ?  
Erv2p +  
Erv2p-E172A +  
Erv2p-D173A +  
Erv2p-D175A +  
Erv2p-D180A +  
Erv2p-K184A +  
Erv2p-R185A +  
Erv2p-E189A +  
Erv2p-K190A +  
Erv2p-E191A + /?  
Erv2p-K193A +  
Erv2p-H195A +  
a the ero1-1 mutant (CKY598) containing either pRS316 (empty vector), wild-type Erv2p 
or the indicated mutant alleles of Erv2p were plated onto YPGal and grown at 24 ˚C or 
37 ˚C for 4 d. 
 
 
 
Table 2.  Gly177 mutants of Erv2p. 
 
Erv2p allele 
Suppression of ero1-1 growth defect at 
37 ˚Ca 
Vector ?  
Erv2p +  
Erv2p-G177A +  
Erv2p-G177S +  
Erv2p-G177V +  
Erv2p-G177L +  
Erv2p-G177M +  
Erv2p-G177P +  
Erv2p-G177F +  
Erv2p-G177D + /?  
Erv2p-G177E + /?  
Erv2p-G177Q +  
Erv2p-G177K +  
Erv2p-G177R +  
a the ero1-1 mutant (CKY598) containing either pRS316 (empty vector), wild-type Erv2p 
or the indicated mutant alleles of Erv2p were plated onto YPGal and grown at 24 ˚C or 
37 ˚C for 4 d. 
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Table 3.  Erv2p-(DYD) mutants. 
 
Erv2p allele 
Suppression of ero1-1 
growth defect at 37 ˚Ca 
Disulfide-linked dimerb 
Vector ?  NA 
Erv2p +  +  
Erv2p-(YD)? ?  ?  
Erv2p-(DYD)? ?  ?  
Erv2p-(DYD)?+2A +  +  
Erv2p-(DYD)?+3A +  +  
Erv2p-(DYD)? CAGC ?  ?  
Erv2p-(DYD)? CAAGC ?  ?  
Erv2p-(DYD)? CAAAGC ?  ?  
Erv2p-(DYD)? CGAC ?  ?  
Erv2p-(DYD)? CGAAC ?  ?  
Erv2p-(DYD)? CGAAAC ?  ?  
a the ero1-1 mutant (CKY598) containing either pRS316 (empty vector), wild-type Erv2p or the 
indicated mutant alleles of Erv2p were plated onto YPGal and grown at 24 ˚C or 37 ˚C for 4 d. 
b the ero1-1 erv2? mutant (CKY899) containing either pRS316 (empty vector), wild-type Erv2p 
or the indicated mutant alleles of Erv2p were labeled with [35S]methionine and alkylated with 
NEM prior to immunoprecipitation with Erv2p antibody. 
NA, non applicable 
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Table 4.  Erv2p suppressor mutants. 
 
Erv2p allele 
Suppression of ero1-1 growth defect at 
37 ˚Ca 
Vector  
Erv2p +  
Erv2p-C176A-C178A ?  
Erv2p-F111S-C176A-C178A  +  
Erv2p-L114S-C176A-C178A +  
Erv2p-P120A-C176A-C178A +  
Erv2p-F111S-C121A-C124A ?  
Erv2p-F111S-C150A ?  
Erv2p-F111S-C176Stop +  
Erv2p-F111S-L171Stop ?  
Erv2p-L114S-C121A-C124A ?  
Erv2p-L114S-C150A ?  
Erv2p-L114S-C176Stop +  
Erv2p-L114S-L171Stop ?  
Erv2p-P120A-C121A-C124A ?  
Erv2p-P120A-C150A ?  
Erv2p-P120A-C176Stop +  
Erv2p-P120A-L171Stop ?  
a the ero1-1 mutant (CKY598) containing either pRS316 (empty vector), wild-type Erv2p 
or the indicated mutant alleles of Erv2p were plated onto YPGal and grown at 24 ˚C or 
37 ˚C for 4 d. 
 
 
Table 5.  Rate of O2 consumption for of His6-Erv2p and His6-Erv2p mutants. 
 
  Rate of O2 consumption (10
2 nmol O2 per sec per nmol of Erv2p)
a 
Thiol substrate Mr b His6-Erv2p 
His6-Erv2p-F111S- 
C176A-C178A 
His6-Erv2p- 
C176A-C178A 
His6-Erv2p- 
C176Stop 
DTT 152 99 ± 7.7 34 ± 1.8 122 ± 7.8 116 ± 8.7 
BMC 256 41 ± 3.3 19 ± 2.1 22 ± 1.1 9 ± 0.8 
NMA 208 17 ± 0.7 19 ± 0.4 13 ± 0.6 11 ± 0.1 
Cysteine 240 16 ± 2.4 15 ± 1.0 2.9 ± 0.2 2 ± 0.3 
Homocysteine 268 4.2 ± 0.2 4.3 ± 0.2 1.9 ± 0.2 1.7 ± 0.1 
?-ME 154 3.6 ± 0.1 3.3 ± 0.3 1.8 ± 0.1 1.7 ± 0.0 
GSH 613 2.2 ± 0.2 4.6 ± 0.2 <0.9c <0.9c 
a Rates of O2 consumption were obtained using 5 mM dithiol substrates or 50 mM monothiol substrates.  The 
average value ± standard deviation of at least three independent assays is presented. 
b Molecular weight of the oxidized form (g/mol). 
c Assays in which there was no decrease in absorbance at 454 nm after 2 h. 
 
 
 
 
 
 
 
 
 
 
Table 6.  Structure and properties of thiol compounds used in this study. 
 
Thiol substrate Structure 
Type of 
substrate pKa 
E 0 ' 
(V) 
Reference 
 
Dithiothreitol 
(DTT) 
  
dithiol 
9.2 
10.1 
-0.33 
Lamoureux 
and 
Whitesides, 
1993; Singh et 
al., 1995 
( ±)-trans-1,2-bis 
(2-mercaptoacetamido) 
cyclohexane (BMC) 
 
dithiol 
8.3 
9.9 
-0.24 
Woycechowsky 
et al., 1999 
 
Glutathione 
(GSH) 
  
monothiol 9.3 -0.21 
Keire et al., 
1992 
Cysteine 
 
monothiol 8.9 -0.19 
Keire et al., 
1992 
Homocysteine 
 
monothiol 9.7 -0.20 
Keire et al., 
1992 
?-Mercaptoethanol 
(?-ME)  
monothiol 10.1 -0.26 
Keire et al., 
1992 
 
N-methylmercapto 
acetamide (NMA) 
  
monothiol 8.3 ND 
Singh et al., 
1995; 
Woycechowsky 
et al., 1999 
ND, non determined      
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Table 7.  Plasmids used in this work. 
 
Name Description Markers 
Source or 
Reference 
pFA11 PGAL1-ERV2 CEN, URA3 Sevier et al., 2001 
pJC15 PGAL1-ERV2-C121A-C124A-HA3 CEN, URA3 Gross et al., 2002 
pAV37 PGAL1-ERV2-C150A CEN, URA3 This study 
pAV38 PGAL1-ERV2-C167A CEN, URA3 This study 
pAV532 PGAL1-ERV2-C150A-C167A CEN, URA3 This study 
pAV538 PGAL1-ERV2-C150A-C167A-C176A-C178A CEN, URA3 This study 
pAV60 PGAL1-ERV2-E172A CEN, URA3 This study 
pAV61 PGAL1-ERV2-D173A CEN, URA3 This study 
pAV63 PGAL1-ERV2-D175A CEN, URA3 This study 
pAV66 PGAL1-ERV2-D180A CEN, URA3 This study 
pAV68 PGAL1-ERV2-D182A CEN, URA3 This study 
pAV294 PGAL1-ERV2-K184A CEN, URA3 This study 
pAV189 PGAL1-ERV2-R185A CEN, URA3 This study 
pAV190 PGAL1-ERV2-E189A CEN, URA3 This study 
pAV191 PGAL1-ERV2-K190A CEN, URA3 This study 
pAV192 PGAL1-ERV2-E191A CEN, URA3 This study 
pAV193 PGAL1-ERV2-K193A CEN, URA3 This study 
pAV194 PGAL1-ERV2-H195A CEN, URA3 This study 
pAV71 PGAL1-ERV2-G177A CEN, URA3 This study 
pAV96 PGAL1-ERV2-G177S CEN, URA3 This study 
pAV183 PGAL1-ERV2-G177V CEN, URA3 This study 
pAV95 PGAL1-ERV2-G177L CEN, URA3 This study 
pAV75 PGAL1-ERV2-G177M CEN, URA3 This study 
pAV77 PGAL1-ERV2-G177P CEN, URA3 This study 
pAV270 PGAL1-ERV2-G177F CEN, URA3 This study 
pAV73 PGAL1-ERV2-G177D CEN, URA3 This study 
pAV184 PGAL1-ERV2-G177E CEN, URA3 This study 
pAV269 PGAL1-ERV2-G177Q CEN, URA3 This study 
pAV72 PGAL1-ERV2-G177K CEN, URA3 This study 
pAV74 PGAL1-ERV2-G177R CEN, URA3 This study 
pAV268 PGAL1-ERV2-(DYD)? CEN, URA3 This study 
pAV404 PGAL1-ERV2-(DYD)?+2A CEN, URA3 This study 
pAV403 PGAL1-ERV2-(DYD)?+3A CEN, URA3 This study 
pAV422 PGAL1-ERV2-(DYD)? CAGC CEN, URA3 This study 
pAV423 PGAL1-ERV2-(DYD)? CAAGC CEN, URA3 This study 
pAV424 PGAL1-ERV2-(DYD)? CAAAGC CEN, URA3 This study 
pAV425 PGAL1-ERV2-(DYD)? CGAC CEN, URA3 This study 
pAV426 PGAL1-ERV2-(DYD)? CGAAC CEN, URA3 This study 
pAV427 PGAL1-ERV2-(DYD)? CGAAAC CEN, URA3 This study 
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Table 7 Continued.  Plasmids used in this work. 
 
Name Description Markers 
Source or 
Reference 
pAV161 PGAL1-ERV2-F111S-C176A-C178A CEN, URA3 This study 
pAV284 PGAL1-ERV2-F111S-C121A-C124A CEN, URA3 This study 
pAV290 PGAL1-ERV2-F111S-C150A CEN, URA3 This study 
pAV377 PGAL1-ERV2-F111S-C176Stop CEN, URA3 This study 
pAV546 PGAL1-ERV2-F111S-L171Stop CEN, URA3 This study 
pAV283 PGAL1-ERV2-L114S-C176A-C178A CEN, URA3 This study 
pAV285 PGAL1-ERV2-L114S-C121A-C124A CEN, URA3 This study 
pAV291 PGAL1-ERV2-L114S-C150A CEN, URA3 This study 
pAV379 PGAL1-ERV2-L114S-C176Stop CEN, URA3 This study 
pAV547 PGAL1-ERV2-L114S-L171Stop CEN, URA3 This study 
pAV176 PGAL1-ERV2-P120A-C176A-C178A CEN, URA3 This study 
pAV470 PGAL1-ERV2-P120A-C121A-C124A CEN, URA3 This study 
pAV289 PGAL1-ERV2-P120A-C150A CEN, URA3 This study 
pAV378 PGAL1-ERV2-P120A-C176Stop CEN, URA3 This study 
pAV548 PGAL1-ERV2-P120A-L171Stop CEN, URA3 This study 
pJC11 ERV2 (1-22?)-His6 AMP Sevier et al., 2001 
pET-14b E. coli  His6-fusion vector AMP Novagen 
pAV79 His6-ERV2 AMP This study 
pAV83 His6-ERV2-C150A AMP This study 
pAV84 His6-ERV2-C167A AMP This study 
pAV549 His6-ERV2-L171Stop AMP This study 
pAV276 His6-ERV2-F111S-C176A-C178A AMP This study 
pAV319 His6-ERV2-L114S-C176A-C178A AMP This study 
pAV287 His6-ERV2-P120A-C176A-C178A AMP This study 
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Table 8.  Primers used in this study. 
 
Primer Sequence 
C150A1 5?- GCAATGTGGGGAGCGCACATTCACAAC-3? 
C167A1 5?- GACATATATGACGCAGCTACCATCCTG-3? 
E172A1 5?- GCTACCATCCTGGCGGACTACGATTGT-3? 
D173A1 5?- ACCATCCTGGAGGCCTACGATTGTGGA-3? 
D175A1 5?- CTGGAGGACTACGCTTGTGGATGTAGT-3? 
D180A1 5?- TGTGGATGTAGTGCCAGCGACGGTAAA-3? 
D182A1 5?- TGTAGTGACAGCGCCGGTAAACGCGTG-3? 
K184A1 5'- AGTGACAGCGACGGTGCTCGCGTGTCTCTCGAG-3' 
R185A1 5'- GACAGCGACGGTAAAGCCGTGTCTCTCGAGAAG-3' 
E189A1 5'- AAACGCGTGTCTCTCGCGAAGGAGGCTAAACAG-3' 
K190A1 5'- CGCGTGTCTCTCGAGGCGGAGGCTAAACAGCAC-3' 
E191A1 5'- GTGTCTCTCGAGAAGGCGGCTAAACAGCACGGT-3' 
K193A1 5'- CTCGAGAAGGAGGCTGCACAGCACGGTTGAACA-3' 
H195A1 5'- AAGGAGGCTAAACAGGCCGGTTGAACAAAGAAA-3' 
G177N1 5?- GAGGACTACGATTGTNNSTGTAGTGACAGCGAC-3? 
?(D173toD175)1 5'- GCTACCATCCTGGAGTGTGGATGTAGTGAC-3' 
del(DYD)2Ala1 5'- GCTACCATCCTGGAGGCTGCTTGTGGATGTAGTGAC-3' 
del(DYD)3Ala1 5'- GCTACCATCCTGGAGGCTGCTGCTTGTGGATGTAGTGAC-3'  
(DYD) CAGC1 5'- ACCATCCTGGAGTGTGCTGGATGTAGTGACAGC-3' 
(DYD) CAAGC1 5'- ACCATCCTGGAGTGTGCTGCTGGATGTAGTGACAGC-3' 
(DYD) CAAAGC1 5'- ACCATCCTGGAGTGTGCTGCTGCTGGATGTAGTGACAGC-3' 
(DYD) CGAC1 5'- ATCCTGGAGTGTGGAGCTTGTAGTGACAGCGAC-3' 
(DYD) CGAAC1 5'- ATCCTGGAGTGTGGAGCTGCTTGTAGTGACAGCGAC-3' 
(DYD) CGAAAC1 5'- ATCCTGGAGTGTGGAGCTGCTGCTTGTAGTGACAGCGAC-3' 
F111S1 5'- GAGAAACTGCACACGTCTATTGGGTTGTATGCA-3' 
L114S1 5'- CACACGTTTATTGGGTCTTATGCAGAACTCTAT-3' 
P120A1 5'- TATGCAGAACTCTATGCATGCGGGGAATGTTCA-3' 
NdeI-Erv2 5'- AAAAAACATATGGAACTATCCATCGCTACGCCGGGC-3' 
Erv2-BamHI 5'- AAAAGGATCCTCAACCGTGCTGTTTAGCCTCCTT-3' 
Erv2-C176Stop-BamHI 5'- AAAAGGATCCTTAATCGTAGTCCTCCAGGATGGT-3' 
Erv2-L171Stop-BamHI 5'- AAAAGGATCCTTAGATGGTAGCACAGTCATATAT-3' 
Gal1 5?- TGCATAACCACTTTAACT-3? 
Erv2mut3 5?- ATTAAGTTGGGTAACGCC-3? 
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Figure 1.  Erv2p Cys150 and Cys167 are required for activity.  (A) The ero1-1 mutant (CKY598) 
containing either pRS316 (empty vector) or various cysteine mutant alleles of Erv2p were plated 
onto YPGal and grown at 24 ˚C or 37 ˚C for 4 d.  (B) ero1-1 erv2? mutants (CKY899) containing 
either pRS316 (empty vector), wild-type Erv2p, or various cysteine mutant alleles of Erv2p were 
labeled with [35S]methionine and alkylated with NEM prior to immunoprecipitation with Erv2p 
antibody. 
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Figure 2.  Conservation of the C-terminus of Erv2p among fungal species.  Multiple sequence 
alignment of the C-terminal half of Erv2p, among fungal species using ClustalX (Thompson et al., 
1997).  This segment shows both the conserved active site (Cys121-Cys124) and tail (Cys176-
Cys178) cysteine pairs.  The cysteines are colored in a dark grey.  Light grey boxes show blocks 
of conserved residues with more than 70% identity.  Acidic and basic amino acid residues in the 
C-terminal tail are colored in red and blue, respectively.  Abbreviations of the species names are 
as follows: Scer, Saccharomyces cerevisiae; Sbay, Saccharomyces bayanus; Smik, 
Saccharomyces mikatae; Skud, Saccharomyces kudriavzevii; Spar, Saccharomyces paradoxus; 
Ecun, Encephalitozoon cuniculi; Cgra, Candida glabrata; Sklu, Saccharomyces kluyveri; Klac, 
Kluyveromyces lactis; Scas, Saccharomyces castellii; Calb, Candida albicans; Dhan, 
Debaryomyces hansenii; Anid, Aspergillus nidulans; Fgra, Fusarium graminearum; Ylip, Yarrowia 
lipolytica; Mgri, Magnaporthe grisea; Ncra, Neurospora crassa; Umay, Ustilago maydis; Egos, 
Eremothecium gossypii, Afum, Aspergillus fumigatus, Kwal Kluyveromyces waltii, Ctro, Candida 
tropicalis, Clus, Candida lusitaniae, Cgui, Candida guilliermondii, Cglo, Chaetomium globosum, 
Cimm, Coccidioides immitis, Rory, Rhizopus oryzae, Ccin, Coprinus cinereus, Pnod, 
Phaeosphaeria nodorum, and Spom, Schizosaccharomyces pombe. 
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Figure 3.  Cys176 interacts with Cys121 in Erv2p-(DYD)?.  (A) The ero1-1 mutant (CKY598) 
containing either pRS316 (empty vector) or various cysteine mutant alleles of Erv2p were plated 
onto YPGal and grown at 24 ˚C or 37 ˚C for 4 d.  (B) ero1-1 erv2? mutants (CKY899) containing 
either pRS316 (empty vector), wild-type Erv2p, or various mutant alleles of Erv2p were labeled 
with [35S]methionine and alkylated with NEM prior to immunoprecipitation with Erv2p antibody.  
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Figure 4.  Erv2p-F111S-C176A-C178A is a monomer.  (A) Analytical gel filtration of Erv2p  
His6-Erv2p wild-type (?), His6-Erv2p-C176A-C178A (?) and His6-Erv2p-F111S-C176A-C178A 
(?).  (B) Standard curve generated with proteins of known molecular weight (?): albumin (67 
kDa), ovalbumin (43 kDa), chymotrysinogen A (25 kDa) and ribonuclease A (13.7 kDa).  The 
apparent molecular weights of His6-Erv2p (?), His6-Erv2p-C176A-C178A (?) and His6-Erv2p-
F111S-C176A-C178A (?) were determined according this curve. 
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Figure 5.  Catalytic mechanism of dimeric Erv2p (A) and monomeric Erv2p (B).  (A) Reduced 
substrate, illustrated here as Pdi1p, attacks the Cys176-Cys178 cysteine pair, resulting in the 
formation of a mixed-disulfide intermediate between the tail and the substrate (step 1-2).  This 
intermediate is resolved by the attack of a second cysteine of Pdi1p, resulting on the formation of 
oxidized Pdi1p and reduced Cys176-Cys178 (step 2-3).  The tail flips into close proximity of the 
Cys121-Cys124 pair (step 4) and the tail cysteines are reoxidized by interacting with the active 
site cysteine pair (step 5).  The reduced Cys121-Cys124 pair is re-oxidized by FAD (step 2) and 
reduced FAD is subsequently reoxidized by O2, with the concomitant production of H2O2 (step 3).  
(B) In contrast, in the monomeric form of Erv2p, the reduced substrate interacts directly with the 
Cys121-Cys124 pair, resulting in the formation of oxidized Pdi1p and reduced Cys121-Cys124 
(step 1-3).  Similarly, the reduced Cys121-Cys124 pair is re-oxidized by FAD (step 4) and the 
reduced FAD is reoxidized by O2, with the concomitant production of H2O2 (step 5). 
 S 
S 
HS   
HS   
FAD 
Pdi1p SH 
SH 
Pdi1p 
HS   
HS   
Pdi1p 
S   
S   
 
SH 
SH 
B 
S 
SH 
Pdi1p 
S   
HS 
 step 1 step 2 step 3 step 4 step 5 
S 
S 
FAD FAD FAD FAD 
S 
S 
S 
S 
O2 
H2O2 
FAD 
HS   
S 
S 
SH 
FAD 
S 
S 
SH 
SH 
FAD 
S 
S 
O2 
H2O2 
Pdi1p S 
S 
HS 
SH 
FAD 
S 
S 
Pdi1p SH 
S 
S 
SH 
FAD 
 step 1 step 2 step 3 step 4 step 5 
A 
 
 
  
 
 
 
 
 
Chapter Five 
 
 
 
Isolation and biochemical characterization of pdi1 temperature-
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Preface 
 
This chapter consists of preliminary data that is my own work.  Some of the data shown 
in this chapter will be incorporated into a paper that is currently in preparation. 
 
Sevier, C.S, Vala, A. and Kaiser, C.A. (2007) Role of glutathione in the isomerization of 
protein disulfide bonds in S. cerevisiae. In preparation. 
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Abstract 
 
Pdi1p is an essential protein in Sacharomyces cerevisiae.  Although the yeast 
Pdi1p was first described in the early 1990's, its main function in vivo is still debated.  
Pdi1p has been shown to catalyze disulfide bond formation by playing various roles in 
the endoplasmic reticulum (ER).  First, together with Ero1p, it is involved in the formation 
of disulfide bonds in secretory proteins, thus working as an oxidoreductase.  Second, it 
might also function as an isomerase, reshuffling disulfide bonds.  Third, it might be 
involved in folding of proteins working as a chaperone.  Recently, it has also been 
suggested that it might play an important role in ER-associated degradation (ERAD). 
Although various functions have been attributed to Pdi1p, it is still unclear which 
of the catalytic activities of Pdi1p is essential for its function in vivo.  To determine 
whether these functions exist in vivo, we have isolated temperature-sensitive alleles of 
Pdi1p.  Characterization of these mutants revealed that Pdi1p might have two different 
functions in the ER.  First, it seems that Pdi1p mainly acts as an oxidase.  Secondly, 
Pdi1p might also be involved in translocation of secretory proteins.  Initial charaterization 
of the pdi1 ts mutants suggests that they might be a useful tool to trap PDI substrates. 
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Results 
 
Isolation of temperature-sensitive pdi1 alleles  
 
Pdi1p plays an important role in the normal function of the ER.  Because it is an 
essential gene, to further understand its role in the ER we isolated temperature-sensitive 
(ts) alleles of Pdi1p having a growth defect when placed at high temperature.  The pdi1 
ts alleles were generated by random-PCR mutagenesis of PDI1, followed by homologous 
recombination into a GAL1-promoted gap plasmid.  The pdi1 ts alleles under the GAL1 
promoter that failed to grow at 37 ˚C were further tested.  The pdi1 alleles that were still 
temperature-sensitive under their own promoter were further studied. 
We tested 45 pdi1 ts alleles under their own promoter and selected five alleles 
that had the most severe growth phenotype at the restrictive temperature of 37 ˚C 
(Figure 1 A and Table 1). 
 
Characterization of pdi1 ts mutants 
 
Addition of dithiothreitol (DTT) to yeast cells selectively perturbs the formation of 
disulfide bonds in the ER without interfering with protein synthesis or secretion of non-
disulfide bonded proteins (Jamsa et al., 1994).  An ero1-1 mutant at the restrictive 
temperature is highly sensitive to DTT (Frand et al., 1998).  Similarly, the pdi1 ts alleles 
are more DTT sensitive than wild-type (Table 3).  As observed for the ero1-1 mutant, the 
unfolded protein response (UPR) is up-regulated in the pdi1 ts mutants at the restrictive 
temperature ((Frand et al., 1998), and data not shown).  With the exception of the pdi1-
16 allele, the pdi1 ts mutants are also sensitive to other drugs that cause ER stress, such 
as tunicamycin and caffeine (Table 3).  In contrast to the ero1-1 strain, the pdi1 ts strains 
are able to grown under anaerobic conditions (data not shown). 
Addition of exogenous oxidant, such as diamide, has been shown to allow ero1-1 
mutants to grow at the restrictive temperature, probably by providing exogenous 
oxidative equivalents that are missing in the ero1-1 mutant (Frand et al., 1998).  
Likewise, addition of exogenous diamide to the medium was able to rescue all pdi1 ts 
alleles tested except for pdi1-16 mutant (Figure 2 and Table 2).   
Addition of glycerol is known to rescue growth phenotypes associated with folding 
defects (Brown et al., 1997; Hampsey, 1997).  As observed for the ero1-1 mutant, some 
of the temperature-sensitive defects of the pdi1 ts alleles were rescued by exogenous 
glycerol (Table 2). 
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The ero1-1 growth defect is rescued by lowering the GSH content, either by 
mutating the enzyme responsible for the first step of biosynthesis of GSH (gsh1? 
background) or by inhibiting the production by GSH by buthionine sulfoximine (BSO) 
(Cuozzo et al., 1999).  Similarly, with exception of pdi1-16 allele, all pdi1 ts mutants were 
rescued by either deletion of GSH1 or by addition of BSO (Figure 3 and Table 4). 
Analysis of the steady state protein levels of the pdi1 ts mutants showed that in 
these mutants there are higher levels of Pdi1p than in the wild-type strain (data not 
shown).  Under conditions of ER stress, cells up-regulate the protein levels of various ER 
resident proteins, including Pdi1p (Sidrauski et al., 1998).  Furthermore, Pdi1p levels are 
up-regulated by a cis-acting element CERP that is activated upon deficiency of protein 
disulphide isomerase activity (Norgaard et al., 2003). 
 
The temperature-sensitive alleles of PDI1 are impaired in oxidative folding 
 
A common assay of ER oxidative folding is the maturation of carboxypeptidase Y 
(CPY), due to the fact that as CPY traverses the secretory pathway its molecular weight 
changes due to post-translational modifications.  CPY is a non-essential yeast vacuolar 
protein that contains 5 disulfide bonds and a free thiol.  It is initially synthesized as a pro-
protein that is oxidized and glycosylated in the ER to a precursor form p1 (67 kDa).  
Upon formation of disulfide bonds it travels to the Golgi, where it acquires additional 
carbohydrates, forming precursor form p2 (69 kDa).  When it reaches the vacuole, the 
pro sequence is cleaved, forming mature protein (m; 61 kDa) (Stevens et al., 1982). 
To determine if the pdi1 ts alleles have a CPY maturation defect, we performed 
pulse chase experiments to follow the maturation of CPY in vivo.  After shifting to the 
restrictive temperature of 37 ˚C for 1 h, the pdi1-5, pdi1-6, pdi1-10 and pdi1-11 alleles 
accumulated the p1 form of CPY, suggesting a defect in maturation of CPY due to 
retention in the ER (Figure 4A).  Interestingly, the pdi1-16 allele also had a defect in CPY 
maturation, but this mutant seems to accumulate a different form of CPY (prepro-CPY, 
non-translocated or non-glycosylated; which migrate in SDS-PAGE gels with similar 
mobilities).  As expected, the CPY maturation defect on the pdi1 ts strains was rescued 
by addition of exogenous diamide (data not shown). 
To further characterize the defect of pdi1-16 ts allele upon temperature shift, we 
decided to compare the maturation of CPY in yeast mutants that are either defective in 
ER translocation (kar2-159 and sec61-2 mutants) or in ER-to-golgi transport (sec12-6 
mutant) (Holkeri et al., 1998; Nakano et al., 1988; Pilon et al., 1998; Vogel et al., 1990).  
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For this purpose, we performed pulse chase experiments to follow the maturation of CPY 
with or without tunicamycin, a glycosylation inhibitor.  After being shifted to the restrictive 
temperature of 38 ˚C for 1 h, the pdi1-16 ts accumulates prepro-CPY as observed in 
kar2-159 and sec61-2 mutants (Figure 4B). 
 
In pdi1 ts mutants secretion of invertase is not impaired 
 
Intracellular transport of secretory proteins that lack disulfides, such as the yeast 
periplasmic enzyme invertase, is not disrupted in the presence of DTT (Carlson et al., 
1983; Jamsa et al., 1994; Lodish et al., 1993).  To rule out that the pdi1 ts mutants have 
a general secretion defect, we assayed these mutants for intracellular accumulation of 
invertase (Carlson et al., 1983).  As observed for ero1-1 mutants grown at the restrictive 
temperatures, the pdi1 ts alleles do not accumulate intracellular forms of invertase, and 
thus do not show any defect in invertase secretion (data not shown).  
To further characterize the translocation defect of pdi1-16 mutant, we used the 
same assay.  As controls, we used yeast mutants that are either defective in ER 
translocation (kar2-159 and sec61-2 mutants) or ER-to-Golgi transport (sec12-6 mutant).  
The intracellular ER form of invertase is observed in the sec12-4 mutant, as this mutant 
is impaired in ER-to-Golgi transport.  As in the kar2-159 mutant, the pdi1-16 ts mutant 
accumulates an intracellular, non-translocated form of invertase (Figure 5).  
 
The pdi1 ts mutants are unable to oxidize CPY 
 
To demonstrate that the CPY p1 form that accumulates after the temperature 
shift in the pdi1 ts alleles (pdi1-5, pdi1-6, pdi1-10 and pdi1-11) does not contain disulfide 
bonds, we used a thiol-modifying agent that reacts only with free thiols.  As controls for 
mobility shifts, we treated the cells with DTT to reduce all the CPY prior to the 4-
acetomido-4'-maleimidylstilbene-2,2'-disulphonic acid (AMS) modification.  We observed 
that in the presence of AMS, the protein runs with the same mobility as CPY treated with 
DTT prior to AMS modification, suggesting that this CPY p1 form in these mutants is in 
the reduced form (Figure 6).  As observed previously, the CPY form observed in pdi1-16 
ts mutant is of higher mobility suggesting that this mutant accumulates a different form of 
CPY (non-translocated).  
Under hyperoxidizing conditions (e.g. treatment of yeast cells with the thiol 
oxidant diamide) proteins that contain reactive thiols, such as CPY, are withheld in the 
ER in oxidized forms (p1 form) and are likely to contain inappropriate intra- or 
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intermolecular disulfide bonds, while the intracellular transport of proteins without 
cysteines, such as prepro-?-factor, proceeds with normal kinetics (Cuozzo et al., 1999).  
Mature CPY can be obtained from cells grown under hyperoxidizing conditions by 
washing out the oxidant and allowing cells to isomerize misoxidized CPY to mature CPY.  
The isomerization process occurs by an initial reduction step followed by an oxidation 
step (Sevier et al., 2007).  These results suggest that misoxidation of CPY is a reversible 
process and points to the existence of a reduction system in S. cerevisiae (Sevier et al., 
2007).  In the pdi1 ts mutants (pdi1-5, pdi1-6, pdi1-10 and pdi1-11) misoxidized CPY 
formed by hyperoxidizing conditions is reduced after washing out the oxidant, suggesting 
that the pdi1 ts alleles are not defective in the oxidase activity thus not able to reoxidize 
reduced CPY (data not shown and (Sevier et al., 2007)). 
 
From this screen we have isolated two different types of pdi1 ts mutants: 1) 
mutants defective in oxidation of disulfide bond in the ER and, 2) mutants defective in the 
translocation or glycosylation of proteins into the ER. 
 
Function of Ero1p and Pdi1p in oxidative folding 
 
Although ERO1 is an essential gene, it is possible to grow cells lacking the ERO1 
gene by addition of exogenous oxidant (diamide) or by lowering the GSH content (gsh1? 
background), suggesting that it is possible to overcome the need for Ero1p (Cuozzo et 
al., 1999; Frand et al., 1998).  In contrast, we were unable to rescue cells lacking PDI1 
by either addition of exogenous oxidant (diamide) or by lowering the GSH content (gsh1? 
background), suggesting a fundamental differences in the role played by these two 
proteins (data not shown).  These results suggest that the essential function of Pdi1p is 
its oxidoreductase activity. 
 
Genetic interactions of pdi1 mutations with mutations in the disulfide bond 
pathway genes 
 
The ero1-1 mutant is synthetic lethal with ire1?, hut1-1 (Hut1p-A265T) and pdi1-1 
(Pdi1p-P106S) mutants (Frand et al., 1998; Tu, 2003).  In contrast to what is observed 
for ero1-1 mutants, only pdi1-16 and pdi1-5 mutants were synthethic lethal or sick with 
ire1?, respectively (Table 5). 
It has been shown previously that ero1-1 hut1? mutants are more sensitive to 
DTT than ero1-1 (Nakanishi et al., 2001).  We tested the ability of the pdi1 ts mutants to 
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suppress the growth defect of pdi1? hut1?.  We found that the pdi1-5 and pdi1-16 ts 
mutants are synthetic lethal with hut1?, while cells containing all other pdi1 ts alleles are 
only synthetic sick (Table 5). 
To address the effect of deletion of the other genes encoding protein disulfide 
isomerases in the yeast ER, we tested the pdi1 ts mutants for their ability to suppress the 
growth defect of double mutants lacking PDI1 and one of the yeast PDI homologs or the 
quintuple mutant lacking PDI1 and all of its homologs (pdi1? mpd1?, pdi1? mpd2?, 
pdi1? eug1?, pdi1? eps1? and pdi1? mpd1? mpd2? eug1? eps1? strains).  The pdi1-16 
ts allele is unable to suppress the growth defect of double mutant pdi1? mpd1? or the 
quintuple mutant (Table 6).  The pdi1-5 ts allele was synthetic sick with all strains tested 
except pdi1? eps1? (Table 6). 
 
Location of the mutations in the predicted secondary structure of Pdi1p 
 
Sequence analysis of the pdi1 ts alleles shows that these carry mutations in both 
the active and inactive thioredoxins domains of Pdi1p (Table 7). Attempts to separate 
individual mutations or mutations by domains were unsuccessful, suggesting that it is 
necessary to have mutations in at least two domains of Pdi1p to obtain the temperature-
sensitivity defect (Figure 7). 
 
Trapping pdi1 ts-substrate mixed disulfides in vivo 
 
To further investigate why the pdi1 ts mutants are defective in oxidative folding, 
we analyzed the in vivo redox state of the pdi1 ts proteins.  The oxidation state was 
analyzed by covalent modification with AMS, a thiol-modifying agent that reacts to free 
thiols only, and the reduced and oxidized forms of the proteins were resolved by SDS-
PAGE.  As controls for mobility shifts, we treated the cells with DTT to reduce all the pdi1 
ts protein prior to the AMS modification.  We were unable to determine the redox state of 
the pdi1 ts proteins, because even in the absence of AMS these pdi1 ts proteins were 
trapped in higher molecular weight complexes (Figure 8).  Under reducing conditions we 
no longer detect these higher molecular complexes, suggesting that they are disulfide-
linked complexes of pdi1 ts and substrate proteins (data not shown). 
As reported for mutants of DsbA, the bacterial homolog of Pdi1p, it is possible 
that the mutations contained in the pdi1 ts mutants slow the thiol-exchange reaction 
between the pdi1 ts proteins and its substrates, thus allowing us to detect mixed-disulfide 
complexes (Kadokura et al., 2004).  Since lowering the GSH content of cells rescued the 
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growth defect of the pdi1 ts mutants, we analysed the formation of the pdi1 ts-substrate 
complexes in cells lacking the GSH1 gene.  Interestingly, the amount of pdi1 ts-substrate 
complexes in these cells was slightly increased (Figure 8).  As a control we 
overexpressed wild-type Pdi1p and were unable to obtain the formation of pdi1 ts-
substrate complexes. 
 
Future directions 
 
The initial characterization of the pdi1 ts mutants was performed.  The pdi ts 
mutants are a tool for analyzing further the function of Pdi1p in vivo but also an important 
tool for the potential trapping of substrates. It will also be interesting to further analyze 
the role of Pdi1p in ER translocation.   
 
Materials and methods 
 
Strains, plasmids and media 
 
S. cerevisiae strains are listed in Table 8.  Isolation and characterization of the 
ero1-1 strain (CKY598) has been described previously (Frand et al., 1998).  Cultures 
were either grown in rich medium (1% Bacto yeast extract and 2% Bacto-peptone 
containing either 2% dextrose (YPD) or 2% galactose (YPGal) as carbon sources) or 
minimal media (0.67% nitrogen base without amino acids supplemented with 16 amino 
acids not including cysteine) containing 2% galactose and 2% raffinose (SMM Gal/Raf).  
For anaerobic conditions, strains were grown in sealed BBL GasPak chamber envelope 
(Becton Dickinson).  Standard genetic manipulations and yeast transformations were 
performed as described (Adams et al., 1997). 
To generate AVY115, the coding sequence of PDI1 was replaced by kanMX6 by 
homologous recombination in AVY111 (a homozygous GAL2 ura3-52 leu2-3, 112 diploid 
background). The resulting heterozygous diploid was transformed with pCS213. After 
sporulation, a viable MATa Ura+ kanMX segregant was selected (CSY314).  The viability 
of CSY314 depends on the episomal PDI1 allele, since this strain is not able to grown on 
medium containing 5-fluorootic acid (5-FOA; Toronto Research Laboratories, Canada). 
Complete gene deletion of GSH1 in a pdi1? background was constructed by 
gene replacement with the kanMX6 cassette by homologous recombination in AVY800 
(Wach et al., 1994).  To make AVY800 the kanMX6 cassette was substituted by natMX6 
cassette by homologous recombination in AVY115 (Goldstein et al., 1999).  Tagging of 
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ERO1 at its C terminus with 13xmyc was performed by homologous recombination, 
resulting in AVY758 (Longtine et al., 1998). 
The ero1-1 pdi1? [pCS213] strain (AVY704) was constructed by crossing an 
ero1-1 strain (CKY598) to a wild type strain (CKY264). The coding sequence of PDI1 
was replaced by kanMX6 by homologous recombination in AVY704.  After 
transformation with pCS213, this strain was sporulated and a viable MATa Ura+ kanMX6 
temperature-sensitive spore was selected (AVY769).  The ire1? pdi1? [pCS213] strain 
(AVY802) was constructed by replacing the IRE1 coding sequence in AVY115.  The 
gsh1? pdi1? [pCS213] strain (AVY831) was constructed by replacing the GSH1 coding 
sequence in AVY800.  The resulting diploid strains were transformed with pCS213 and 
sporulated.  A viable MATa Ura+ kanMX6 natMX6 was selected (AVY844 and AVY876, 
respectively).  The viability of AVY769, AVY844 and AVY876 depends on the episomal 
PDI1 allele, since these strains are not able to grown on medium containing 5-FOA. 
The mpd1? pdi1? [pCS213], mpd2? pdi1? [pCS213], eug1? pdi1? [pCS213] and 
eps1? pdi1? [pCS213] strains were constructed replacing the MPD1, MPD2, EUG1 or 
EPS1 coding sequences by kanMX6 by homologous recombination in AVY800.  After 
transformation with pCS213, these strains were sporulated and a viable MATa Ura+ 
kanMX6 natMX6 temperature-sensitive spore was selected (AVY882, AVY888, AVY894 
and AVY900, respectively).  The mpd1? mpd2? eug1? eps1? pdi1? [pCS213] strain 
(AVY967) was constructed by crossing an mpd1? mpd2? eug1?I strain (AVY918) to an 
eps1? pdi1? [pCS213] strain (AVY897).  The viability of AVY882, AVY888, AVY894, 
AVY900 and AVY967 depends on the episomal PDI1 allele, since these strains are not 
able to grown on medium containing 5-FOA. 
To generate strains AVY580-596, CSY314 was transformed with LEU2-based 
plasmids carrying the pdi1 ts alleles under their own promoter (pAV336-pAV458).  The 
transformants were streaked in 5-FOA containing medium to select for colonies that only 
contain the pdi1 ts allele and that have lost the wild-type PDI1-containing plasmids.  
The pdi1? suc2-?9 [pCS213] strain was constructed by crossing a suc2-?9 strain 
(CKY406) to a pdi1? strain carrying an exogenous copy of wild-type PDI1 [pCS213] 
(CYY314).  This strain was sporulated and a viable MATa Ura+ natMX6 temperature-
sensitive spore was selected (AVY957).  The pdi1? suc2-?9 [pAV458] strain  was 
constructed by transforming AVY957 with LEU2-based plasmid carrying the pdi1 ts allele 
under their own promoter (pAV458).  The transformants were streaked in 5-FOA 
containing medium to select for colonies that only contain the pdi1 ts allele and that have 
lost the wild-type PDI1-containing plasmids (AVY1030).  
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Plasmid construction 
 
Plasmids used in this work are listed in Table 8.  To make pAV9 an ApaI-SacI 
fragment of 2572 bp from pCT37, containing the GAL1 promoter and PDI1, was 
subcloned into the same sites of pRS315 (Sikorski et al., 1989). 
To generate pCS213, pBH1966 was cut with BamHI and SalI and gap repair by 
homologous recombination with genomic PDI1 from CKY263.  To create a plasmid 
containing the 5' untranslated region (UTR) of PDI1, we amplified genomic DNA with 
SalI-5'UTR-Pdi1, 5'-AAA AAA GTC GAC GGA AAT TGG TAC CAC CCA GGT CGG 
CGG CTA-3' and 5'UTR-Pdi1-BamHI primers 5'-AAA AAA GGA TCC TGC TTG CAA 
CAA GAA AAT GCA CGC GTA ACA-3'.  This PCR product was inserted into SalI and 
BamHI sites of pRS315 (Sikorski et al., 1989).  To create plasmids containing the pdi1 
alleles under their own promoter, DNA fragments containing the pdi1 alleles that 
conferred temperature sensitivity under the GAL1 promoter were subcloned into BamHI 
and SacII sites of pAV320.  The same DNA fragments were subcloned into the same 
sites in pRS306 (Sikorski et al., 1989) for integration at the PDI1 locus by two-step gene 
replacement. 
 
Isolation and integration of pdi1 temperature-sensitive alleles 
 
PCR mutagenesis of the PDI1 gene was preformed as described (Muhlrad et al., 
1992).  A 1762 bp DNA fragment containing 196 base pair of the 5' UTR was amplified 
from pAV9 with the following primers Gal1, 5?-TGCATAACCACTTTAACT-3? and Pdi3, 5?- 
CAATTCATCGTGAA TGGCATC-3? using AmpliTaq Gold (Perkin Elmer) in the presence 
of 0.25 mM MgCl2 and one-fifth the normal concentration of dATP (0.2 mM dATP). 
The resulting PCR fragment and pAV9 (described above) cut with BamHI and 
SacII were transformed into CKY564.  Transformants in SC Gal/Raff-leucine plates were 
replica-plated onto plates with 5-FOA at 24 °C versus 37 °C.  Plasmids that conferred 
temperature-sensitivity were obtained at a frequency of 1-2 colonies per 100 colonies 
tested and were tested by retransformation.  The pdi1 alleles that conferred temperature 
sensitivity under the GAL1 promoter were subcloned into pAV320 (pRS315 vector 
containing PDI1 promoter).  These plasmids were further tested and the ones that still 
conferred temperature sensitivity under the PDI1 promoter were studied further. 
 
Assays for growth in the presence of DTT, diamide or BSO 
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Strains were grown selectively to exponential phase at 24 ˚C.  Triplicate lawns of 
2 x 106 cells were plated into YPD and 10 μl of 2 M DTT applied to lawns in 6 mm filter 
disks (Fisher Scientific).  Diameters of the zone of inhibition were measured after 
incubation for 1-2 d at 30 ˚C. 
To test for diamide (Sigma) and DL-buthionine-[S,R]-sulfoximine (BSO; Sigma) 
rescue of temperature-sensitive strains, lawns of 1 x 106 cells were plated into YPD or 
SC, respectively.  Then, 10 μl of 0.6 M diamide or 10 μl of 50 mg ml-1 BSO were applied 
to the lawns in 6 mm filter disks before incubation at 37 ˚C (for pdi1 ts mutants) or 30 ˚C 
(for CSY314). 
 
CPY immunoprecipitation 
 
For CPY immunoprecipitation, strains were grown at 24 ˚C in synthetic minimal 
medium (SMM) lacking methionine with 2% glucose to exponential phase.  Cells were 
resuspended in overnight medium at a concentration of 1.8 OD600 ml
-1 at 24 ˚C and 
shifted to 38 ˚C for 1 h before labeling with [35S]methionine and cysteine (EXPRESS, 
NEN).  Cells were then suspended in 10% (w/v) TCA and lysed with glass beads.  
Protein pellets were then incubated in sample buffer (80 mM Tris-HCl [pH 6.8], 2% SDS, 
10% glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.01% bromophenol blue).  
Cell extracts were suspended in 1 ml IP buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 
1% Triton X-100 and 1 mM PMSF) and preadsorbed with fixed Staphylococcus A cells 
(Sigma) before incubation with CPY antibody (1 OD600 units of cells were incubated with 
1 μl of anti-CPY).  Immune complexes were collected with protein A-Sepharose 
(Pharmacia), washed in IP buffer containing 0.1% SDS, washed in IP buffer without 
detergent, and solubilized in sample buffer.  Samples were analyzed on a non-reducing 
8% SDS-PAGE and visualized with a 445si PhosphoImager (Molecular Dynamics).  
When necessary tunicamycin (10 μg ml-1, Sigma) was added to cells 10 min before 
labeling.  Cells were labeled with [35S]methionine and cysteine (EXPRESS, NEN) for 10 
min at 38 ˚C and chased for 15 min. 
To examine the redox state of CPY, strains were grown as described before.  
Strains were resuspended in overnight medium at a concentration of 1.8 OD ml-1 at 24 ˚C 
and shifted to 38 ˚C for 1 h before labeling with [35S]methionine and cysteine 
(EXPRESS, NEN).  When necessary strains were treated with 5 mM DTT 10 min before 
labeling.  After labeling, samples were TCA precipitated and incubated in sample buffer 
containing 15 mM 4-acetoamido-4'-maleimidylstilbene-2,2'-disulfonic acid (AMS, 
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Molecular Probes).  Samples were resolved on a non-reducing 8% SDS-PAGE gel and 
analyzed with a 445si PhosphorImager (Molecular Dynamics). 
 
Induction of the unfolded protein response 
 
Strains expressing pJC104 (Sidrauski et al., 1996) were grown in selective 
medium at 24 ˚C and resuspended 1 x 107 cells ml-1 in YPD.  Cultures were given 0 or 
2.5 μg ml-1 of tunicamycin (Sigma) and incubated at 30 °C or 37 °C for 2.5 h.  Cells were 
permeabilized and ?-galactosidase activity assayed as described (Guarente, 1983).  Two 
transformants were assayed per strain and the experiment repeated twice. 
 
Protein extracts, and immunoblotting 
 
Whole-cell extracts were prepared by resuspending 5 OD600 units of cells in 30 μl 
sample buffer (60 mM Tris-HCl [pH 6.8], 2% SDS, 100 mM DTT, 10% glycerol, 0.001% 
bromophenol Blue) and boiled for 2 min.  Cells were lysed by agitation with glass beads, 
and an additional 70 μl of sample buffer was added.  The equivalent to 0.75 OD600 units 
of cells were analyzed by 8% SDS-PAGE and analyzed by immunoblotting with 
antiserum to Pdi1p. 
For invertase assay, cells were grown to the exponential phase in YEP with 2% 
glucose.  Two OD600 units of cells were centrifuged and resuspended in YEP medium 
0.1% glucose (derepressing conditions) and aerated at 37°C for 2-3 h.  Cells were 
washed with 10 mM sodium azide.  Cell pellets were suspended in 20 μl of sample buffer 
(80 mM Tris-HCl [pH 6.8], 10% glycerol, 2% SDS, 100 mM DTT, 2 mM PMSF, 0.01% 
bromphenol blue) and boiled for 2 min followed by disruption by glass bead lysis.  An 
additional 130 μl of sample buffer was added, and samples were heated to 95°C for 3 
min.  Proteins were separated on 7.5% SDS-PAGE and analyzed by immunoblotting with 
antiserum to invertase. 
To examine the redox state of Pdi1 ts protein, strains were grown as described 
above.  When necessary strains were treated with 5 mM DTT for 10 min.  Samples were 
TCA precipitated and cells were lysed by agitation with glass beads.  Cell pellets were 
resuspended in sample buffer containing 15 mM AMS.  Samples were resolved on a 
non-reducing 8% SDS-PAGE gel and analyzed by immunoblotting with antiserum to 
Pdi1p. 
Immunoblotting was performed as described (Elrod-Erickson et al., 1996).  The 
following antibodies were used for western blot detection: rabbit anti-invertase at 1:1,000 
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dilution, and rabbit polyclonal anti-PDI 1:10,000 (a gift from T. Stevens, University of 
Oregon, Eugene, Oregon), and donkey anti-rabbit IgG-HRP (1:10,000 dilution; 
Amersham).  Blots were developed by chemiluminescence (ECL system; Amersham) 
and detected on a Kodak Image Station 440. 
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Table 1.  Temperature-sensitive alleles of Pdi1p. 
 
Pdi1p allelea 
Suppression of pdi1? 
growth defect at 24 ˚C 
Suppression of pdi1? 
growth defect at 37 ˚C 
Vector ?  NA 
PDI1 +  +  
pdi1-5 +  ?  
pdi1-6 +  ?  
pdi1-10 +  ?  
pdi1-11 +  ?  
pdi1-16 +  ?  
a The CSY314 strain (pdi1? pCS213) was transformed with either pRS316 (empty vector), PDI1 
or pdi1 temperature-sensitive alleles.  The transformants were streaked on SC + 5-FOA plates 
and grown at RT for 3 d. 
NA - non applicable 
 
 
Table 2.  Characterization of pdi1 temperature-sensitive alleles. 
 
Pdi1p allelea CPY defect 
Growth 
YPD + DIA 37 ˚C 
Growth YPGly 
37 ˚C 
PDI1 No + +  
pdi1-5 Yes + ?  
pdi1-6 Yes + +  
pdi1-10 yes + +  
pdi1-11 yes + +  
pdi1-16 yes ? ?  
a the various yeast strains (AVY580, AVY585-6, AVY590-1 and AVY596) were platted onto YPD 
containing diamide or YPGly plates and grown at RT for 3 d. 
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Table 3.  Further characterization of pdi1 temperature-sensitive alleles. 
 
Pdi1p allelea 
Growth 
YPD + 7.5mM DTT 
Growth 
YPD + 10 mM Caff 
Growth  
YPD+ 1 μg/ml Tun 
PDI1 +  R R 
pdi1-5 ?  VS VS 
pdi1-6 ?  VS VS 
pdi1-10 +  R S 
pdi1-11 ?  S S 
pdi1-16 + /?  R R 
a the various yeast strains (AVY580, AVY585-6, AVY590-1 and AVY596) were platted onto YPD 
containing either DTT, Caffeine or Tunicamycin plates and grown at RT for 3 d.  R, resistant; S, 
sensitive; VS, very sensitive. 
 
 
Table 4.  Suppression of growth defect of the temperature-sensitive alleles of Pdi1p by 
blocking GSH synthesis.  
 
Pdi1p allelea 
Growth 
YPD 
37 ˚C 
gsh1?  
background 
Growth YPD  
37 ˚C 
Growth 
SC 
37 ˚C 
Growth 
SC + BSO 
37 ˚C 
PDI1 + + + + 
pdi1-5 ?  +/- ?  + 
pdi1-6 ?  +/- ?  + 
pdi1-10 ?  + ?  + 
pdi1-11 ?  + ?  + 
pdi1-16 ?  ?  ?  ?  
a the various yeast strains (AVY580, AVY585-6, AVY590-1, AVY596 and AVY1018-AVY1023) 
were plated on YPD or SC medium containing BSO grown at 24 ˚C and 37 ˚C for 3 d. 
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Table 5.  Synthetic lethality of temperature-sensitive alleles of Pdi1p with ero1-1, ire1?, 
and hut1?. 
 
Pdi1p allelea 
Suppression of 
ero1-1 pdi1? 
growth defect at 24 
˚C 
Suppression of 
ire1? pdi1? 
growth defect at 37 ˚C 
Suppression of 
hut1? pdi1? 
growth defect at 24 
˚C 
PDI1 + + + 
pdi1-5 +/?  ?  ?  
pdi1-6 + ?  +/?  
pdi1-10 + + + 
pdi1-11 + ?  +/?  
pdi1-16 ?  ?  ?  
a AVY769, AVY844 and AVY870 strains were transformed with either pRS316 (empty vector), 
PDI1 or pdi1 temperature-sensitive alleles.  The transformants were streaked on SC + 5-FOA 
plates and grown at RT for 3 d. 
 
 
 
 
 
 
 
 
Table 6.  Synthetic lethality of temperature-sensitive alleles of Pdi1p with genomic deletion of Pdi1p homologs. 
 
Pdi1p mutant 
allelea 
mpd1? pdi1? 
growth defect  
at 24 ˚C 
mpd2? pdi1? 
growth defect  
at 24 ˚C 
eug1? pdi1? 
growth defect  
at 24 ˚C 
eps1? pdi1? 
growth defect  
at 24 ˚C 
mpd1? mpd2? eug1? 
eps1? pdi1? 
growth defect  
at 24 ˚C 
PDI1 + + + + + 
pdi1-5 +/?  +/?  +/?  + +/?  
pdi1-6 + + + + + 
pdi1-10 + + + + + 
pdi1-11 +/?  + + + +/?  
pdi1-16 ?  +/?  +/?  +/?  ?  ?  
a the AVY882, AVY888, AVY894, AVY900 and AVY967 strains were transformed with either pRS316 (empty vector), PDI1 or pdi1 
temperature-sensitive alleles.  The transformants were streaked on SC + 5-FOA plates and grown at RT for 3 d. 
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Table 7.  Mutations in pdi1 temperature-sensitive alleles. 
 
Allele Base change Amino acid change PDI domain 
T62C F21S SS 
G132C E44D a 
T155C V52A a 
T491C V164A b 
A557G N186S b 
A628T M210L b 
A689T E230V b 
A902T H301L b' 
A970G K324E b' 
A1024G I342V b' 
A1049G E350G b' 
T1111C; T1112G F371R  
A1231G R411G a' 
A1262G D421G a' 
A1317T E439D a' 
pdi1-5 
A1378G K460E a' 
T59C V20A SS 
A368G E123G a 
A443G D148G b 
C448G P150A b 
T529C F177L b 
A689G E230G b 
A728T E243V b' 
A1019C D340A b' 
A1024G I342V b' 
A1034G E345G b' 
A1165G I389V a' 
pdi1-6 
T1418C L473S a' 
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Table 7 Continued. Mutations in pdi1 temperature-sensitive alleles. 
 
Allele Base change Amino acid change PDI domain 
T44C L15P SS 
T94G S32A a 
T395C V132A a 
A548G K183R b 
T554A F185Y b 
A628G M210V b 
T685A F229I b 
T770C L257S b' 
A797T D266V b' 
A816T E272D b' 
A1121T Q374L  
pdi1-10 
 
T1190C V397A a' 
T137C I46T  
T506C I169T b 
A752G Q251R b' 
A791G Y264C b' 
T980C L327S b' 
A1061T K354M b' 
T1070G L357W b' 
A1103G Q368R  
A1329T R443S a' 
T1429C F477L a' 
pdi1-11 
 
T1463C V488A  
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Table 7 Continued.  Mutations in pdi1 temperature-sensitive alleles. 
 
Allele Base change Amino acid change PDI domain 
A5G K2R SS 
G79A V27M  
T151A L51M a 
A304G I102V a 
A521G N174S 
b (abolish N-linked 
Glyc.) 
A549C K183N b 
A590G D197G b 
A649G N217D b 
A658C K220Q b 
A865T N289Y b' 
A996T E332D b' 
A1121C Q374P  
T1133C V378A a' 
A1172T N391I a' 
A1273G N425D 
a' (abolish N-linked 
Glyc.) 
T1439C I480T a' 
pdi1-16 
A1499G K500R  
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Table 8.  Yeast strains used in this study. 
 
Strain Genotype Source 
CKY263 MATa ura3-52 leu2-3,112 GAL2 Kaiser lab 
collection 
CKY598 MATa ero1-1 ura3-52 leu2-3,112 GAL2 Kaiser lab 
collection 
CSY314 MAT? ura3-52 leu2-3, 112 GAL2 pdi1?::kanMX6 [pCS213] Sevier collection 
AVY111 MATa/? ura3-52/ura3-52 leu2-3, 112/leu2-3, 112 GAL2/GAL2 This study 
AVY115 MATa/? ura3-52/ura3-52 leu2-3, 112/leu2-3, 112 GAL2/GAL2 
PDI1/pdi1?:kanMX6 
This study 
AVY800 MATa/? ura3-52/ura3-52 leu2-3, 112/leu2-3, 112 GAL2/GAL2 
PDI1/pdi1?::natMX6 
This study 
AVY840 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 [pCS213] This study 
CKY598 MATa ura3-52 leu2-3, 112 ero1-1 GAL2 Kaiser lab 
collection 
AVY769 MATa ura3-52 leu2-3, 112 GAL2 ero1-1 pdi1?::kanMX6 
[pCS213] 
This study 
AVY844 MATa ura3-52 leu2-3, 112 GAL2 ire1?::natMX6 pdi1?::kanMX6 
[pCS213] 
This study 
AVY876 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
gsh1?::kanMX6 [pCS213] 
This study 
AVY870 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
hut1?::kanMX6 [pCS213] 
This study 
AVY880 MATa ura3-52 leu2-3, 112 GAL2 mpd1?::kanMX6 This study 
AVY886 MATa ura3-52 leu2-3, 112 GAL2 mpd2?::kanMX6 This study 
AVY892 MATa ura3-52 leu2-3, 112 GAL2 eug1?::kanMX6 This study 
AVY898 MATa ura3-52 leu2-3, 112 GAL2 eps1?::kanMX6 This study 
AVY882 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
mpd1?::kanMX6 [pCS213]  
This study 
AVY888 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
mpd2?::kanMX6 [pCS213] 
This study 
AVY894 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
eug1?::kanMX6 [pCS213]  
This study 
AVY900 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
eps1?::KanMX6 [pCS213] 
This study 
CSY304 MAT? mpd1?::kanMX6 eug1?::kanMX6 ura3-52 leu2-3, 112 
GAL2 
Sevier collection 
CSY306 MAT? mpd1?::kanMX6 mpd2?::kanMX6 ura3-52 leu2-3, 112 
GAL2 
Sevier collection 
CSY308 MAT? mpd1?::kanMX6 mpd2?::kanMX6 eug1?::kanMX6 ura3-
52 leu2-3, 112 GAL2 
Sevier collection 
AVY967 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
mpd1?::kanMX6 mpd2?::kanMX6 eug1?::kanMX6 
eps1?::kanMX6 [pCS213] 
This study 
AVY580 MATa a pdi1?::kanMX6 ura3-52 leu2-3, 112 GAL2 [pAV336] This study 
AVY585 MATa pdi1?::kanMX6 ura3-52 leu2-3, 112 GAL2 [pAV341] This study 
AVY586 MATa pdi1?::kanMX6 ura3-52 leu2-3, 112 GAL2 [pAV342] This study 
AVY590 MATa pdi1?::kanMX6 ura3-52 leu2-3, 112 GAL2 [pAV452] This study 
AVY591 MATa pdi1?::kanMX6 ura3-52 leu2-3, 112 GAL2 [pAV453] This study 
AVY596 MATa pdi1?::kanMX6 ura3-52 leu2-3, 112 GAL2 [pAV458] This study 
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Table 8 Continued.  Yeast strains used in this study. 
 
Strain Genotype Source 
AVY1018 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
gsh1?::kanMX6  [pAV336] 
This study 
AVY1019 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
gsh1?::kanMX6 [pAV341] 
This study 
AVY1020 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
gsh1?::kanMX6 [pAV342] 
This study 
AVY1021 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
gsh1?::kanMX6 [pAV452] 
This study 
AVY1022 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
gsh1?::kanMX6 [pAV453] 
This study 
AVY1023 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 
gsh1?::kanMX6 [pAV458] 
This study 
CKY406 MATa ura3-52 leu2-3, 112 suc2-?9 Kaiser Lab 
collection 
EHY33 MATa ura3-52 leu2-3, 112 kar2-159 suc2-?9 Elisabeth Hong 
collection 
CKY156 MAT? ura3-52 leu2-3, 112 ade2 pep4-3 sec61-2 Kaiser Lab 
collection 
CKY407 MAT? ura3-52 leu2-3, 112 sec12-4 suc2-?9 Kaiser Lab 
collection 
AVY957 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 suc2-?9 
[pCS213] 
This study 
AVY1030 MATa ura3-52 leu2-3, 112 GAL2 pdi1?::natMX6 suc2-?9 
[pAV458] 
This study 
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Table 9.  Plasmids used in this work 
 
Name Description Markers 
Source or 
Reference 
pCT37 pGal1-PDI1 CEN, URA3 
Tachibana et 
al., 1992 
pAV9 pGal1-PDI1 CEN, LEU2 This study 
pBH1966 pPPDI1-PDI1-CGHS-CGHS CEN, TRP1 
Norgaard et al., 
2001 
pCS213 pPPDI1-PDI1 CEN, URA3 This study 
pAV336 pPPDI1-PDI1 CEN, LEU2 This study 
pAV337 pPPDI1-pdi1-1 CEN, LEU2 This study 
pAV338 pPPDI1-pdi1-2 CEN, LEU2 This study 
pAV339 pPPDI1-pdi1-3 CEN, LEU2 This study 
pAV340 pPPDI1-pdi1-4 CEN, LEU2 This study 
pAV341 pPPDI1-pdi1-5 CEN, LEU2 This study 
pAV342 pPPDI1-pdi1-6 CEN, LEU2 This study 
pAV449 pPPDI1-pdi1-7 CEN, LEU2 This study 
pAV450 pPPDI1-pdi1-8 CEN, LEU2 This study 
pAV451 pPPDI1-pdi1-9 CEN, LEU2 This study 
pAV452 pPPDI1-pdi1-10 CEN, LEU2 This study 
pAV453 pPPDI1-pdi1-11 CEN, LEU2 This study 
pAV454 pPPDI1-pdi1-12 CEN, LEU2 This study 
pAV455 pPPDI1-pdi1-13 CEN, LEU2 This study 
pAV456 pPPDI1-pdi1-14 CEN, LEU2 This study 
pAV457 pPPDI1-pdi1-15 CEN, LEU2 This study 
pAV458 pPPDI1-pdi1-16 CEN, LEU2 This study 
pAV637 pPPDI1-pdi1-5 N-term CEN, LEU2 This study 
pAV644 pPPDI1-pdi1-5 C-term CEN, LEU2 This study 
pAV638 pPPDI1-pdi1-6 N-term CEN, LEU2 This study 
pAV645 pPPDI1-pdi1-6 C-term CEN, LEU2 This study 
pAV639 pPPDI1-pdi1-10 N-term CEN, LEU2 This study 
pAV642 pPPDI1-pdi1-10 C-term CEN, LEU2 This study 
pAV640 pPPDI1-pdi1-11 N-term CEN, LEU2 This study 
pAV646 pPPDI1-pdi1-11 C-term CEN, LEU2 This study 
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Figure 1.  Isolation of a pdi1 ts alleles.  (A) The pdi?  strain covered by PDI1 (pAV336) or the 
indicated pdi1 ts alleles (pAV337-pAV342, pAV449-pAV458) were plated on rich medium and 
incubated at 24 ˚C and 37 ˚C for 2 d.  (B) Growth curve of the pdi1? strain covered by pdi1 ts 
alleles at 24 ˚C (left panel) and 37 ˚C (right panel).  (?) ero1-1, (?) pdi1? PDI1, (?) pdi1? pdi1-6, 
(?) pdi1? pdi1-10, (?) pdi1? pdi1-11, and (?) pdi1? pdi1-16. 
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Figure 2.  Addition of oxidant rescues pdi1 ts alleles.  The ero1-1 (CKY598), pdi1? [pCS213] 
(AVY580) and pdi1? [pdi1 ts alleles] (AVY585-6, AVY590-1 and AVY596) strains were plated on 
rich medium containing increasing concentrations of diamide (D1 - 0.1 mM diamide, D2 - 0.25 mM 
diamide, D3 - 0.5mM diamide) and incubated at 37 ˚C for 3 d. 
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Figure 3.  Blocking the excess of GSH rescues the pdi1 ts alleles.  (A) Scheme of GSH 
biosynthesis.  (B) The pdi1? gsh1? PDI1 (AVY1018) and pdi1? gsh1? pdi1 ts alleles (AVY1019-
AVY1023) were plated on rich medium YPD and incubated at 37 ˚C for 3 d.  (C) The ero1-1 
(AFY397), pdi1? PDI1 (AVY580) and pdi1? pdi1 ts alleles (AVY585-6, AVY590-1 and AVY596) 
were plated on complete minimal medium containing BSO and incubated at 37 ˚C for 3 d. 
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Figure 4.  CPY transport is impaired in pdi1 ts alleles.  Wild type (CKY263), ero1-1 (CKY598), 
pdi1? [pCS213] (AVY580) and pdi1? [pdi1 ts alleles] (AVY585-6, AVY590-1 and AVY596) were 
shifted to the restrictive temperature of 38 ˚C for 1 h and pulse labeled with [35S]methionine for 10 
min, followed by a chase for the indicated times, and immunoprecipitated with CPY antibody. 
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Figure 5.  The pdi1-16 ts mutant accumulates the intracellular form of invertase.  Wild-type 
(CKY263), ero1-1 (AFY397) , kar2-159 (AVY etc) were shifted to the restrictive temperature of 38 
˚C for 1 h.  Intracellular invertase was detected by immunoblotting. 
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Figure 6.  The pdi1 ts alleles are required for oxidation of CPY.  Wild type (CKY263), ero1-1 
(CKY598), pdi1? [pCS213] (AVY580) and pdi1? [pdi1 ts alleles] (AVY585-6, AVY590-1 and 
AVY596) were shifted to the restrictive temperature of 38 ˚C for 1 h and pulse labeled with 
[35S]methionine for 10 min.  DTT was added to a final concentration of 5 mM to samples 3, 8 and 
11, 10 min before labeling.  Cells pellets were lysed under non-reducing conditions in the 
presence of 20 mM AMS (lanes 2-3, 5, 7-8, 10-11 and 13-14) or in the absence of AMS (lanes 1, 
4, 6, 9 and 12).  CPY was immunoprecipitated and samples resolved by non-reducing SDS-
PAGE. 
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Figure 7.  Isolation of mutaions of pdi1 ts alleles.  The pdi?  strain covered by PDI1 (pAV336) or 
the indicated pdi1 ts alleles (pAV637-646) were plated on rich medium and incubated at 24 ˚C 
and 37 ˚C for 2 d. 
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Figure 8.  The pdi1 ts alleles accumulate pdi1 ts-substrate complexes.  The pdi1? [pCS213] 
(AVY580) and pdi1? [pdi1 ts alleles] strains (AVY585-6, AVY590-1 and AVY596) or the pdi1? 
gsh1? [pCS213] (AVY1018) and pdi1? gsh1? [pdi1 ts alleles]  (AVY1019-23) were shifted to the 
restrictive temperature of 38 ˚C for 1 h.  Pdi1p was detected by immunoblotting. 
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Players in disulfide bond formation pathways: 
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Ero1-dependent and -independent disulfide bond formation pathways  
 
The main pathway of disulfide bond formation in the ER of S. cerevisiae uses two 
essential proteins, Ero1p and Pdi1p, that by means of a shuttle mechanism, transfer 
disulfide bonds to secretory proteins (Frand et al., 1998).  Recently, a second pathway 
has been defined, in which in the absence of Ero1p, overexpressed Erv2p can transfer 
oxidizing equivalents to Pdi1p (Sevier et al., 2001). In this thesis, the isolation and 
biochemical and structural characterization of Erv2p are described (Chapter 2).  The 
catalytic mechanism of disulfide transfer in Erv2p is described in detail in Chapter 3 and 
Chapter 4.  
 
Search for substrates of Erv2p 
 
When overexpressed, Erv2p can be found in mixed disulfides with Pdi1p (Sevier 
et al., 2001). Furthermore, recombinant Erv2p is able to oxidize Pdi1p in vitro, although 
this reaction is extremely slow.  For this reason, it is unclear whether Pdi1p is a 
physiological substrate of Erv2p (Sevier et al., 2001, and Chapter 3).  Besides Pdi1p, it is 
unknown whether there are other physiological substrates of Erv2p.  Intermediates of a 
disulfide exchange reaction are short-lived and difficult to observe; therefore, despite 
various efforts, other Erv2p substrate(s) are still unknown.   
Although in vitro studies (described in Chapter 3) suggested that Erv2p 
suppressor mutants are more promiscuous, it is also unknown if wild-type Erv2p and 
suppressor mutants share the same substrates in vivo or if wild-type Erv2p is a more 
specific oxidoreductase.  Mutants that are impaired in the resolution of mixed disulfides 
with substrate proteins have been used by other groups to find physiological substrates 
(Frand et al., 1999; Kadokura et al., 2004).  Some of the mutants designed in this study 
(see Chapters 3 and 4), such as Erv2p-E191A and Erv2p-CGA2C, have a slight defect in 
activity and might be useful for this end.  Identification of physiological substrates of wild-
type and suppressor mutant Erv2p will be valuable for our understanding of the 
mechanism of disulfide bond transfer and its specificity. 
 
The function of Erv2p: still a mystery 
 
The question concerning the physiological function of Erv2p still remains open.  
One interesting hypothesis is that in yeast, Erv2p acts in stationary phase when the ATP 
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and FAD levels drop and when the activity of Ero1p might be compromised.  It has been 
reported that the mRNA levels of Erv2p are increased during stationary phase (Stein et 
al., 1998). 
 
Erv2p homologs are involved in disulfide bond formation in non-ER locations 
 
 For a long time, the formation of disulfide bonds was viewed as a process that 
occurs exclusively in the ER.  The isolation of members of the QSOX/ERV family that are 
localized to non-ER compartments, such as the mitochondrial intermembrane space or 
the cytoplasm of virus-infected cells, changed this view.   
Recent studies showed that Erv1p, a member of the ERV/QSOX family that has 
FAD-dependent sulfhydryl oxidase activity, together with Mia40p, oxidizes proteins in the 
intramembrane space of the mitochondria (Mesecke et al., 2005; Rissler et al., 2005; 
Tokatlidis, 2005).  The importance of Erv1p function is indicated by the fact that it is an 
essential gene necessary for the proper function of the mitochondria (Lange et al., 2001; 
Lisowsky, 1994). Both flavin and GSH play a role in the ER disulfide bond formation 
pathway, but it is still unknown whether these factors play a role in the disulfide bond 
formation pathway in the mitochondria as well.  Interestingly, there is a flavin transporter, 
FLX1, and a GSH transporter system in mitochondria (Bafunno et al., 2004; Rebbeor et 
al., 1998; Tzagoloff et al., 1996). 
A pathway for disulfide bond formation in viral proteins in the cytosol of the host 
cell is also performed by a homolog of Erv2p named E10R (Senkevich et al., 2000).  It is 
currently unknown how disulfide bond formation can occur in such a reducing 
environment.  Surely, future studies will reveal new mechanisms of disulfide bond 
formation in other cellular compartments. 
 
How is FAD transported into the ER lumen? 
 
Both Ero1p and Erv2p are FAD-dependent oxidoreductases (Sevier et al., 2001; 
Tu et al., 2002).  One interesting question is how the FAD is transported into the ER to 
fulfill the requirements of Ero1p and the sulfhydryl oxidase Erv2p.  Since the ER 
membrane seems to be impermeable to free FAD, the existence of a FAD transporter 
has been suggested but its identity is still unknown (Tu et al., 2002). 
 
ER redox homeostasis and oxidative folding 
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The activities of Ero1p and Erv2p are directly linked with the formation of H2O2 
(Gross et al., 2006; Sevier et al., 2001).  Thus, inappropriate oxidation of substrates or 
heavy load of protein thiols in the secretory pathway would lead to increased H2O2 
formation, which could be very damaging to the cell.  Lowering the levels of Ero1p in C. 
elegans by RNAi eliminates the significant accumulation of peroxides in the cell due to 
ER stress (Harding et al., 2003). 
A remaining challenge is to discover how the ER copes with this oxidative stress 
and how this information is integrated into other related signaling pathways.  In Chapter 
3, I discuss a mechanism of shuttle of disulfides between two cysteine pairs in Erv2p that 
seems to confer specificity to disulfide transfer to substrate proteins, which is also used 
by Ero1p (Sevier et al., 2006).  Regulating the activity of these enzymes. can be used to 
control the amount of ROS produced.  Another potential mechanism to control ROS 
production is by the enzymatic removal of H2O2; thus there may be a catalase in the ER, 
which would disprotonate H2O2. 
 
Specificity in disulfide transfer - variations on a theme 
 
Transfer between two cysteine pairs is a conserved mechanism of some thiol 
disulfide oxidoreductase such as Ero1p, Erv2p and DsbB.  In general, specificity of 
disulfide transfer reactions can also be achieved in various other ways.   
DsbB, a transmembrane protein involved in disulfide bond formation pathways in 
E. coli, preferentially oxidizes DsbA, a monomeric protein, and not DsbC or DsbG, which 
are dimeric proteins.  Converting DsbC into a monomeric protein, by mutation of residue 
Gly49 to Arg or Glu or by truncating the N-terminal domain (which is necessary for 
dimerization), allows DsbC to become a substrate of DsbB (Bader et al., 2001). 
High MW thioredoxin reductase and glutathione reductase have the same fold, 
except that the former has a C-terminal tail containing a second redox cysteine pair 
(Sandalova et al., 2001). GSSG is the natural substrate of glutathione reductase, yet 
GSSG is not a substrate for high MW thioredoxin reductase. A comparison between the 
crystal structure of these two enzymes revealed that the residues involved in GSH 
binding are conserved in both structures.  However, the presence of the C-terminal tail in 
thioredoxin reductase prevents interaction of GSSG with the active site cysteines by 
blocking access to them (Sandalova et al., 2001). 
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Thus, specificity of disulfide bond formation has evolved in various ways, and 
future studies will likely reveal other mechanisms. 
 
Is there an isomerization pathway in yeast?  PDI, GSH or an uncharacterized 
reductase - who's to blame? 
 
The E. coli disulfide bond isomerization pathway has been fairly well 
characterized: the periplasmic membrane protein DsbD gives reducing equivalents to the 
soluble periplasmic protein DsbC, which shuffles disulfide bonds in protein substrates 
until the native conformation is achieved (Rietsch et al., 1996).  In contrast, the precise 
mechanism and players of the disulfide bond isomerization pathway in the ER have not 
been identified. 
It is still in debate whether the reduced form of Pdi1p (or Pdi1p containing only 
one of the Cys-X-X-Cys motif reduced) can function as an isomerase (Tian et al., 2006).  
If so, and if indeed there is an analogous pathway of isomerization in the ER, it is 
possible that either glutathione or an uncharacterized ER reductase may be responsible 
for maintaining a portion of Pdi1p in the reduced form, allowing it to function as an 
isomerase in vivo.  The other possibility is that Pdi1p is not involved in the isomerization 
pathway in the yeast ER and that glutathione or an uncharacterized ER reductase is 
responsible for this activity.   
To study disulfide bond isomerization in the yeast ER we need to find a secretory 
marker protein that contains at least two disulfide bonds.  Carboxypeptidase Y is a good 
model, since it contains 11 cysteines and therefore has numerous potential disulfide 
bond connectivities.  As it traverses the secretory pathway it acquires various post-
translational modifications that allow the various forms to be differentiated by SDS-
PAGE. Furthermore, it has been shown that under hyperoxidizing conditions (e.g. 
treatment of yeast cells with the thiol oxidant diamide) proteins that contain reactive 
thiols, such as CPY, are withheld in the ER in oxidized form (p1 form) likely to contain 
inappropriate intra- or intermolecular disulfide bonds, while the intracellular transport of 
proteins without cysteines, such as prepro-?-factor, proceeds with normal kinetics 
(Cuozzo et al., 1999).  Therefore, the ability of the cell to isomerize disulfide bonds can 
be easily assayed.  The oxidative folding of misoxidized CPY can be assessed in cells 
deficient in glutathione, Pdi1p or any of the Pdi1p-homologs to test whether each is 
involved in the isomerization pathway. 
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Role of PDI homologs? Different specificity? 
 
Despite the increasing number of PDI family members and the large number of 
reports being made in the last five years, there are still a lot of questions regarding the 
physiological role of these proteins, their mechanism of action and their substrates.  For 
example, the yeast ER contains five PDI-like proteins, namely Pdi1p, Eug1p, Mpd1p, 
Mpd2p and Eps1p (Norgaard et al., 2001). Their role in disulfide bond formation and their 
substrate specificity is still unknown. 
Recent studies suggest that PDI homologs may participate in discrete protein 
maturation pathways.  ERp57 promote disulfide bond formation in glycoproteins, 
including MHC class I, thought the interaction with lectin chaperones calnexin and 
calreticulin (Ellgaard et al., 2003).  Furthermore, preferential expression of members of 
the human PDI family in different tissues, suggests these proteins contribute the folding 
of tissue specific proteins.  For example, PDIp, EndoPDI, and PDILT are highly 
expressed in pancreas, endothelia, and testis cells,  respectively (Sullivan et al., 2003; 
van Lith et al., 2005; Volkmer et al., 1997). 
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